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The development, use, and understanding of severity of illness scoring systems has 
advanced rapidly in the last decade; their weaknesses and limitations have also 
become apparent. This work follows some of this development and explores some 
of these aspects. It was undertaken in three stages and in two countries. The first 
study investigated three severity of illness scoring systems in a general Intensive 
Care Unit (ICU) in Cape Town, namely the Acute Physiology and Chronic Health 
Evaluation (AP ACHE II) score, the Therapeutic Intervention Scoring System 
(TISS), and a locally developed organ failure score. All of these showed a good 
relationship with mortality, with the organ failure score the best predictor of 
outcome. The TISS score was felt to be more likely to be representative of 
intensiveness of medical and nursing management than severity of illness. The 
AP ACHE II score was already becoming widely used world-wide and although it 
performed less well in some diagnostic categories (for example Adult Respiratory 
Distress Syndrome) than had been hoped, it clearly warranted further investigation. 
Some of the diagnosis-specific problems were eliminated in the next study which 
concentrated on the application of the AP ACHE II score in a cardiothoracic 
surgical ICU in London. Although group predictive ability was statistically 
impressive, the predictive ability of AP ACHE II in the individual patient was 
limited as only very high AP ACHE II scores confidently predicted death and then 
only in a small number of patients. However there were no deaths associated with 
an AP ACHE II score of less than 5 and the mortality was less than 1 % when the 
APACHE II score was less than 10. 
vi 
Finally, having recognised the inadequacies in mortality prediction of the AP ACHE 
II score in this scenario, a study was undertaken to evaluate a novel concept: a 
combination of preoperative, intraoperative, and postoperative (including 
AP ACHE II and III) variables in cardiac surgery patients admitted to the same 
ICU. The aim was to develop a more precise method of predicting length of stay, 
incidence of complications, and ICU and hospital outcome for these patients. 
There were 1008 patients entered into the study. There was a statistically 
significant relationship between increasing Parsonnet (a cardiac surgery risk 
prediction score), APACHE II, and APACHE III scores and mortality. By 
forward stepwise logistic regression a model was developed for the probability of 
hospital death. This model included bypass time, need for inotropes, mean arterial 
pressure, urea, and Glasgow Coma Scale. Predictive performance was evaluated 
by calculating the area under the receiver operating characteristic (ROC) curve. 
The derived model had an area under the ROC curve 0.87, while the Parsonnet 
score had an area of0.82 and the APACHE II risk of dying 0.84. It was concluded 
that a combination of intraoperative and postoperative variables can improve 
predictive ability. 
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Chapter 1 Introduction and aims 
CHAPTER 1 
Introduction and aims of the thesis 
1.1 Introduction and general comments 
Clinical prediction is an ancient medical art that has only recently developed a 
scientific aspect. This has been largely shaped by three elements, namely the 
construction of large patient databases, the use of multiple logistic regression and 
other statistical tests to analyse these databases, and the ready availability of 
microcomputers and sophisticated software to perform these analyses (Ephron & 
Tibshirani 1991 ). In the last decade predictive indices have proliferated, mainly in 
conjunction with or as an offshoot of severity of illness scoring. 
Outcome prediction has become particularly important in critical care medicine 
with patients and their families expecting a high degree of accuracy in this respect, 
although accuracy has probably become more difficult in recent years as modern 
life-support technology becomes more successful in delaying death than restoring 
health. It has therefore become more important to stratify patients at an early stage 
into those with reversible conditions who can be saved and those who will 
inevitably die. In addition the cost of medical care is extremely high, with the mean 
daily cost of survivors in an Intensive Care Unit (ICU) in the United Kingdom (the 
country where two parts of this study were carried out) being £550 and that 
nonsurvivors £816 (Ridley et al 1993 ). Cost has increased dramatically in the last 
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decade (Jacobs & Noseworthy 1990), with much of the expenditure occurring in 
the ICU setting and in the last few weeks or months oflife. More recently cost has 
been highlighted by the development of new and expensive drugs and life support 
devices, such as monoclonal antibodies for sepsis, and Intravenacaval Oxygenation 
(IVOX) for ARDS. Many more will surely follow. 
These developments have emphasised the need for accurate prediction of severity 
of disease, both for optimal patient care and appropriate resource utilisation in an 
era of shrinking medical funding, and also for acceptable scientific evaluation of 
these new therapeutic modalities. In addition, it has been postulated that we are in 
the midst of the "third revolution" in medical care, namely the era of assessment 
and accountability (Reiman 1988). Severity scoring systems have been developed 
in this setting; they are now regarded by many as prognostic indicators and there 
has inevitably been much confusion and unrealistic expectation about their abilities 
which has led to inappropriate use in many instances. It is not generally realised 
that the technology is still evolving, and that the needs of physicians may have 
moved forward faster than the technology and its understanding. Indeed, although 
predictions for patient groups are good, the effectiveness of severity scores in 
predicting individual outcome has been clearly shown to be less useful (Schafer et 
al 1990). 
Clinical judgement has long been the benchmark by which medical decision making 
has been measured. This has been based upon clinical experience, from which 
many valuable medical traditions and clinical aphorisms have arisen. It is therefore 
2 
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not surprising that predictive indices have met with some suspicion and there has 
been both reluctance to use them and fears that their use will negate clinical skills. 
This is not entirely unjustified as predictive indices will never be able to cater for all 
aspects of the clinical picture, will not always be able to assign the appropriate 
importance to certain variables, may not precisely fit the clinical scenario, and may 
not take into account newer therapies. They also cannot take account of common 
sense or "gut feeling". Although it is reassuring to have numerical data and 
accurate statistics to back a decision, it is important to remember that ( as 
commented in an editorial on TPN and AP ACHE II scoring in The Lancet), 
"statistics should be used as the drunken man uses the lamppost - for support 
rather than illumination" (Anonymous 1986). 
1.2 Aims of the thesis 
1.2.1 Study 1 
The first study aimed to evaluate the application and usefulness of three severity of 
illness scoring systems in a general ICU. These included the AP ACHE II score 
(which was newly developed at the time), TISS (recently updated at the time), and 
an organ failure score which had been empirically derived locally. 
1.2.2 Study 2 
Recognising some of the diagnosis-specific problems of severity scoring systems, 
the second study aimed to take the theme of AP ACHE II scoring further by 
3 
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evaluating its predictive value in more detail and in a more homogeneous setting, 
namely a cardiothoracic ICU. 
1.2.3 Study 3 
Having found difficulties in predicting outcome in individual cardiothoracic surgery 
patients, the third study aimed to use a novel combination of preoperative, 
intraoperative, and postoperative predictive indices (including AP ACHE II and III 
scores) to develop a better prognostic index for cardiac surgical patients, and to 
develop a predictive index for length ofICU stay and for the occurrence of 
complications. 
4 
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CHAPTER 2 
Literature review. Severity scoring in general intensive care 
2.1 Scope and mode of the literature review 
2.1.1 Scope of the literature review 
This literature review concentrates on the more frequently cited references in major 
medical journals in two main areas, namely general scoring systems in Intensive 
Care (discussed in Chapter 2) and predictive indices for cardiac surgery (discussed 
in Chapter 3). It examines their history, rationale, ethical applications, principles of 
development, and clinical and research utilisation. The emphasis on the Acute 
Physiology And Chronic Health Evaluation (AP ACHE) scoring system and its 
derivatives is deliberate and is due to the extensive research that has gone into each 
of its developments, and to the number of publications about its use. 
This review mentions only briefly specialised scoring systems for specific 
conditions, while abstracts of papers or posters presented at scientific meetings are 
not included, unless they are particularly important or are known to have been 
submitted for publication and are in press. In addition, only some of the more 
recent references were felt to be relevant in the field of cardiac surgery, as the 
indications, techniques, and results have changed so significantly in the past two to 
three decades. 
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2.1. 2 Mode of the literature review 
A search was made of Index Medicus by the CD Plus software on CD ROM in 
December 1992 and again in June 1994. The following key words were found in 
various combinations to produce the broadest yet most specific search: 
• Intensive care units 
• Critical care 
• Coronary artery bypass (adverse effects, mortality, statistics, trends, utilisation) 
• Severity of illness index 
• APACHE 
• Medical audit 
The search was limited to human studies, those published in the English language, 
and adult patients (including middle age and aged). It included the years 1976-
1993. Further references were found by review of the bibliographies in the selected 
papers, by careful scanning of the current literature, and by communication with 
experts in the field of severity scoring systems. More than 600 references were 
found in this way and the more important ones were selected as mentioned above. 
2.2 History of scoring systems 
2. 2.1 Basic principles of predictive indices 
Although relatively new in critical care (which is itself fairly new), predictive 
indices have been in use for many years, with conditions for fair comparison 
between clinical judgement and predictive indices having been specified at an early 
stage (Meehl 1954). Their evaluation and application have been fully reviewed and 
6 
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contrasted in a wide variety of clinical scenarios (Shapiro 1975, Wasson et al 1985, 
Dawes et al 1989). The conclusions varied, and may well be related to the timing 
of the papers. The first author assessed the skill of rheumatologists in predicting 
certain clinical outcomes regarding creatinine clearance, biopsy results, and serum 
complement levels (but not death) in patients. He presented a formula for 
measuring predictive accuracy and by this method found that statistical algorithms 
were not as accurate as the best physicians tested (Shapiro 1975). The second 
paper reviewed published reports of clinical prediction rules and found that the 
prediction rules, patients, and clinical setting were often inadequately defined. 
They warned that this inattention to basic principles might cause the objectives of 
these indices to not be achieved (Wasson et al 1985). Three potential deficiencies 
in study design might affect the validity of a prediction rule. These were poor 
definition of the outcome event, imprecise definition of the predictive findings, and 
failure to blind the investigator who assigns the diagnosis. 
The last study was a broad overview comparing the predictive index ( actuarial 
method) with clinical judgement in a variety of circumstances (Dawes et al 1989). 
In the actuarial method human judgement is eliminated and conclusions are 
dictated by the relationship between established data and the condition 
investigated. Examples given included the distinction between neurosis and 
psychosis, the diagnosis of progressive brain dysfunction based on intellectual 
testing, and the prediction of survival time following the diagnosis of Hodgkin's 
disease. The actuarial method was shown to be superior in these and other 
scenarios. Resistance to the actuarial method certainly exists; the authors describe 
it as irrational and abusing the basic principles of probability. Subsequent studies 
7 
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comparing clinical assessment with AP ACHE II and III scoring are reviewed 
below. 
2.2.2 Defining the outcome measure 
This thesis concentrates on mortality which is a binary variable and therefore much 
simpler to define than quality oflife. However it may be argued that quality of life 
(rather than simple survival) measured at some point after ICU discharge is the 
most useful measure of the effectiveness ofICU therapy, as it would be 
counterproductive to put severely handicapped individuals back into the 
community. No scoring system has been designed to predict quality of life, 
although there is no shortage of instruments to measure this entity. Some of the 
more recently developed and general indices include the Sickness Impact Profile 
(Bergner et al 1981 ), and the Uniscale (Spitzer et al 1981 ). 
Quality of life has been measured following intensive care, but the studies are 
difficult to compare as they differ in methods, patients, and follow-up time. Some 
of them are briefly reviewed. One year after ICU discharge 60% of those 
previously employed had returned to work (Goldstein et al 1986), while in another 
study performed at the same time interval 44% of patients had returned to their 
normal pre-hospital activity (Dragsted & Qvist 1989c). Also at one year, there 
was little difference in activities of daily living between elderly and young patients 
(Rockwood et al 1993). In a further study, 62% of patients not retired or home-
makers were working between 16 and 20 months after ICU discharge (Sage et al 
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2. 2. 3 Early scoring systems 
Early accounts of predictive indices in intensive care are scanty. The Therapeutic 
Intervention Scoring System (TISS), an important landmark which appeared in its 
first form in 1974 (Cullen et al 1974), is fully reviewed below. The same author 
identified physiological abnormalities as being significantly related to mortality; it 
was also recognised that it was becoming possible to document results of intensive 
care in comparable groups of patients (Cullen 1977). Thibault et al identified the 
aged and chronically ill as the major consumers of intensive care, noted that 
mortality was high in the aged (more so in the long-term than in the short-term), 
and concluded that there was a need to identify further predictors of mortality 
(Thibault et al 1980). An early predictive model for ICU patients (the Condition 
Index Score) was developed in 1981 (Snyder et al 1981 ). This used regression 
analysis to weight a variety of "conditions" that might occur in ICU patients, and 
to formulate a model to calculate probability of survival. The patient numbers 
were small (455 patients in the estimation group and 43 in the verification group) 
and the number of conditions was large (225 potential conditions of which 195 
were actually observed). It is not an easy or practical score, but the most 
important part of the study was probably the recognition that such scores could be 
used to establish objective criteria for admission and discharge to ICU, compare 
the quality of care between ICUs, be used as a basis for multicentre studies, and to 
establish appropriate numbers oflCU beds for a hospital or region. These 
principles are equally important today. AP ACHE was also published in 1981 
(Knaus et al 1981 ); the development of modem scoring systems began here and 
will be followed in detail below. 
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2.3 Rationale and ethics of scoring systems 
2. 3.1 Ranonale of scoring systems 
The original aim of AP ACHE was to classify groups of p
atients according to 
severity of illness (Knaus et al 1981 ). The authors felt thi
s could be useful in 
comparing outcome, evaluating new technology, and plan
ning for ICU needs. The 
ability of AP ACHE II to calculate a disease-specific risk o
f dying for the individual 
patient (Knaus et al 1985a) by a logistic regression equati
on led the way for the 
goal of severity of illness scoring to become mortality pre
diction. This 
unfortunately has led to much misunderstanding and disap
pointment: the ability of 
a scoring system to predict mortality for a group of patien
ts cannot be extrapolated 
to individual patient predictions. Nevertheless, most seve
rity of illness scoring 
systems can be appropriately used for comparison of ICU
 results, adjusted for 
diagnosis and severity of illness. They can also be used fo
r stratification of patients 
into randomised trials. 
For mortality prediction models to improve medical care,
 they ideally need the 
following characteristics (Selker 1993 ). 
1. They should be accurate and easy to use in the clinical
 setting. In addition they 
should have the same mortality prediction when used pro
spectively as when used 
retrospectively. 
2. Mortality risk should be predictable from data availabl
e in the first minutes of 
hospital admission. 
3. Hospitalisation should not affect the mortality predicto
r. 
4. They should require only data that are collected in the
 usual care of the patient. 
10 
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5. They should use only objective and universally collected information. 
6. They should not be susceptible to differences in ICU admission policies and 
practice. 
7. They should be accurate at all levels of mortality risk i.e. be well calibrated. 
8. They should not add to the burden of hospital record-keeping. 
9. They should be open to inspection and testing. 
These characteristics are presently met by no scoring system currently available 
although the more recently developed AP ACHE III, Simplified Acute Physiology 
Score (SAPS) II, and Mortality Probability Model (MPM) II go some way towards 
meeting them. Nevertheless they give excellent (if ambitious) guidelines and 
direction for further development. 
2. 3. 2 Prediction and probability 
It is important to separate the concept of prediction from that of probability (all 
current ICU severity systems provide estimates of the probability of hospital 
mortality). Prediction is a binary variable: the patient is predicted either to live or 
to die. On the other hand, probability expresses a risk for a group of patients. For 
the individual patient this may not be particularly useful as even when the 
probability of death is for instance 0. 99, one cannot say whether any specific 
individual patient will be one of 99 patients expected to die or the single patient 
expected to live. That predictive indices work at all is in fact unexpected, as 
general chaos theory shows that "predictability is the exception rather than the 
rule" (Firth 1991). 
11 
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The conversion of a probability to a prediction may be based on a decision rule to 
divide the range of probabilities into dichotomous groups of "predicted to live" and 
"predicted to die". The usual cutpoint for this is a probability of 0. 5, but any other 
cutpoint could be used instead. 
2. 3. 3 Ethics and the application of severity scoring systems 
A certain proportion ofICU deaths will follow some restriction of therapy; 39% of 
ICU deaths in 7265 admissions were preceded by DNR (Do Not Resuscitate) 
orders (Zimmerman et al 1986), while 45% of deaths in another ICU study were 
preceded by withdrawal of therapy (Smedira et al 1991 ). The principal reason for 
the decisions in the latter study was the clinical impression of a poor prognosis; 
there was no mention of predictive indices being used. 
Policy statements on withholding and withdrawing mechanical ventilation issued by 
the National Institutes ofHealth (NIH Workshop summary 1986) and on life-
sustaining therapy by the American Thoracic Society (American Thoracic Society 
1991) and Stanford University (Ruark et 1988) have clarified many of the most 
controversial issues in these areas, but although they make some powerful 
statements, they do not go into specific details of when and how to withhold or 
withdraw therapy. Current practices worldwide may be guided by these statements 
but the patient selection and actual withdrawal practices probably differ. The 
principal medical reasons or justification for withdrawal of life support include 
brain death (Black 1978, Pallis 1983), severe neurological dysfunction after 2-7 
days of intensive care (Levy et al 1981, Levy et al 1985, Jennett et al 1979), and 3 
or more organ failure after 3 or 4 days of organ failure (Knaus et al 1985b ). More 
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sophisticated computer-generated prognostic indices exist (Chang et al 1988, 
Knaus et al 1991a) but are presently not widely available. Occasionally a severe 
but not in itself fatal illness in a patient with chronic ill-health will result in 
withdrawal of life support although the more usual circumstance is that such 
therapy would not be initiated. In addition there are many subsets of patients in 
whom mortality is known to be very high from the evidence in published studies; 
this information may be used to help make withdrawal decisions (Osborne 1992). 
The definitions, legal opinions, and policy statements that guide current practice 
are constantly changing (Luce & Raffin 1988, Teres 1993) and presumably will 
continue to evolve. 
There is always the possibility that clinical application of predictive indices without 
due caution will simply cause the predictions they make to be self-fulfilling and 
thereby perpetuate the impression that they are perfectly calibrated and mistakes 
are not being made. An editorial following the paper of Levy et al on prognosis in 
hypoxic-ischaemic coma (Levy et al 1985) strongly warned against using hypoxic-
ischaemic coma outcome data to make clinical decisions (Black 1985). 
It would appear that availability of predictive indices has already been shown to 
alter patient management in patients with head trauma (Murray et al 1993), and in 
general ICUs (Knaus et al 1990). In the former study, provision of a predictive 
index caused less aggressive therapy to be used in patients with a poor prognosis 
and more active therapy to be used in those with a good prognosis. On a similar 
note, in the latter study, when feedback was provided on patients with 3 or more 
organ-systems in failure (Knaus et al 1985b ), there was a small but significant 
increase in decisions to stop active treatment, while ICUs that did not participate in 
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the feedback showed no change in decision making. The authors claimed, 
however, that it was difficult to eliminate other influences. The ethical 
appropriateness of using prognostic scoring systems in clinical management has 
been recently reviewed (Luce & Wachter 1994). 
Already physiology based severity scores can be mathematically calculated by 
direct input of variables from both the patient monitoring system ( data from which 
need to be verified by a nurse to eliminate artefacts) and laboratory computers. A 
score is thereby automatically generated. In the case of AP ACHE III, a prognostic 
estimate can be produced on line and in real time if one has the right hardware and 
software (APACHE Medical Systems Inc.), as has been pictorially demonstrated 
(Knaus et al 1991 b). This facility is not widely available but it is of great concern 
that the prognostic estimate so given may influence both management decisions 
and the attitude of medical and nursing staff towards patients. 
2.4 Principles of development of scoring systems 
The steps needed for the development of a scoring system have now been clearly 
defined (Kollef & Schuster 1994 ). They can be listed as follows: 
1. Selection of the outcome variable. 
2. Selection of the patient population. 
3. Selection of variables as risk factors. 
4. Collection and analysis of the database so acquired. 
5. Statistical development of the prediction model. 
6. Validation of the model. 
7. Evaluation of the model's impact and utility. 
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8. Updating of the system. 
The "new generation" (AP ACHE Ill, MPM II, SAPS II) of severity scores are 
based on these sound principles. 
2.4.1 Dynamic vs static scores 
Dynamic scores are scored on consecutive days ( and may use some comparison 
between the daily scores) while static scores are based on a single day's data. 
There are several reasons why day one scoring alone may be inadequate for 
outcome prediction (Chang et al 1988): 
1. The pathophysiology of disease is a dynamic process and cannot be fully 
assessed by a single day's measurements. 
2. The development of complications and organ-system failure have important 
prognostic implications. 
3. Major clinical decisions should not be based on a single assessment. 
The vast majority ofICUs do not have the resources to collect scores on 
consecutive days of a patient's admission, making the debate somewhat academic. 
However, automated data collection by data management systems is already 
achievable and, if the high price falls, may become widely available in the not too 
far distant future. Automated scoring and outcome prediction could be 
simultaneously developed ( as has already happened with AP ACHE III), making 
dynamic scoring systems easily accessible. 
The development of a dynamic scoring system based on AP ACHE II and organ-
system failure is discussed below. AP ACHE III is also meant to be scored daily 
and risk estimates are thereby updated. No other scoring systems are dynamic in 
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nature although :tvfl>M has a separate model to be applied at 24 hours and there are 
further models being developed (Lemeshow et al 1993). 
2.4.2 Physiological vs binary variable scores 
AP ACHE and SAPS are based on abnormal physiology, while :tvfi>M is based on 
the presence or absence of binary variables. Physiological variables are routinely 
collected and are familiar to most observers with their abnormalities ( and the 
degree and implications of those abnormalities) being easily recognised. Binary 
variables are simply either present or absent, and they stand or fall by the ease of 
application of their definitions. Early examples of scores based on binary variables 
are the Goldman index to predict cardiac complications in patients undergoing 
noncardiac surgery (Goldman et al 1977) and the asthma severity score (Fischl et al 
1981). Many of the variables comprising both these scores were subjective clinical 
variables, subject to interobserver bias. In addition, misclassification of a single 
variable resulted in a large error in prediction. 
The variables in the more recent :tvfi>M are much more objective, with well 
explained definitions in the text (Lemeshow et al 1993 ). In addition, there are 15 
and 13 variables in the admission and 24 hour models respectively, which would 
lead to a smaller error if any single variable were misclassified. 
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2.5 APACHE: development and refinements 
2.5.1 APACHE 
The forerunner of current severity of illness sc
oring systems was AP ACHE 
(acronym for Acute Physiology And Chronic H
ealth Evaluation), which was 
introduced in 1981 (Knaus et al 1981 ). Seven
 experienced physicians combined 
their wisdom to agree on 34 physiological var
iables likely to reflect severity of 
illness, assigning each a weight from O to 4 de
pending on the degree of 
derangement from normal. These variables in
cluded simple and routine 
measurements such as temperature, heart rate
, and blood pressure, as we11 as less 
routine ones like serum lactate, ECG abnorma
lities, and serum osmolarity. To this 
was added a preadmission health evaluation to
 derive the AP ACHE score. The 
score was well correlated with mortality in 58
2 admissions to a university hospital 
ICU and 223 admissions to a community hosp
ital ICU. Full statistical validation 
for APACHE has been presented (Wagner et 
al 1983). Although APACHE was 
both novel and logical in its concept, it was im
practical for routine use because of 
the large number of physiological measuremen
ts (many of which were not routinely 
performed) that had to be collected. 
2.5.2 APACHE II 
It was thus the much slimmed-down AP ACHE
 II score published in 1985 (Knaus 
et al 1985a) that rapidly gained widespread ac
ceptance and that has become 
extremely widely used in both general ICUs an
d those managing specific clinical 
problems. AP ACHE II evaluates the deviatio
n from normal of 11 physiological 
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variables ( similar to the original AP ACHE, each variable scoring O points if within 
the normal range and from 1 to 4 points as the deviation from normal increases); it 
also includes the Glasgow Coma Scale, and allocates points for age and chronic 
health. The selected variables were the smallest number that reflected 
physiological derangement of all organs and still maintained statistical precision. 
Full details of these variables and the method of application of AP ACHE II appear 
in Chapter 4. AP ACHE II has now been validated worldwide. However in no 
study has AP ACHE II been accurate enough to confidently predict outcome in the 
individual patient, even though it has the ability to calculate a disease-specific risk 
of dying for the individual patient. AP ACHE II is easy to use, needing only simple 
physiological measurements and routinely performed blood tests, and all the 
information needed to do so is available in the original paper, although there are 
parts of the methodology that are problematic ( see below). AP ACHE in all its 
developments has been thoroughly reviewed (Wong & Knaus 1991, Wisner 1992). 
2.5.2.1 Other uses of APACHE 11 
2.5.2. 1. 1 Standardised mortality ratio (SMR) 
The calculation of a disease-specific risk of dying for the individual patient allows 
the comparison between predicted deaths and actual deaths (standardised mortality 
ratio or SMR) and thereby can contrast the performance of different hospitals 
while taking into account severity of illness (Knaus et al 1986). The performance 
of this function in 5030 patients from 13 USA hospitals showed a wide variation in 
SMRs (from 0.59 to 1.58, P<0.01) and allowed for the identification of positive 
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and negative features in the participating ICUs. The variations in performance 
appeared to be principally related to the structure, interaction, and coordination of 
the medical and nursing staff In particular, a full-time unit director, controlling 
policy for therapy as well as for admission and discharge, and 24 hour in-unit 
physician coverage, seemed to be important. From the nursing side, important 
factors were adequate staffing, continuity of care, and a consistent senior charge 
nurse. 
The SMR may be the only way to adjust results of intensive care according to 
severity of illness. However, just like the equation for risk of dying (from which it 
is of course derived) it relies heavily on the correct reason for admission being 
chosen, and this is not always easy. Lead-time bias (discussed below) may also 
alter mortality rates and hence the SMR. 
2. 5. 2. 1. 2 Identification of low risk patients 
Another use of AP ACHE II scoring has been identifying patients at low risk of 
requiring any ICU intervention other than monitoring (Wagner et al 1987). A risk 
threshold of the Acute Physiology Score component of the APACHE II score was 
derived for three primary categories ofICU admission ( elective surgery, emergency 
surgery, and nonoperative). This application was remarkably successful with only 
4.4% of the validation sample patients identified as low-risk actually receiving 
active treatment. AP ACHE II could therefore be used to guide more appropriate 
utilisation ofICU facilities. 
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2.5.2.1.3 Cost analysis and quality control 
The cost of the first day ofICU management was significantly related to the 
AP ACHE II score in a United Kingdom study of 90 general ICU patients (Ridley 
et al 1993); a simple model was developed to predict the cost of the first day in 
ICU from the AP ACHE II score. In contrast to this finding, AP ACHE II was 
found to be unsuitable for cost containment and quality assurance in a much larger 
USA study of 372 surgical ICU patients, as grouped APACHE II scores did not 
correlate with total hospital charges or length of ICU stay (Civetta et al 1990). 
These differences may be explained by the size of the studies, the types of patient, 
or by different medical practices and costs in the respective countries (Osborne & 
Evans 1994). 
2.5.2.1.4 Allocation of funding 
In order to confirm anecdotal evidence that patients admitted as emergencies for 
acute chest problems to a United Kingdom hospital had become more ill between 
1985 and 1990, AP ACHE II scoring was rather ingeniously used. The 1990 
AP ACHE II scores were significantly higher than those of 1985 and enabled the 
medical services to obtain an extra £ 100000 of funding from the authorities (Irwin 
& Jessop 1993). 
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2.5.2.2 Criticisms and problems with APACHE II 
2.5.2.2.1 Interpretation of the methodology 
There are many pitfalls in the precise interpretation of the method of scoring; a 
recent paper outlines and clarifies some of these (Palazzo & Patel 1993). They 
include difficulties with definitions of variables (see Chapter 4) but most 
importantly, difficulty in defining a single reason for ICU admission (an important 
factor in the equation for risk of dying). These differences in interpretation may 
lead to very different scores being obtained for the same patient by different data 
collectors. 
2.5.2.2.2 lnterobserver variability 
Although interobserver variability between AP ACHE II data collected by residents 
and nurses is statistically small in groups of patients, there may be a significant 
variability in the individual patient (Holt et al 1992). In their study evaluating 
AP ACHE II scoring in 120 consecutive patients, the scores of residents and nurses 
differed in 79 patients. In most, but not all cases, the differences were small. The 
most common causes of error were incorrect choice of highest or lowest value as 
the worst, and error in Glasgow Coma Scale score. 
2.5.2.2.3 Timing of scores 
A criticism that has been made of the AP ACHE II method is that early and efficient 
treatment (e.g. in an operating theatre or Accident and Emergency department) 
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correct physiologic abnormalities and make the score lower than it would have 
been and therefore invalid for prognostic purposes. The data on this issue is 
contradictory. One study using data collected on 756 patients either in the 
Accident and Emergency unit or immediately on admission to ICU showed that 
AP ACHE II scored this way significantly underestimated mortality in drug 
overdose and trauma (Waters et al 1990). In other words, the scores were lower 
than would have been expected with the observed mortality (this observation may 
also be interpreted as showing that the AP ACHE II coefficients are not validated 
for admission scoring). Another study compared emergency room and 
conventional ( worst over the first 24 hours) AP ACHE II scores in trauma patients 
(McAnena et al 1992). In this case the conventional scores were significantly 
lower than those obtained in the emergency room. 
2.5.2.2.4 Use of admission scores 
In a subset of patients from the original AP ACHE II database, the worst 
physiological value over the first 24 hours was also the admission value (Knaus et 
al 1985a). Although the full admission AP ACHE II scores were close to the worst 
scores, they were not identical and the authors recommended that worst values 
should continue to be used. 
The use of admission scores throughout the patient's ICU admission may not 
reflect events that occur subsequent to admission. This has been highlighted in a 
study in which multivariate analysis was carried out to determine patient variables 
associated with outcome (Ferraris & Propp 1992). The occurrence of iatrogenic 
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complications, renal failure, or sepsis were all significantly associated with 
mortality, more so than the admission AP ACHE II score. 
The predictive accuracy of AP ACHE II appears to decrease with the length of time 
a patient stays in the ICU. Predicted and actual outcomes were compared in 
patients grouped according to their length ofICU stay. Using a risk of death of 
0.4 as a cutoff point (patients with a risk ofless than 0.4 were predicted to live, 
and those with a risk greater than 0.4 were predicted to die), the misclassification 
rate was 1 1. 6%-15. 7% for patients staying between 1 and 3 days, but rose to 
38. 7% for patients staying for 6 or 7 days (Sleigh et al 1992). 
2.5.2.2.5 Source of ICU admission 
Another criticism (that has subsequently been addressed in the AP ACHE III 
methodology) is that AP ACHE II does not take the source ofICU admission into 
account. The importance of this was demonstrated in a study of 235 Medical ICU 
patients where the predicted and actual mortality rates of those admitted from the 
emergency department were similar, but there were differences in those patients 
admitted from hospital wards, the intermediate care unit, and other hospitals 
(Escarce & Kelley 1990). In addition, logistic regression analysis showed an 
independent association between admission source and risk of death. 
Lead-time bias is another aspect of this problem. Differences in ICU admission 
policies and practice have been addressed in a study in which lead-time bias was 
felt to influence the differences in mortality between two Danish ICUs (Dragsted et 
al 1989a). Measured severity of illness was similar, but 35% of patients in the 
hospital with the higher mortality rate were transfers from other units. This 
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potentially confounding bias needs to be identified if comparisons of hospitals' 
performance are to be made. 
2.5.2.2.6 Response to therapy 
AP ACHE II scores were originally thought (but not proven) to be independent of 
therapy. However total interventions scored in a point system according to their 
intensity were inversely related to AP ACHE II scores in patients who died and 
directly related to AP ACHE II scores in patients who survived (Civetta et al 1992). 
This strongly suggests that AP ACHE II is in fact dependent on therapeutic 
manoeuvres. 
Along the same lines, it was suggested that as physiological data can be strongly 
influenced by medical and nursing intervention, scoring systems based on them 
should not be used for audit (Boyd & Grounds 1993). They argue that ICUs that 
are performing well may have the same SMR as ICUs that are performing badly. 
As an example, one ICU could be promptly diagnosing and treating physiological 
abnormalities. The AP ACHE II scores might be low because the physiology has 
not been allowed to become too abnormal. This would lead to a low prediction of 
mortality, but the mortality rate would also be low because of efficient treatment. 
Another ICU might be slower to respond. AP ACHE II scores would be higher, as 
would predicted risk of dying. Mortality might also be higher. The ratio between 
predicted and actual mortality (i.e. the SMR) might however be similar for these 
two hypothetical ICUs. 
This paper stimulated much discussion, with no fewer than five letters appearing in 
The Lancet in response. One writer felt the authors' argument to probably be 
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correct, but that it should not obscure the value of scoring systems in directing the 
audit of patient care in ICUs (Rothwell 1993}, while others went so far as to say 
that physiological data alone were inappropriate for comparison of ICU 
performance (Hasibeder et al 1993). In contrast, their argument was felt to be 
improbable (Chang & Bihari 1993), and their advice misguided (Palazzo et al 
1993). Finally, it was felt that potential biases should be recognised and 
understood, but that they should not invalidate the audit process (Holt et al 1993). 
2.5.2.2. 7 Patient subgroups 
AP ACHE II has been perceived to be less successful in postoperative surgical 
patients (Cerra et al 1990). those receiving total parenteral nutrition (Hopefl et al 
1989), oncology patients (Abbott et al 1991, Dart et al 1991), those with 
cardiogenic pulmonary oedema (Fedullo et al 1988), AIDS patients with 
respiratory failure ( Chu 1993 }, and one study of patients with acute renal failure 
(Schaefer et al 1991 ). Reasons may include the small numbers of such patients in 
the original AP ACHE II database, or to unusual characteristics of the subgroups 
themselves. 
2.5.3 Use of APACHE in general ICU settings 
AP ACHE II has been successfully used in a number of general I CU s (including 
general surgical ICUs) throughout the world. The larger studies include those 
from the USA (Knaus et al 1985a, Marsh et al 1990, Lockrem et al 1991, Rutledge 
et al 1991 }, the Middle East (Jacobs et al 1988), Africa (Turner et al 1988, Joshua 
25 
Chapter 2 Literature review: general intensive care 
et al 1989), Europe (Dragsted & Qvist 1989b, Giangiuliani et al 1989, Berger et al 
1992), the Far East (Chen et al 1993, Lee et al 1993, Oh et al 1993), and the UK 
(Chisakuta & Alexander 1990, Rowan et al 1993). The use of AP ACHE II scoring 
has also been reported in a comparative study between New Zealand and the USA 
of patient selection for intensive care (Zimmerman et al 1988). All of these studies 
showed that in general terms AP ACHE II was applicable worldwide (Kruse & 
Carlson 1993); the large UK study was in some respects an exception. This study 
evaluated 8796 admissions to 26 general ICUs in Britain and Ireland. The 
predicted and actual mortality rates were generally close but were significantly 
different in certain disease categories; it was felt that the AP ACHE II predictive 
equation (USA derived) did not fit all of the local data and might need modification 
for use in the UK. This is the largest study of AP ACHE II outside the USA (in 
fact it is larger than the original study used to derive AP ACHE II), and it creates 
concern that larger studies in other centres might have reached the same 
conclusion. 
2.5.4 Use of APACHE II in specific areas 
AP ACHE II has also been used in a surprisingly wide variety of specific disorders. 
Those in which the prime purpose has been the evaluation of AP ACHE II scoring 
include the following (Figure 2.1 ). 
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Figure 2.1 
Specific disorders (with references) in which APACHE II has been used. 
1. Outcome in haematological malignancy (Johnson et al 1986). 
2. Usefulness of total parenteral nutrition (Chang et al 1986). 
3. Outcome in abdominal sepsis (Bohnen et al 1988, Sleigh et al 1989). 
4. Outcome in haemodialysis (Dobkin & Cutler 1988). 
5. Outcome in cardiogenic pulmonary oedema (Fedullo et al 1988). 
6. Outcome in haematological malignancy (Lloyd-Thomas et al 1988). 
7. Outcome in patients receiving total parenteral nutrition (Hopefl et al 1989). 
8. Outcome in mechanically ventilated patients (Knaus 1989). 
9. Outcome in pancreatitis (Larvin & McMahon 1989, Wilson et al 1990, Roumen 
et al 1992). 
10. Outcome in acute renal failure (Maher et al 1989, Schaefer et al 1991 ). 
11. Outcome in acute myocardial infarction (Moreau et al 1989). 
12. Outcome in upper gastrointestinal haemorrhage (Schein & Gecelter 1989). 
13. Organ failure and mortality in postoperative surgical patients (Cerra et al 
1990). 
14. Outcome in trauma (Rhee et al 1990, Vassar et al 1992). 
15. Outcome in oncology patients (Abbott et al 1991, Dart et al 1991). 
16. Prediction of nosocomial infection risk (Bueno-Cavanillas et al 1991 ). 
17. Outcome after cardiac arrest (Nikanen et al 1991, Ebell & Preston 1993 ). 
18. Outcome in coronary care (Teskey et al 1991). 
19. Outcome in cardiothoracic surgery (Turner et al 1991). 
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(Figure 2.1 continued ... ) 
20. Prediction of morbidity and mortality after liver resection (Gagner et al 1991). 
21. Outcome in breast cancer (Headley et al 1992). 
22. Outcome in rheumatologic disease (Kollef & Enzenauer 1992). 
23. Prediction of septic complications after cardiac surgery (Kreuzer et al 1992). 
24. Outcome in asthma (Day et al 1993). 
24. Outcome in AIDS patients with respiratory failure (Chu 1993). 
Most of the above predictive applications of AP ACHE II have been perceived to 
be successful although some of this may be related to differences in the 
expectations of the users and to observer bias. Less successful applications include 
the following: postoperative surgical patients, those receiving total parenteral 
nutrition, oncology patients, those with cardiogenic pulmonary oedema, AIDS 
patients with respiratory failure, and one of the studies of patients with acute renal 
failure (Schaefer et al 1991 ). In two studies not specifically evaluating the 
performance of AP ACHE II, the scoring system underestimated mortality in adult 
respiratory distress syndrome (ARDS), with predicted mortality being 39% and 
actual mortality 45% (Kraus et al 1993), while in the other study it significantly 
overestimated mortality: predicted mortality was 39.6% and actual mortality 16% 
(Hickling et al 1990). 
The reasons for these "failures" of AP ACHE II are perhaps less than complex, and 
involve the inaccuracy of individual patient predictions. AP ACHE II was often 
misunderstood (Knaus et al 1991 a); the above is perhaps one of the 
misunderstandings. 
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The application of AP ACHE II scoring in mechanically ventilated patients (Knaus 
1989) illustrated two important points about the system which are in fact pertinent 
to most of its applications. The first was that when the AP ACHE II score was 
more than 25, mortality varied from 28% to 100% according to the disease 
category. The second point was that AP ACHE II scores on days 4 and 7 improved 
the ability to estimate a fatal outcome; very few studies have performed sequential 
AP ACHE II scoring. 
2. 5. 5 Derivatives of APA CHE II 
2.5.5.1 Daily trend plus organ-system failure 
A derivative of AP ACHE II, using the trend of daily scores and integrating organ-
system failure (Chang et al 1988), has shown promise in prediction of outcome but 
has not gained as wide acceptance as the original AP ACHE II. It analyses the rate 
of change relative to the previous day's AP ACHE II score and organ failure 
coefficient. An algorithm predicts those patients who will eventually die (Chang et 
al 1988). It has been compared with clinical judgement (Chang et al 1989). The 
computer model had no false positive predictions of death while doctors and nurses 
had a false positive predictive rate for death of between 7.7% and 16.7% (Chang et 
al 1989). The authors stress that computer predictions were not acted upon. The 
software is called (rather unfortunately, and soon to be changed) RIP (Riyadh ICU 
Program, Copyright RWS Chang, Medical and Associated Software House, 
London, UK), now in version 4, and is commercially available. The authors of a 
small study from Ireland found incorrect predictions in two patients scored in this 
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way; although they did not apply the methodology strictly or correct for organ 
failure (Chisakuta & Alexander 1990). When correctly used on 1155 patients in a 
teaching hospital ICU in Wales, the RIP predictions had a sensitivity of 14.8% and 
specificity of99.8%, incorrectly predicting three deaths (Jacobs et al 1992). 
RIP has also been used to classify ICU patients into four groups: those who 
benefitted from intensive care, those who might have benefitted, those who would 
never or would no longer have benefitted, and those who did not need intensive 
care (Jacobs et al 1989). The authors conclude that more appropriate utilisation of 
limited facilities could result from such use. 
2.5.5.2 Sickness Score 
Another scoring system based on AP ACHE II is the Sickness Score (Bion et al 
1988), derived from the analysis of 128 ICU patients. This score modifies the 
physiology components of the AP ACHE II score by conversion to SI units, 
changing from haematocrit to haemoglobin, and assessing oxygenation using the 
ratio of inspired oxygen concentration and the arterial oxygen tension. In addition 
the cardiovascular variables are scored two-hourly, the scores summed, and then 
rescored according to an averaging protocol (Bion et al 1988). The definitions for 
chronic health have also been broadened. The proportion of change in score from 
day 1 to day 4 is calculated. Estimation of probability of death is calculated by 
logistic regression analysis. In the above study, the predictive power of the 
Sickness Score on admission was 74.4%, while that of the staff nurses was 73.9%, 
the sisters 70.3%, and the resident SHO and consultant both 65.8% (Bion et al 
1988). 
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2.5.5.3 Rapid Acute Physiology Score 
Also based on AP ACHE II is the Rapid Acute Physiology Score (RAPS). This 
was developed and tested on 283 patients as a severity indicator for transport of 
critically ill patients (Rhee et al 1987). It incorporates the blood pressure, heart 
rate, and respiratory rate components of the APACHE II score (with identical 
point allocation) and allocates from Oto 4 points for the Glasgow Coma Scale. It 
correlated well with worst AP ACHE II variables; the best predictor of outcome 
was worst AP ACHE II score but pretransport RAPS also had significant predictive 
power for mortality. The advantage of RAPS is that it is easy to calculate, relying 
only on easily available and simple clinical variables (without the need for 
laboratory tests); the authors conclude that it complements APACHE II and may 
have limited utility when used alone. 
2.5.6APACHE III 
2.5.6.1 Introduction 
The most recent version of AP ACHE is the AP ACHE III prognostic system 
(Knaus et al 1991 a), designed to be capable of delivering objective probability 
estimates. The predictions from the original database are most impressive: within 
24 hours ofICU admission, 95% of patients could be given a risk estimate within 
3% of that observed with the area under the receiver operating characteristic 
(ROC) curve of0.90; this is in fact only a modest improvement over APACHE II 
which had a ROC area of0.86 (Knaus et al 1991a). However APACHE III 
requires a greater amount of data than AP ACHE II and uses complicated score 
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algorithms which remain copyright material; it is marketed as a hardware and 
software package by AP ACHE Medical Systems Inc. (Washington, USA). 
2.5.6.2 Development of APACHE Ill 
The description of the development of AP ACHE III took up a whole supplement 
(funded by the George Washington University research group) of Critical Care 
Medicine (AP ACHE III study design: analytic plan for evaluation of severity and 
outcome, Volume 17, Number 12, December 1989), leading to an editorial 
justification for this amount of attention (Shoemaker 1989), and a well argued 
perspective and appraisal demanding careful attention, scrutiny, and peer review of 
severity of illness scoring (Teres 1989). 
For the APACHE III data collection, twenty-six hospitals and ICUs were selected 
randomly through the USA and 14 volunteered to participate. Variable selection 
included 212 disease categories and 20 physiological parameters (selected on the 
basis of past experience and clinical judgement). Data collection ran from May 
1988 to November 1989, and all patients were followed up to hospital discharge. 
The methodology excluded patients with bums, patients younger than 16 years of 
age, and patients admitted to exclude myocardial infarction. In addition, patients 
had to remain in the ICU for a minimum of 4 hours. Data on coronary artery 
bypass patients was collected for separate analysis. The integrity of data collection 
was ensured by a training course for participants followed by quality assurance and 
reliability studies. Statistical analysis involved multivariate logistic regression, with 
categoric and continuous weighting to determine component variables and weights. 
32 
Chapter 2 Literature review: general intensive care 
There were 17 440 patients in total. Ninety percent of the patients were randomly 
divided into estimation and validation halves. 
2.5.6.3 Differences from APACHE II 
In the final version, AP ACHE III differed from AP ACHE II as follows. Potassium 
and bicarbonate measurements were abandoned, while the pH score incorporated 
measurement of PaC02, and the neurology score was refined. Both of the latter 
are scored by referring to tables. Urea, urine output, albumin, bilirubin, and 
glucose were added. The age and chronic health weightings were changed, as was 
the weighting for each individual variable. The AP ACHE III score comprises the 
sum of the physiology points, the age points, and the chronic health points. More 
precise details of its application appear in Chapter 4. 
2.5.6.4 The APACHE Ill predictive equation 
The AP ACHE III score (published, "shareware") is only one part of the AP ACHE 
III predictive equation (copyright) which includes weighting for 78 different 
disease categories, the treatment location prior to ICU admission, and the 
occurrence of emergency surgery. The equation then employs natural 
antilogarithm mathematics to calculate the probability of dying for the individual 
patient. The natural antilogarithm of the equation equals the risk of hospital 
mortality divided by 1 minus the risk . 
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2.5.6.5 Ongoing research 
Data collection and database accumulation is ongoing, under the auspices of 
APACHE Medical Systems Inc. The database had over 120000 patients by 
December 1993 (WA Knaus, personal communication), and is expanding 
internationally. In the United Kingdom, 19 ICUs (17 from the South West Thames 
region) are taking part in AP ACHE III data collection; when there is enough data 
the predictive equations will be refined for local use. AP ACHE III may also be 
used to calculate standardised mortality ratio and predict length of ICU stay, 
allowing comparison between the performance ofICUs (Knaus et al 1993b). 
2.5.6.6 Applications of APACHE Ill 
AP ACHE III has not yet been applied in a wide variety of scenarios, although this 
will almost certainly change. 
The role of the Glasgow Coma Scale score in the AP ACHE III predictive ability 
was examined in 15973 non-trauma patients from the AP ACHE III database 
(Bastos et al 1993 ). It was found that the Scale itself had a significant but non-
linear relationship with outcome, although discrimination in intermediate score 
levels was reduced. In addition, the overall predictive ability of AP ACHE III was 
improved by the incorporation of the Glasgow Coma Scale score. 
AP ACHE III was used to quantify the mortality risk of 519 ICU patients ( drawn 
from the AP ACHE III database of 17 440 patients) admitted with a primary 
diagnosis of sepsis (Knaus et al 1992). While the mortality rates of patient groups 
with "sepsis syndrome" and "septic shock" differed significantly, the range of 
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individual patient risks in these groups and in the patients not meeting these criteria 
merged into one another. 
A further and more innovative use of AP ACHE III scoring was to develop a model 
to predict survival for patients entering clinical trials. Such a model was created 
from the analysis of AP ACHE III predictions for 1195 patients with sepsis 
syndrome, based on 58737 patients admitted to 107 hospitals in the USA and 
Europe (Knaus et al 1993a). This model was used in the retrospective analysis of a 
phase III clinical trial using an Interleukin 1 (IL-1) receptor antagonist in sepsis 
syndrome (to date only in abstract form). This study included 893 patients from 
the USA, Canada, and Europe. Although overall there was no difference in 28 day 
mortality between placebo and treatment with high or low dose IL-1 receptor 
antagonist, there was a similar benefit in both dosages when the predicted mortality 
was more than 24%. In all clinical trials there are low-risk patients who will 
survive without a new therapy, and high risk patients who will die whatever 
therapy they are given. Risk stratification such as that delivered by AP ACHE III, 
provided it is available at the time the therapy needs to be given, may distinguish 
patients in whom new (and expensive) therapy is likely to be of benefit. 
AP ACHE III has also been used to compare case-mix, structure, resource 
utilisation, and outcome performance between ICUs in teaching and non-teaching 
hospitals (Zimmerman et al 1993a). The teaching hospital ICUs dealt with more 
complex patients, had twice the number of physicians providing services for these 
patients, used more resources (with increased risk of diagnostic tests and invasive 
procedures), and mostly had better risk-adjusted survival rates. In a further study, 
nine ICUs were selected from the AP ACHE III database for on-site analysis 
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(Zirnmennan et al 1993b ). Although there was a wide variation in risk-adjusted 
survival rates, this could not be correlated with differences in ICU structure and 
organisation, or by on-site clinical judgement. However the authors felt that there 
were good and bad practices observed; the better practices included a patient-
oriented culture, strong leadership, good and effective communication and 
coordination, and an open collaborative approach to problem solving and conflict 
management. 
2. 5. 7 Scoring systems and clinical judgement 
2.5.7.1 General ability of physicians 
Before comparing scoring systems with clinical judgement, the predictive skills of 
physicians need to be examined. In intensive care, the accuracy of physicians' 
outcome predictions is poorly defined. Firstly, individual predictive ability may be 
poor. When 20 ICU physicians were asked to predict survival on each patient's 
fourth ICU day, they predicted death in only 41 % of patients who died and survival 
in 87% of those who survived (Perkins et al 1986). In another study, many 
patients thought certain to die (100% certainty) lived, and patients thought certain 
to live, died (Poses et al 1989). Secondly, physicians may disagree amongst 
themselves. When physicians' quantitative prognostic judgements for 269 ICU 
admissions were assessed, there was good overall discriminating ability but more 
than 40% of patients provoked disagreements of at least 20 percentage points 
between physicians (Poses et al 1989). 
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Reasons for these discrepancies are complex but may include the following 
arguments. People have been shown to have an optimistic bias about personal 
risks. This has been reviewed (Weinstein 1989). Optimism is greatest for risks 
where the person has little personal experience of that risk, for risks of low 
probability, and for risks that may be controllable by personal action. Thus, 
physicians may extrapolate their own optimism about personal risks to the 
condition of their patients. Alternatively, they may be misguided by their personal 
overoptimistic view of overall ICU mortality. Poses et al evaluated the effects of 
"ego bias" on the prognostic judgements of physicians. Ego bias includes the 
optimistic bias about personal risks described above; it also involves an optimistic 
bias about personal good fortune. It may be strongest in people who have little 
control over their environment. In their study of 201 medical and surgical ICU 
patients, predictions for individual patients were compared with predictions for the 
overall ICU mortality rate. House officers made predictions for individual patients 
that were significantly more optimistic than their judgements of the overall survival 
rate, thus displaying ego bias. However, the attending physicians showed the 
reverse, with more optimistic predictions for the overall survival rate than for 
individuals (Poses et al 1991 ). This latter characteristic is known as "reverse ego 
bias". The authors felt that the difficult conditions, beyond their control, 
experienced by the house officers may have caused their ego bias, while the more 
secure attending physicians had no such need and may have realised that down-
playing their chances of success would be more productive. 
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2.5.7.2 APACHE and clinical judgement 
Both AP ACHE II and AP ACHE III have been subjected to extensive comparison 
with clinical judgement. Mortality predictions by clinicians were better than those 
of AP ACHE II in two studies in general ICU patients (Brannen et al 1989, Marks 
et al 1991) and one in surgical patients (Meyer et al 1992), while there was no 
significant difference in a third study (Kruse et al 1988). In a further study 
physicians again performed better than AP ACHE II in estimating mortality, but 
AP ACHE II was better calibrated in the central probability ranges (McClish & 
Powell 1989). AP ACHE III, on the other hand, was slightly better at mortality 
prediction than clinicians and in addition was more consistently accurate at all 
levels of mortality (Knaus et al 1991 b ). However. the differences determined in 
the above studies are small and are probably of minimal or no clinical significance. 
2.6 Other severity of illness scoring systems 
2. 6.1 Simplified Acute Physiological Score (SAPS) 
The original AP ACHE score (Knaus et al 1981) had too many physiological 
variables for routine use; this problem was addressed by the much shorter 
Simplified Acute Physiological Score (SAPS), using only 14 easily obtained and 
readily available physiological variables (Le Gall et al 1984). These include age, 
heart rate, systolic blood pressure, temperature, respiratory rate, urine output, 
blood urea, haematocrit, white cell count, serum glucose, potassium, sodium and 
bicarbonate, and the Glasgow Coma Scale. For reasons that are not entirely clear, 
the AP ACHE II score published shortly afterwards (Knaus et al 1985a) caught on 
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more readily and widely, although SAPS remained popular in Europe. The SAPS 
principles are similar to those of AP ACHE II, with component weights ranging 
from O to 4 depending on the degree of derangement from normal; the variables 
and the component weights are only slightly different from those used in AP ACHE 
II. 
In 679 unselected patients in 8 French ICUs, SAPS correlated well with hospital 
mortality (Le Gall et al 1984). SAPS has also been used in clinical studies of 
ARDS. Although SAPS on admission was shown to be not significantly different 
between survivors and nonsurvivors, it improved in survivors and got worse in 
nonsurvivors (Mancebo et al 1987). This is stated as having been confirmed in the 
European Collaborative Study of ARDS (Artigas et al 1992), although the actual 
figures are not presented. 
SAPS was compared with an oxygen consumption index in critically ill ventilated 
surgical ICU patients (van Lanschot et al 1988). SAPS was significantly lower in 
survivors than nonsurvivors but failed to be useful in providing a prognosis in the 
individual patient. However there was no significant difference in oxygen 
consumption index between survivors and nonsurvivors. 
A simplified version of SAPS has been proposed by using a multiple logistic 
regression analysis of the 14 original variables; only five variables needed to be 
retained (Viviand et al 1991). This model was compared with SAPS in a further 
set of 446 patients and there was no difference in discriminating power. 
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2.6.1.1 SAPS II 
An update of SAPS, named SAPS II, is based on analysis of 13152 patients 
(randomly divided into developmental and validation models) in 137 ICUs in 12 
countries (Le Gall et al 1993). It includes 12 physiology variables (Figure 2.2, 
ranges of scores and points allocated not presented here), age, type of admission 
(scheduled surgical, medical, and unscheduled surgical), and underlying disease 
(metastatic cancer, haematologic malignancy, and AIDS). SAPS II excludes bum 
patients, coronary care patients, and all cardiac surgery patients. 
No primary diagnosis or reason for admission is needed to perform SAPS II 
scoring. From the SAPS II score a probability of hospital mortality may be 
calculated. The equation for this calculation includes both the actual SAPS II 
score and a shrinking power transformation of the score using the natural logarithm 
Figure 2.2 
Physiological variable making up the SAPS II score 
Heart rate 
Systolic blood pressure 
Temperature 
Arterial oxygenation (Pa0z/Fi02 ratio) 
Urine output 
Urea 








Glasgow Coma Scale 
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When predicted and actual mortalities were compared, the area under the receiver 
operating characteristic curve was 0.86 in the validation sample. Future directions 
for SAPS II include scoring on a daily basis and enlarging the database with 
periodic quality checking of the predictive model. 
2.6.2 The Mortality Prediction Model (MPM) 
The Mortality Prediction Model (MPM) (Lemeshow et al 1985) differs 
significantly from other scoring systems. It employs 7 binary (i.e. the variable is 
either present or absent) clinical variables selected by multiple logistic regression 
and weighted by a statistical technique known as maximum likelihood. In addition, 
different variables are scored at admission (none of which are treatment-dependent) 
and at 24 hours (these reflect both treatment and clinical condition). From these 
variables is calculated a probability of hospital mortality, rather than a score. The 
predictions were closely correlated with actual outcome, and although MPM 
performed better than the Acute Physiology Score component of AP ACHE II and 
SAPS in the hands of the authors (Lemeshow et al 1987), in another relatively 
small study it did not show significant predictive ability in patients with septic 
shock ( Arregui et al 1991). In a further study goodness-of-fit was better for 
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AP ACHE II than MPM when comparing observed and predicted outcome; MPM 
overestimated deaths ( Castella et al 1991). 
The MPM was validated in a separate group of 1997 patients (Teres et al 1987) 
where the admission but not the 24 hour model accurately predicted mortality. 
The authors subsequently described an improvement, deriving mortality models 
from data gathered at admission, at 24 hours, and at 48 hours (Lemeshow et al 
1988). The variables for each of these models differ slightly. The serial 
observations substantially enhanced predictive ability. The MPM has also been 
effectively used to assess the effect of timing of ICU admission on outcome. 
Patients admitted to ICU within 1 day of hospital admission had a lower actual 
than predicted mortality, while patients admitted later had the opposite (Rapoport 
et al 1990a). In a large study of2749 patients, MPM was used to study resource 
use. The relationship between severity of illness (as measured by MPM) and 
resource use was not linear, but within each diagnosis-related group, MPM 
explained a statistically significant percentage of the variability in resource use 
(Rapoport et al 1990b ). 
2.6.2.1 MPM II 
MPM II (this time called Mortality Probability Model) was published late in 1993 
(Lemeshow et al 1993). The model was developed on 12610 ICU patients in 12 
countries and validated on a further 6514 patients. Patients younger than 18 years, 
bum patients, and coronary care and cardiac surgery patients were excluded. The 
result was an admission (MPMo) and 24 hour (MPM24) model; both models were 
42 
Chapter 2 Literature review: general intensive care 
well calibrated and discriminated well. The :MPMo contains 15 variables (Figure 
2.3) readily obtained on admission and well defined in the text; it is the only 
scoring system available for use on admission to ICU. The MPM24 contains five 
of the admission variables as well as 8 variables easily obtained at 24 hours. Both 
:MPMo and MPM24 were well calibrated (by Hosmer-Lemeshow goodness-of-fit 
testing) and both discriminated well (by ROC curve analysis). 
Figure 2.3 
Variables in the MPMo 
Physiology Coma or deep stupor 
Heart rate >= 150 beats/minute 
Systolic Blood Pressure <= 90 mm Hg 









Intracranial mass effect 
Age ( 10-year odds ratio) 
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2.6.3 The organ-system failure (OSF) score 
The organ-system failure (OSF) score (Knaus et al 1985b) was developed in 
parallel with AP ACHE II. Strict definitions were developed for 5 organ-systems, 
namely cardiovascular, respiratory, renal, haematologic, and neurologic (see Figure 
2.4). The numbers and duration of OSF were evaluated against hospital outcome 
for 5677 ICU admissions (2719 of whom developed OSF) from 13 hospitals. A 
very accurate predictive value for death resulted from the analysis. Thus the failure 
of three or more organ-systems on the fourth day of OSF carries a 96% mortality, 
whilst two OSF carries a 56% to 68% mortality from the third day of OSF. The 
predictive abilities of this system, together with the tight 95% confidence intervals 
presented, would potentially make it a useful tool for helping to make decisions 
about withdrawal of therapy. 
Figure 2.4 
Definitions of organ-system failure (Knaus et al 1985b) converted to SI units 
where appropriate. 
1. Cardiovascular failure (presence of one or more of the following): 
A Heart rate ~ 54/min. 
B. Mean arterial pressure~ 49 mmHg. 
C. Occurrence of ventricular tachycardia and/or fibrillation. 
D. Serum pH~ 7.24 with a PaC02 ~ 6.53 kPa. 
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(Figure 2.4 continued ... ) 
2. Respiratory failure (presence of one or more of the following): 
A. Respiratory rate ~ 5/min or :2'. 49/min. 
B. PaC02 2 6.67 kPa. 
C. AaD02 :2'. 46.7 kPa. 
D. Dependent on ventilator on fourth day of organ-system failure. 
3. Renal failure (presence of one or more of the following): 
A. Urine output~ 479 ml/24 hours or ~159 ml/8 hours. 
B. Serum BUN 2 100 mg/100 ml. 
C. Serum creatinine 2 308 µmol/1. 
4. Haematologic failure (presence of one or more of the following): 
A. White cell count ~ 1000/mm3. 
B. Platelet count~ 20 OOO/mm3. 
C. Haematocrit ~ 20%. 
5. Neurologic failure: 
Glasgow Coma Scale~ 6 (in the absence of sedation). 
2. 6.4 The ODIN (organ dysfunction and/or infection) model 
The ODIN system evaluates the presence or absence of dysfunction in six organ 
systems (respiratory, cardiovascular, renal, haematologic, hepatic, and neurologic) 
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and the presence or absence of infection (F agon et al 1993). The definitions of 
organ dysfunction are slightly different from the organ-system failure definitions 
above (Knaus et al 1985b ); they are said to have been derived from a review of the 
literature. There was a direct and statistically significant increase in mortality with 
increase in ODIN. Multiple logistic regression analysis was then used to 
demonstrate the relationship between each ODIN and calculate a probability of 
death. When predicted and actual death rates for ODIN, SAPS, and AP ACHE II 
were compared, there was no statistical difference in area under the receiver 
operating characteristic curve. The ODIN score is computed for the first 24 hours 
ofICU admission only and has not been used in a dynamic fashion. 
2. 6. 5 Therapeutic Intervention Scoring System (TISS) 
The Therapeutic Intervention Scoring System (TISS) first appeared in 1974 
(Cullen et al 1974). Fifty-seven monitoring or therapeutic interventions were 
scored from 1 to 4 points depending on their intensity. The sum of the points 
acquired in a 24 hour period make up the TISS score. TISS was found by the 
authors to be useful in determining appropriate utilisation ofICU facilities, 
providing information on nurse staffing ratios, validating a classification of patients 
into categories of severity, and analysing cost relative to extent of ICU care. 
TISS was updated in 1983 (Keene & Cullen 1983) to include 76 variables. This 
update took into account newer therapeutic modalities; some items were added, 
some deleted, and the points for some adjusted. A comparison of the updated 
score with the original score in 100 consecutive patients revealed no significant 
difference (Keene & Cullen 1983), although the method of comparison might not 
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be acceptable today (Bland & Altman 1986). There has been no update since this 
time, although various hospitals have introduced their own minor variations to 
incorporate new and expensive treatment modalities, and an "official" update, 
which will be orientated towards fairer evaluation of medical patients, is expected 
in the near future. 
It was suggested (perhaps rather optimistically) that TISS could provide the 
following information (Keene & Cullen 1983): percentage of bed occupancy, 
classification of patients into classes of severity, identification of inappropriate ICU 
admissions, daily intensity of care delivered, identification of patients discharged 
too soon or not soon enough, follow up of care after discharge, nurse to patient 
ratio, and number of ICU beds needed. 
The TISS has proved to be a strong predictor of total ICU admission costs (Slatyer 
et al 1986). In addition, it has been used to suggest ICU admission and discharge 
criteria (with a cut-off of 10 TISS points), as well as effective utilisation of nursing 
staff (Adam et al 1989). In this study the authors suggest that a single nurse could 
manage two patients with a total of24 TISS points between them. These points 
seem rather low; in the Adult ICU at the Royal Brompton National Heart and Lung 
Hospital a single nurse manages a patient with up to 80 TISS points (the mean 
daily TISS score is around 50 points) and patients are usually discharged with 30 
to 40 TISS points (unpublished data, collected at the time of the third study). 
The TISS has also been used to predict the risk of nosocomial infection (Bueno-
Cavanillas et al 1991). In this study a day one TISS score of more than 20 points 
and an AP ACHE II score of more than 12 points were both positively associated 
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with nosocomial infection; on multivariate analysis there was no such association 
with APACHE II but each TISS point suggested an infection risk increase of 6%. 
On a theoretical basis however, (as it would be impossible to prove scientifically) 
TISS may not accurately reflect severity of illness as much as it reflects the level of 
medical and nursing intervention. For the same patient, the score may vary 
according to the aggressiveness or invasiveness of different treatment philosophies, 
as well as to the availability of resources and financial constraints. Details of the 
interventions, their scores, and their practical application appear in Chapter 5. 
2. 6. 6 The system outcome score (SOS) and outcome index 
Another scoring system developed from stepwise logistic regression of a variety of 
variables is the system outcome score (Gilbert & Schoolfield 1991). At the end of 
two stages of analysis of 2 777 consecutive patients, five clinical variables were 
identified; stepwise discriminate analysis was then applied and points were 
allocated to the variables by expressing each variable's discriminate index as a 
percentage of the sum of all indices and then normalising to a total summation 
maximum of ten. The final SOS components and values are detailed in Figure 2.5. 
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Figure 2.5 
SOS components and values. 
Component 
Glasgow Coma Scale< 5 
Fi02 > 0.5 
Administration of sympathomimetic amine > 12 hours* 
Oliguria < 0.5 ml/kg/hour for 8 hours 
Coagulopathy after first admission day 
TOTAL 








Cluster analysis was then used to provide mortality predictions and the system was 
then validated in a further 2860 patients. Three patterns of unpredicted mortality 
were identified. These included sudden deterioration, delayed clinical 
deterioration, and patients dying with inappropriately low maximum SOS. Review 
of the care of these patients could then take place to see if there were any 
identifiable deficiencies in their medical care. The authors feel that their system is 
especially useful in assessing ongoing quality of patient care and medical 
surveillance, the latter use being especially relevant after an episode of malicious 
interference in their own institute (Istre et al 1985). 
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2. 6. 7 Clinical sickness score 
The clinical sickness score (Watters et al 1989) was developed in Zambia, an area 
where laboratory tests are not easily available. It was derived from 624 
consecutive admissions to a Surgical ICU in Lusaka and allocates scores from O to 
4 for pulse, systolic blood pressure, respiratory rate, urine output, temperature, 
Glasgow Coma Scale, and age. This score is simple to perform using the above 
clinical variables, and was significantly associated with outcome in this study. 
The clinical sickness score was compared with AP ACHE II in 97 admissions to a 
District General Hospital ICU in England (Sinclair et al 1991 ). This is a small 
study, and the age weighting was excluded from the methodology. Nevertheless 
there was significant correlation between the two scoring systems both for all 
patients and for hospital survivors; correlation for nonsurvivors was not significant. 
2. 6. 8 Simpler indicators of outcome 
The systems described here are noteworthy for their simplicity, ease of use, and 
wide area of application. They will be briefly described here. 
2.6.8.1 The Computerised Severity Index 
The Computerised Severity Index calculates a severity score that incorporates the 
ICD-9-CM code for patient diagnosis and a severity score between 1 and 4 (Hom 
& Hom 1986). Severity is based on a set of objective signs. Its uses include 
adjustment of cost to severity of illness, quality of care assessment, prediction of 
posthospital needs, the incentive to efficiency, and physician practice profiles. 
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2.6.8.2 The comorbidity score 
The comorbidity score defines a comorbidity as a preexisting condition (in addition 
to the active primary diagnosis) which has to either require treatment during the 
hospital admission or has permanently altered organ function (Gross et al 1988). 
The authors found that the number of comorbidities varied directly with the 
development of nosocomial infection, appearance of new complications, and length 
ofICU stay. 
2.6.8.3 The McCabe-Jackson scoring system 
The McCabe-Jackson scoring system uses clinical judgement to assign one of three 
risk groups to an individual patient: rapidly fatal (e.g. acute leukaemia), ultimately 
fatal (e.g. chronic leukaemia, cirrhosis with bleeding varices), and nonfatal 
(McCabe & Jackson 1962). 
2.6.8.4 The American Society of Anesthesiologists (ASA) classification 
The American Society of Anesthesiologists (ASA) classification uses clinical data 
to assign a patient to a Physical Status class between I and V. Class I describes a 
healthy patient, Class II patients have mild systemic disease but no functional 
limitation, Class III have severe systemic disease and definite functional limitation, 
Class IV patients have severe systemic disease that is a threat to life, and Class V 
patients are moribund and unlikely to survive 24 hours with or without operative 
intervention (Dripps et al 1961 ). 
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The above four systems have been compared with each other and with AP ACHE II 
in 105 patients (Gross et al 1991). All systems correlated well with the authors' 
own comorbidity score. In addition, AP ACHE II, the Computerised Severity 
Index, and the McCabe-Jackson scoring system were comparable predictors of 
comorbidity. The authors concluded that the selection of one or other system 
would depend on the resources available and the intended uses. 
2.6.8.5 The Visceral System Failure Index 
The Visceral System Failure Index incorporating 11 empirically derived visceral 
"systems" (including conventional organ-systems and severe sepsis, major surgery, 
disseminated malignancy, major blood transfusion, and major trauma) was used in 
a small study of 79 patients in Australia (Kelly et al 1986). It was significantly 
correlated with mortality only when there were 4 system failures ( and not at less 
than 4 failures, or at 5 or more failures). The numbers are too small to draw any 
conclusions. 
2.6.8.6 The Hanover Intensive System 
The Hanover Intensive System (HIS) seems to have been empirically derived and 
includes simple assessments of cerebral, cardiovascular, respiratory, 
gastrointestinal, renal, and immunological function (Lehmkuhl et al 1989). In a 
study of 215 surgical ICU patients it was found to be superior to AP ACHE II and 
TISS in predicting death; it was also useful in clinical decisions about reoperation 
and for administrative decisions predicting intensity of nursing care. The authors 
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seem hostile towards AP ACHE II ( describing the variables as a "potpourri") and 
TISS ( describing the measurements as "bewildering"). The HIS looks simple and 
easy to use; it remains to be seen if it becomes popular and can be widely validated. 
2.6.8.7 Critical Care Scoring System 
The Critical Care Scoring System (Yeung et al 1990) is applicable only in patients 
managed with pulmonary artery catheters. This score is largely based on 
haemodynamic data; the rationale for its development was that in patients with 
circulatory or respiratory failure and needing pulmonary artery catheters the 
authors found a surprisingly high mortality (45.7%) with relatively low APACHE 
II scores (less than 14). Their scoring system managed to significantly improve 
mortality prediction in such patients. 
2.6.8.8 POSSUM 
The POSSUM (acronym for Physiological and Operative Severity Score for the 
enumeration of Mortality and morbidity) was developed as a simple scoring system 
for general surgical patients, whose main use would be for audit (Copeland et al 
1991 ). When compared with AP ACHE II in 117 admissions to a post-surgical 
high dependency unit, POSSUM had a superior predictive value for 30 day 
mortality (Jones et al 1992). 
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2. 7 New scoring systems 
The need for further scoring systems is perhaps summed up by the titles of two 
recent editorials: "New and improved" scoring systems (Civetta 1990) and Do we 
need a new severity score? (Le Gall & Lemeshow 1991). The former was 
prompted by the appearance of the Critical Care Scoring System (Yeung et al 
1990), which met with guarded approval, and the latter by a new score based on 
logistic regression analysis of all the variables making up the currently used 
prognostic indices (Sarmiento et al 1991). This score was felt to be seriously 
flawed on the basis of the methodology employed. Le Gall and Lemeshow felt that 
it would be better that current severity scores were further studied and periodically 
modified to cater for differences in ICU patient mix and the development of new 
technologies. 
2.8 Specialised scoring systems for specific disorders 
There is a vast number of scoring systems applicable only to specific disorders. 
Only the better known ones will be described here and then not in any depth. In 
their own circumscribed diagnostic categories they may be extremely effective; this 
will not be critically reviewed here. 
2.8.1 Trauma 
For head injury the main scoring systems are the Glasgow Coma Scale (Teasdale & 
Jennett 1974, Jennett et al 1979), and for general trauma the Injury Severity Score 
(Baker et al 1974, Copes et al 1988), the Trauma Score (Champion et al 1981 ), the 
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Abbreviated Injury Scale (Civil & Schwab 1988), the TRISS Method (Boyd et al 
1987) and the ASCOT score (Champion et al 1990). 
2. 8. 2 Paediatrics 
The best known score for paediatrics is the neonatal Apgar score (Apgar 1953). 
More recent scores include the Pediatric Risk of Mortality (PRISM) score (Pollack 
et al 1988) and the neonatal CRIB score (The International Neonatal Network 
1993). 
2. 8. 3 Pancreatitis 
The Ranson score (Ranson et al 1974) is probably the best known and most widely 
used score for patients with pancreatitis. A more recent addition is the Glasgow 
Score (Blarney et al 1984). 
2.8.4 Burns 
Bum patients are commonly scored by the Bum Index (Feller et al 1980). Other 
scores include those ofBaux (Stem & Waisbren 1978), Bull (Bull 1971), and Roi 
(Roi et al 1983). More recently, logistic regression indices have been used and 
compared with the established indices (Zoch et al 1992). 
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2. 8. 5 Septic shock 
Patients with septic shock may be scored by the Complete and Simplified Septic 
Shock Scores (Baumgartner et al 1992). 
2. 8. 6 Non-traumatic coma 
Prognostic estimates for patients with non-traumatic coma may be made from the 
detailed descriptions of the clinical course of patient groups (Levy et al 1981, Levy 
et al 1985, Edgren et al 1994). 
2. 8. 7 Comparison of general and specific scoring systems 
The performance of specific scoring systems is sometimes not as good as general 
scoring systems, even in their perceived speciality. In pancreatitis for instance, 
AP ACHE II performs as least as well as the Ranson score (Larvin & McMahon 
1989, Wilson et al 1990, Roumen et al 1992). However, in head trauma the 
Glasgow Coma Scale was superior to the Acute Physiology Score component of 
AP ACHE II, SAPS, and TISS in predicting outcome, as measured by both correct 
prediction of outcome and area under the ROC curve (Rocca et al 1989). 
2.9 Summary 
Severity of illness scores have developed substantially over the past ten to fifteen 
years and current scoring systems are based on mathematically and statistically 
sound principles. Databases are continuing to expand and predictive equations to 
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be refined. The prognostic power of scores is increasing and there are few ICUs 
that do not use some form of severity scoring as part of their basic data collection. 
Economics may demand the expansion of medical audit and severity scoring is at 
its best here. Economics may also demand more appropriate use of ICU facilities 
and it is here, at "the intersection of economics and ethics in the intensive care 
unit" (Lanken 1994) that the most interesting developments in severity scoring may 
yet be seen. 
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CHAPTER3 
Literature review. Severity scoring and predictive indices in cardiac 
surgery 
3.1 General scoring systems in cardiac surgery 
3.1.1 Introduction 
Cardiac surgery patients (and in particular Coronary Artery Bypass Graft [CABG] 
patients) have been almost entirely avoided or ignored by evaluations of general 
severity of illness scoring systems, especially the more recent AP ACHE III score 
(Knaus et al 1991 ), MPM II (Lemeshow et al 1993) and SAPS II (LeGall et al 
1993).. This may well be a reflection of the difficulties both expected and 
encountered in predicting outcome in such patients, as well as to the availability of 
specific risk predictors for cardiac surgery. This theme is more fully explored in 
the introductions to Chapters 6 and 7. The risk predictors are not ideal either, and 
it has been recently stated that "an objective scoring system pertinent to the 
cardiothoracic ICU would be extremely timely and useful" (Rafkin & Hoyt 1994). 
3.1.2 APACHE II 
In the AP ACHE II database, there were 90 patients classified as "Postoperative, 
admission due to chronic cardiovascular disease" and 225 as "Postoperative, heart 
valve surgery", out of a total of 503 0 patients. Our study evaluating the use of 
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AP ACHE II scoring in 811 cardiothoracic surgery patients, including 527 CABG 
patients out of 7 65 cardiac surgery patients (Turner et al 1991 ), is thus the largest 
study of a general severity of illness scoring system to be published in this field. It 
forms part of this thesis and is fully described below. The conclusions were that 
low AP ACHE II scores and risk of dying predicted survival with some certainty 
(the mortality was 0.93% when the APACHE II score was less than 10) but that 
only very high scores accurately predicted death, and then only in a small number 
of patients. The relationship between the AP ACHE II score and mortality was 
linear and statistically significant but AP ACHE II did not have the power to 
definitively predict death and thereby influence decisions to withdraw therapy. 
AP ACHE II has however been used in the prediction of septic complications after 
cardiac surgery. It was found to be superior to single variables such as fever, white 
cell count, and cardiac output in differentiating between patients who developed 
sepsis and those who did not. An AP ACHE II score of 19 had a positive 
predictive value of 86% and a negative predictive value of 96% in predicting septic 
complications (Kreuzer et al 1992). 
3.1.3 APACHE III 
Patients admitted to ICU after CABG were excluded from the AP ACHE III data 
collection and prognostic system (Draper et al 1989, Knaus et al 1991) and 
although they are to be analysed separately (Knaus WA, personal communication) 
this data is not yet available. Patients undergoing heart valve surgery have 
however been used in the original AP ACHE III database although in small 
numbers: there were only 211 such patients ( 1.2%) out of a total of 17 440 patients 
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(Knaus et al 1991 ). AP ACHE III has not been independently validated in this ( or 
any other) setting. 
3.1.4 SAPS II, MPM I and II 
No cardiac surgery patients at all were evaluated in SAPS II (LeGall et al 1993) or 
the Mortality Prediction Models I and II (Lemeshow et al 1988, Lemeshow et al 
1993). 
3.2 Cardiac surgery operative risk systems 
3.2.J Introduction 
A variety of cardiac surgery operative risk systems have been developed from 
analyses of large numbers of patients, the largest and most important of which are 
detailed in Table 3 .1 together with their methodology and end points; they will not 
be individually described further. 
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Table 3.1 
Cardiac surgery risk analyses with their descriptions and end-points. 
First author (date) Description End-point 
Oldham (1972) High/low risk groups Mortality 
Loop (1975) Risk factors Mortality 
Kennedy (1980) Risk factors, calculation Mortality (CASS) 
Pelletier ( 1980) Risk factors Mortality 
Kennedy ( 1981) Risk factors Mortality (CASS) 
Junod (1987) CASS calculation Mortality 
Edwards ( 1989) Bayesian analysis Mortality 
Parsonnet (1989) Simple score Mortality 
Bolsin (1990) Simple score Mortality, duration 
Hammermeister ( 1990) Regression model Major complications 
Hannan (1990) Regression model Mortality 
Higgins (1992) Simple score Morbidity, mortality 
Tuman (1992) Simple score Morbidity, mortality 
Geraci (1993) Risk factors Mortality, morbidity 
Daly (1993) Simple score Mortality (males only) 
Grover (1993) Regression model Mortality 
3.2.2 Interpretation of the literature 
Several of the above risk systems derive a numerical score, some of which are 
simple sums of points allocated for the presence or absence of risk factors, while 
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others involve calculation of exponential functions. The former are easy to apply 
at the bedside (which is where they are needed if they are to be used clinically and 
just for research purposes) but perhaps less accurate than those that employ 
logistic regression analyses and may need scientific calculators or microcomputer 
programs to perform. Some sort of balance between these extremes would be 
useful. 
Unfortunately interpretation of the literature is very confusing, as all the risk 
systems evaluate different patient populations and types of operation (some include 
CABG only), as well as different combinations of predictive factors and end-points 
(with different definitions for each of these), and although some more recent ones 
have used earlier studies as their basis, no single system has gained widespread 
acceptance. This is a pity, as the studies involve a total of tens of thousands of 
patients. 
A further problem may be that the above studies span many years; patient profile 
and mortality have changed during that time (Naunheim et al 1988) and cardiac 
surgery continues to change. Results from the earlier studies may no longer be 
applicable. 
Finally, apart from the Bayesian model (Edwards et al 1989), there is no risk 
stratification in any of the studies. Raw mortality data may not be the most 
appropriate outcome measure. 
3.2.3 Independent validation 
It would appear that only the Parsonnet system has been independently validated in 
any study other than its instigative one (Nashef et al 1992). This brief study of 
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1071 patients in a British hospital, with minimal description of the methods used, 
has been criticised for both its methodology and its conclusions (Spiegelhalter 
1992). In the same letter this statistician criticises the unclear and unconventional 
derivation of the Parsonnet score and the tests used to correlate its predictions and 
outcomes (Spiegelhalter 1992). 
Some uniformity in risk determination may emerge in the UK, where the 
Association of Cardiothoracic Anaesthetists (ACT A) has determined that the score 
of Bolsin et al (Bolsin et al 1990) should be used to assess operative risk. A large 
multicentre database has been established with substantial funding and there is a 
strong statistical input. 
3.2.4 Collaborative Study in Coronary Artery Surgery (CASS) 
The largest study of coronary artery bypass surgery patients, with more than 25000 
patients when fully reviewed in the literature (Anderson 1986), is almost certainly 
the Collaborative Study in Coronary Artery Surgery (CASS), which has been 
reported at various times and with regard to various subgroups. These subgroups 
include left main-stem disease (Chaitman et al 1980), left ventricular aneurysm 
(Faxon et al 1982), unstable angina (McCormick et al 1985), patients older than 65 
years (Gersh et al 1983), the effects of sex and physical size (Fisher et al 1982), 
and repeat surgery (Foster et al 1984). 
CASS has been comprehensively reviewed (Anderson 1986). It is impressive in 
size and scope and consists of two elements: a randomised trial of surgical versus 
medical therapy, and a registry which includes a risk equation to estimate hospital 
mortality. The risk equation incorporates (in descending order of importance) age, 
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left main coronary artery stenosis greater or equal to 90%, female sex, left 
ventricular score (a combination of ejection fraction and wall motion abnormality), 
and left ventricular end-diastolic pressure (Kennedy et al 1980); it involves 
exponential functions and needs a computer or programmable calculator to 
perform. A simplified method of determining left ventricular function (as a 
substitute for the complex left ventricular score) has been described (Pierpont et al 
1985). 
3. 2. 5 Other large studies 
Another impressively large study of over 12000 coronary artery surgery patients 
comes from Australia (Iyer et al 1993 ). The study analyses operative mortality and 
myocardial infarction in patients undergoing CABG for the first time between 1978 
and 1990. The overall operative mortality was impressively low at O. 99%, and 
showed what superficially appeared to be a decreasing trend between 1978 and 
1990, with a mortality of0.4% for the final year of the study, although univariate 
analysis showed epoch of operation not to influence the outcome. 
By stepwise logistic regression, the authors found that age, female sex, poor 
ventricular function, the presence of unstable angina, and bypass time were related 
to higher operative mortality, and they derived a general logistic model risk 
equation from this data. By similar statistical methods, the epoch of the operation, 
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3.2. 6 Patients with an intraaortic balloon pump 
In a more limited or defined setting, variables to predict mortal
ity in patients who 
need an intraaortic balloon pump to separate from cardiopulmo
nary bypass have 
been identified from an analysis of 322 such patients. These in
clude need for 
temporary pacing, advanced age, preoperative blood urea nitro
gen concentration, 
and female sex (Baldwin et al 1993). 
3. 2. 7 Parsonnet score 
The Parsonnet score is described in some detail, as it was selec
ted by the Royal 
Brompton National Heart and Lung Hospital to assess preoper
ative risk for 
patients undergoing cardiac surgery. The authors retrospectiv
ely analysed 17 
variables ( all of which had to be available for every patient, and
 to be objective and 
not derived measurements) in 3 500 adult patients undergoing o
pen-heart surgical 
procedures (Parsonnet et al 1989). The outcome measure was
 death within 30 
days. Using univariate and multivariate logistic regression a m
odel was derived, 
using 15 statistically significant variables. This model was then
 tested 
prospectively in 1332 patients, and the predicted vs observed m
ortality correlation 
coefficient was O. 99. The following variables were excluded fr
om analysis as they 
were either too subjective, indefinable, or unavailable: the pres
ence of chronic 
obstructive airways disease, bypass time, the number of bypass
 grafts and the use 
of the internal mammary artery, and operative priority. The va
riables making up 
the score appear in Figure 3. 1. 
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Figure 3.1 
Variables making up the Parsonnet score, with their respective points. 
Female sex 
Morbid obesity(> l .5X ideal weight) 
Diabetes 
Hypertension (Systolic BP> 140 mm Hg) 
Ejection fraction Good (~ 50%) 
Fair (30-49%) 
Poor (<30%) 
Age 70-74 years 
75-79 years 
~ 80 years 
Reoperation First 
Second 
Preoperative Intraaortic Balloon Pump 
Left ventricular aneurysm surgery planned 
Emergency surgery after PTCA */catheter 
Dialysis dependency 
Catastrophic states 
Other rare events 
Valve surgery Mitral 
Pulmonary artery pressure ~ 60 mm Hg 
Aortic 
Peak Systolic Gradient > 120 mm Hg 
CABG and valve surgery 
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3.2. 7 .1 Problems with the Parson net score 
3. 2. 7. 1.1 Methodology 
The methodology of the score has been criticised on two points (Spiegelhalter 
1992). Firstly it is not clear in the text as to where univariate and multivariate 
analyses were performed. Secondly, the comparison between the anticipated and 
the observed mortality, and between two different models, was tested by simple 
regression. The quoted measure of correlation was a correlation coefficient. The 
correct method of comparing two methods of clinical measurement, by plotting the 
difference against the mean, has been described (Bland & Altman 1986). 
3.2. 7.1.2 Allocation of points 
In general, the definitions and criteria for the variables that make up the score are 
objective and simple to apply. The most glaring weakness in the score is the 
arbitrary allocation of points in the "catastrophic states" and "other rare events" 
categories (up to 50 and 10 points respectively at the discretion of the surgeon). 
This is subject to wide variations between scorers, even if a single scorer always 
allocates the same number of points for a certain condition. In addition, the 
exclusion of potentially important variables such as operative priority and chronic 
obstructive airways disease may weaken the predictive ability. Finally, there are 
differences in interpretation as to whether patients undergoing valve surgery and 
with pulmonary artery pressure~ 60 mm Hg or peak systolic gradient> 120 mm 
Hg should score points for both that valve surgery and the pressure abnormality. 
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3.3 Individual risk factors in CABG surgery 
In a recent review, the effects of impaired left ventricular function, older age, sex, 
and reoperation were singled out as consistent predictors of high operative risk 
(Rosenfeldt & Wong 1993). Another review again singles out the risk factors 
analysed in the above papers, but adds that anaesthetic strategy and the prevention, 
detection, and treatment of perioperative ischaemia are important (Koch & 
Estafanous 1993). 
A wide variety of risk factors have been identified in cardiac surgery; most of these 
appear in the risk systems evaluated in the section above. Even the anaesthetist has 
been implicated as an independent risk factor. In a recent study, both anaesthetist 
and bypass time were identified as being significantly associated with hospital death 
or raised cardiac enzymes (Merry et al 1992). 
The individual factors described below have been well established in CABG 
surgery where patient numbers are large; they are generally accepted but less well 
established for other cardiac surgery procedures. Each factor is well represented in 
the literature and only the most important or recent studies will be reviewed. 
3. 3.1 Gender 
Operative mortality in women is higher than in men. This was clearly shown in the 
CASS study, where most of this risk was attributed to their smaller vessels and 
stature (Fisher et al 1982). Subsequent studies have also shown female sex to be 
an independent risk factor (Loop et al 1983, Hannan et al 1992). The effect 
continues in the long term; ten and fifteen year survival is significantly worse in 
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females than in males (Rahimtoola et al 1993). However concerns have been 
raised that this increased risk may have become a self-fulfilling prophecy, as 
women may be referred for surgery later than men (Tobin et al 1987, Khan et al 
1990, Bickell et al 1992). 
3.3.2Age 
Older age is an independent predictor of operative mortality (Weintraub et al 1991, 
O'Connor et al 1992). Patients over 65 years were shown to have significantly 
higher mortality in the CASS study (Gersh et al 1983). The effect of age has been 
recently reviewed (Mohan et al 1992). Twenty-one studies of at least 100 patients 
from 1973 to 1991 were included in the review, which examined both mortality 
and morbidity. In general terms, both these end-points were higher in the elderly. 
Not all studies reached statistical significance; nevertheless there were no studies 
that showed significantly worse mortality or morbidity in the younger age ranges. 
However female gender ceases to be a risk factor in the elderly; in octogenarians 
there was a trend towards lower operative mortality than men (Mohan et al 1992), 
and older women (70 years or older) were at no greater risk of mortality or 
postoperative complications when compared with younger women or older men 
(King et al 1992). In addition, in patients aged 80 to 93 years, female sex was not 
associated with a worse functional outcome (Glower et al 1992). 
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3.3.3 Impaired left ventricular function 
Poor left ventricular function consistently emerges as an important predictor of 
operative risk. In a recently published study of 124 71 patients undergoing CABG, 
operative mortality was 2.3% for left ventricular ejection fraction greater than 
40%, 4.8% for left ventricular ejection fraction of 20% to 40%, and 9.8% for left 
ventricular ejection fraction ofless than 20% (Christakis et al 1992). In the CASS 
study, operative mortality was 1. 9% when the left ventricular ejection fraction was 
more than 49% and 6. 7% when it was less than 19%; in addition mortality 
increased as the left ventricular wall motion score became more abnormal 
(Kennedy et al 1981 ). More recently, both left ventricular ejection fraction and 
end-diastolic pressure were found to be significantly associated with mortality 
(O'Connor et al 1992). Long term results are also associated with left ventricular 
function; ten and fifteen year survival was significantly worse in patients with 
abnormal left ventricular function (Rahimtoola et al 1993). 
3. 3. 4 Reoperation 
Reoperation is technically more difficult than first-time surgery; in addition as 
surgical results improve and patients outlive their grafts the incidence of 
reoperation will increase from the current 8.3 % (Aki et al 1992). Reoperation 
rates increase with time. For the first five postoperative years the rate of 
reoperation was 0.6% per year but it rose to 2% per year from years 6 to 15 
(Rahimtoola et al 1993). Not unexpectedly, reoperation carries higher risks. This 
is confirmed in the CASS data (Foster et al 1984) and in a large Australasian study 
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(Osaka et al 1988) as well as a study from the Netherlands where the 30 day 
mortality was 7.5% (Verheul et al 1991) and one from the lTK where the 30 day 
mortality was 5.2% (Akl et al 1992). In addition, postoperative morbidity is high 
and perioperative myocardial infarction rates may be more than 9% (Salomon et al 
1990). The risks are not generally thought to be unacceptable when compared 
with the benefits: actuarial survival rates of 90% at 5 years and 88% at 10 years 
have been achieved (Akl et al 1992). 
Even third-time operations are being performed. Numbers are obviously small but 
a recent study of 13 patients observed a hospital mortality of 7. 7% and impressive 
symptomatic improvement (Merrill et al 1993). 
3. 3. 5 Diabetes mellitus 
The data on diabetes mellitus is not as clear. In addition, diabetes may be difficult 
to separate from associated factors such as atherosclerosis, hypertension, and renal 
failure. Diabetics with autonomic dysfunction who underwent ophthalmic surgery 
had a greater incidence of cardiovascular !ability than nondiabetic controls (Burgos 
et al 1989). Although hospital stay was increased in diabetic patients undergoing 
CABG, the overall morbidity was not increased (Clement et al 1988). In another 
study, there was an increased incidence of postoperative arrhythmias, wound 
infections, and respiratory failure (Fietsam et al 1991 ). In insulin dependent 
diabetics with chronic renal failure and silent coronary artery disease, 
revascularisation decreased cardiac morbidity and mortality (Manske et al 1992). 
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3.3. 6 Emergency surgery 
The CASS data for surgery in patients with unstable angina demonstrated an 
operative mortality of 3. 9% and 7 year cumulative survival rate of 79% 
(McCormick et al 1985). Emergency operation after failed angioplasty led to 
significantly higher mortality (12%), morbidity, and length of hospital stay 
(Parsonnet et al 1988). "True" emergency surgery was analysed in 117 patients 
over a five year period; hospital mortality was 14.5% and 36% of patients 
developed major complications (Edwards et al 1990). 
3. 3. 7 Obesity 
Obesity has been shown to be an independent risk factor for perioperative 
morbidity in patients undergoing CABG (Prasad et al 1991 ). In addition obese 
patients had a greater incidence of recurrent angina at a mean follow up time of 
36.9 months. 
3. 3. 8 Confounding issues 
Potential confounding issues when examining risk factors over a period of time 
include differences in operative technique and in patient population. With regard 
to operative technique, the use of arterial grafts has now become widespread and 
long term graft patency is impressive. They include the internal mammary artery 
(Acinapura et al 1992, Naunheim et al 1992), gastroepiploic artery (Suma et al 
1993 ), and more recently a re-emergence of the use of the radial artery ( A car et al 
1992). 
72 
Chapter 3 Literature review: cardiac surgery 
Patient populations also change over time. Higher risk patients are now likely to 
be considered for surgery (N aunheim et al 1988, Jones et al 1991). Populations 
will continue to change as more operations are performed. In addition, with 
patients outliving their grafts or valve replacements, the number of reoperations is 
certain to increase. 
3.4 Summary 
Dissatisfaction with general severity scoring systems may be related to unrealistic 
expectations but areas such as cardiac surgery remain problematic. In this group, 
the changes in both the operative techniques and the patient profiles have led to 
difficulties in interpreting the literature and the large number of preoperative 
predictive systems available may bear witness to this problem. With general 
severity of illness scoring systems avoiding cardiac surgery patients, there certainly 
may be a need to combine preoperative data with intraoperative and postoperative 
physiology, in order to obtain better predictive ability. 
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Methods applicable to the thesis as a whole are discussed in this chapter. More 
specific methods used only in, or relevant only to the separate studies are discussed 
in the Protocol sections of the relevant chapters. 
4.2 Type of study 
All three studies undertaken were prospective and descriptive, with no 
interventions performed upon the patients. 
4.3 Scoring systems 
4.3.1 APACHE II 
The AP ACHE II score (Knaus et al 1985) is based on 11 physiological 
measurements, the Glasgow Coma Scale, age, and previous health status. Each 
physiological measurement is scored from 0-4 points depending on its deviation 
from normal and the total score is determined from the most deranged value of 
each measurement in a designated 24 hour period (generally the first 24 hours in 
the ICU). An example of an AP ACHE II scoring sheet with definitions for age and 
chronic health points is shown in Figure 4. 1. 
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Figure 4.1 
An example of an APACHE II scoring sheet with definitions for age and 
chronic health points (reproduced from Critical Care Medicine 1985; 13:820). 
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4. 3. 1. 1 Problems with the APACHE II methodology 
There have been many criticisms levelled at the objectiveness of the AP ACHE II 
method. Areas of particular concern which were not discussed in Chapter 1 
include the following: 
1. Arterial blood gas analysis. This may be uninterpretable or unrepresentative of 
the acute physiological status of the patient in congenital heart disease, chronic 
pulmonary disease, and in ventilatory manoeuvres such as permissive hypercapnia. 
In addition, if this test happens to be performed more frequently, the likelihood of 
an abnormal result and higher AP ACHE II points might increase. 
2. Glasgow Coma Scale. Extreme caution may be needed in sedated patients, 
those with polyneuritis, or those who are simply deaf. 
3. Emergency surgery. The precise definition of what constitutes emergency 
surgery is open to interpretation. 
4. Reason for admission. For the same patient there may be several reasons for 
admission, which may occasionally give very different risks of death for the same 
AP ACHE II score. 
4.3.1.2 Management of APACHE II methodological problems 
Specific controversial points (Palazzo & Patel 1993) were dealt with in the 
following way in these studies: 
1. Timing of scores. All AP ACHE II data were collected from measurements 
performed in the first 24 hours after ICU admission (Knaus et al 1985). In the 
second and third studies, if a patient was admitted to ICU just prior to surgery, the 
24 hour period began on return from the operating theatre. 
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2. Missing data. There were no missing data for AP ACHE II scoring. 
3. Age. Although AP ACHE II should not strictly be applied to patients under 18 
years of age, we have used it in a few such patients as they have been considered 
"adult" enough to be in an adult ICU. 
4. Chronic health points. These were rigorously applied according to the criteria of 
Knaus et al (Knaus et al 1985). 
5. Blood gases. The pH was taken from the blood gas with the worst value for 
oxygenation (the worst pH during the first 24 hours was independently and 
separately documented in the third study). 
6. Acute renal failure. This was regarded a rise in serum creatinine (to more than 
13 5 µmol/l within the last 24 to 48 hours) and oliguria (less than 13 5 ml urine over 
a consecutive 8 hour period). 
7. Glasgow Coma Scale. This was always scored as 15 (best possible value) unless 
there was clear evidence of neurological dysfunction over and above that caused by 
anaesthetic agents, sedatives, opioid analgesics, and muscle relaxants. It was 
retrospectively scored if abnormalities presumed to have been present all along 
were noted once sedation had worn off 
4.3.2 APACHE III 
The AP ACHE III Prognostic system (Knaus et al 1991) is described in Chapter 1. 
The component variables and their weightings that make up the AP ACHE Ill score 
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Figure 4.2 
Component variables and their weightings that make up the APACHE III 
score (reproduced from Chest 1991;100:1622-1624). 
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Chapter 4 Methods 
(Figure 4.2 continued ... ) 
APACHE III PHYSIOLOGIC SCORING FOR ACID BASE ABNORMALmES 





7.25, <7.30 9 
7.J-0. < 7.35 
7-l.5- <7.40 0 
7.40- < 7.45 5 
7.45. < 7 • .50 0 I 2 
7.50- < 7.55 
7 . .55- < 7.6-0 3 12 
7.60- <7.65 0 
·...-· ~. 
?7,65 
4.3.2.1 Management of APACHE Ill methodological problems 
Much of the AP ACHE Ill methodology is very similar to AP ACHE II and basic 
principles will not be repeated here. Specific points were dealt with in the 
following way in the third study: 
1. Blood gases. The pH/PC02 score was taken from the blood gas with the worst 
value for oxygenation. 
2. Urine output. If a patient who remained in the ICU for less than 24 hours had a 
24 hour urine output of less than 2000 ml, that patient was automatically given a 
value of 2000 ml. If the output was greater than 2000 ml, the value was rounded 
off to the nearest I 00 ml. 
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3. Missing data. Missing data points were tagged as such and the patients were 
given the mean values for the whole study and scored no AP ACHE III points for 
those variables. 
4.4 Computer hardware 
4.4.1 Apple (Apple Computer Inc.) 
The data collection for the first study was performed using an Apple II personal 
computer. 
4.4.2 IBM (International Business Machines Corporation) 
Data collection and all analyses ( database, spreadsheet, graphics, and statistics) for 
the second and third studies were performed using IBM-compatible personal 
computers. They ranged from an IBM XT personal computer with 4 MHz 8086 
microprocessor, through those with 80286 and 803 86 microprocessors, to a more 
recent machine with 66 MHz i486 DX2 microprocessor and 8 Mb of RAM. 
4.4.3 VAX mainframe computer (Digital Equipment Corporation) 
AV AX mainframe computer at the University of Cape Town was used to run the 
BMDP statistical software (see below). 
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4.5 Computer software 
4. 5.1 dBASE II 
dBASE II (Ashton-Tate, Torrance, California, USA) is an early version of a 
programmable relational database (used on an Apple personal computer). 
4.5.2 dBASE IV 
dBASE IV (Ashton-Tate, Torrance, California, USA) is a further development of 
the above relational database with its own programming language and structured 
query language. 
4.5.3 Riyadh ICU Program (RIP) 
The Riyadh ICU Program (RIP) 3.0 (Copyright R Chang 1988, Medical and 
Associated Software House, London, UK) is a DOS based data management 
program consisting of a data entry interface, a database, a number of simple 
statistical functions, and a structured query option which can provide a wide 
variety of reports. It is designed by clinicians specifically for use in an ICU and its 
analyses and predictions are based on a refinement of the AP ACHE II scoring 
system (Chang et al 1987). It was produced to be used for audit, for resource 
management, and as an aid to clinical decision making. 
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4. 5. 4 Paradox 
Paradox 2.0 (Ansa Software, Belmont, California, USA) and Paradox for Windows 
1.0 (Borland International Inc, Scotts Valley, California, USA) are two 
developments of a powerful relational database. The latter program has the 
advantage of an ability to form direct links with Object Vision and to be read 
without the need for conversion in a Quattro Pro spreadsheet. 
4. 5. 5 Object Vision 
ObjectVision 2.1 (Borland International Inc, Scotts Valley, California, USA) is a 
program designed to visually create Windows applications without experience in 
computer programming. The interface is a form which is customised by the user to 
create an unlimited variety of configurations. Procedures and calculations, as well 
as mathematical functions, can be embedded by means of a value tree into an 
application to calculate further field values or carry out commands. Data entered 
into such a program can be automatically linked to a database (in this case a 
Paradox database). The final program can be extFemely sophisticated and can be 
used by someone with minimal knowledge of computers. Examples of an 
Object Vision form and value tree are shown in Chapter 7. 
4.5.6 Quattro Pro 
Quattro Pro for Windows 5. 0 (Borland International Inc, Scotts Valley, California, 
USA) is a Windows based spreadsheet with numerous graphical, mathematical, and 
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statistical functions. It has the advantage of being able to directly read files of 
several formats, including (importantly in this study) Paradox files. 
4. 5. 7 Epistat 
Epistat (Copyright Tracy L Gustafson, Round Rock, Texas, USA) is a simple 
shareware statistical package with basic tests such as 2x2 table analysis. 
4. 5. 8 I nstat 
Instat 2.04 (GraphPad Software, San Diego, California, USA) is a slightly more 
sophisticated statistical package which is extremely user-friendly and has a number 
of help-screens and explanations of the tests and the results. 
4. 5. 9 StatGraphics 
StatGraphics 4.0 and 5.0 (Manugistics Inc, Rockville, Maryland, USA) are 
developments of a powerful personal computer based statistical analysis package. 
They contain more than 250 statistical and system procedures as well as more than 
50 types of graphical function. 
4.5.JOBMDP 
BMDP 7.0 (BMDP Statistical Software Inc., Los Angeles, California, USA) is a 
powerful statistical package capable of performing logistic regression analyses and 
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receiver operating characteristic (ROC) curve analysis. It was run on a VAX 
mainframe computer at the University of Cape Town. 
4.6 Statistical methods 
4. 6.1 Statistical tests 
There was no statistical analysis performed in the first study, apart from the 
calculation of means. 
In the second study, data was statistically analysed using the chi-square test (for 
two-by-two tables), chi-square test for trend and departure from trend (for relation 
between scores and mortality), and the Mann-Whitney test (for two-sample 
analysis of non-parametric data). 
The statistical tests used in the third study are fully described in Chapter 7. 
Statistical analysis was performed using the statistical packages described above. 
4. 6. 2 Statistician 
A qualified statistician (Vic Aber from the National Heart and Lung Institute, 
London) assisted with the analysis of the second study and with the planning of the 
third study. He advised on the way data should be entered and stored for the latter 
study, the best computer hardware and software to use, and on what statistical 
tests would be necessary for the analysis of the data. He tragically died during the 






SEVERITY OF ILLNESS SCORING IN A MULTIDISCIPLINARY 
INTENSIVE CARE UNIT 
5.1 Introduction 
Study 1 
At the beginning ofthis study, severity of illness scoring systems were a relatively 
novel phenomenon with exciting potential applications. None of those then 
available had been extensively validated or gained widespread acceptance, and 
experience with them in South Africa was limited and had not been published. 
These scoring systems included the TISS (Keene & Cullen 1983), SAPS (Le Gall 
et al 1984), and APACHE II score (Knaus et al 1985a). Full descriptions of these 
systems appear in Chapter 2. In addition there were no established definitions of 
organ failure, an area thought by many clinicians as likely to be of major prognostic 
significance, and possibly more important for this purpose than severity of illness 
scores. 
5.1.1 Aims of this study 
This study therefore aimed to evaluate the TISS and AP ACHE II systems in a 
general ICU, with respect to general utility and outcome predictive ability, and to 
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prospectively evaluate a set of locally developed definitions of organ failure ( see 
below for these definitions). ICU mortality was the proposed endpoint. 
5.2 Protocol 
5.2.1 Site 
Groote Schuur Hospital in Cape Town is a general hospital functioning as a 
primary, secondary, and tertiary referral centre. It is an undergraduate and 
postgraduate teaching hospital affiliated to the University of Cape Town, as well as 
being a basic and post-basic training centre for nurses and paramedical personnel. 
It has a potential total of approximately 1700 beds though due to staffing 
constraints this is not realised and only about 1450 beds are utilised. The hospital 
is state-funded and admits all patients; the fee structure is based on income and 
patients unable to pay receive free treatment. It is important to state that even at 
the time of the study the hospital was fully racially integrated in terms of both 
patients and staff 
The Respiratory ICU is a multidisciplinary ICU which admits all categories of 
patient. It has 10 beds in two open-plan units of 6 and 4 beds; there is a separate 
3-bedded isolation unit. It is staffed by a full-time director (who controls policy for 
admission, discharge, and therapy), two full-time consultant anaesthetists, and four 
part-time consultant pulmonologists who take part in the consultant call roster. 
There are two registrars from the Department of Medicine and two from the 
Department of Anaesthetics who provide 24 hour in-house physician cover. 
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5. 2. 2 Entry criteria 
All patients admitted to the Respiratory ICU at Groote Schuur Hospital during 
1985 and 1986 were included in this study. The patients were admitted from all 
disciplines including medicine, surgery, trauma, obstetrics and gynaecology, and 
there were also referrals from outside hospitals, both private and state-funded. 
Criteria for ICU admission were stringent: the majority of patients admitted 
required ventilatory support and/or intensive haemodynamic monitoring. Patients 
with primary cardiac disease were usually admitted to a specialised coronary care 
unit while neurosurgery and cardiac surgery patients were also usually admitted to 
specialised units unless they had multisystem dysfunction or developed multiple 
organ failure. 
In addition, all patients admitted to the Respiratory ICU in 1989 had their risk of 
dying calculated from the AP ACHE II risk equation in order to assess the 
performance of the ICU (Knaus et al 1985a). 
5. 2. 3 Exclusion criteria 
There were no exclusion criteria. 
5. 2. 4 Data collection 
All data were collected prospectively onto a specially designed data sheet. This 
sheet was initially filled in by the registrar looking after the patient, and on 
discharge of the patient a consultant checked it for accuracy and data integrity. 
Data collected included demographic information, primary and secondary 
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diagnoses, and detailed information on the clinical course of the patient, procedures 
performed, drugs used, complications, and outcome. Patients were scored on 
TISS, AP ACHE II and the Cape Town organ failure score (see section below for 
definitions) during the first 24 hours of admission. From the data sheet, data were 
entered into a dedicated database for analysis ( dBase II, Ashton-Tate, Torrance, 
California, USA) on an Apple (Apple Computer Inc.) microcomputer. When new 
computer hardware and software became available, the database program was 
rewritten for dBase IV (Ashton-Tate, Torrance, California, USA) on an IBM 
(International Business Machines Corporation) microcomputer. This program 
included the calculation of the risk of dying for each patient (Knaus et al 1985a). 
5. 2. 5 Therapeutic Intervention Scoring System (TISS) 
The Therapeutic Intervention Scoring System (TISS) was introduced in 1974 
( Cullen et al 197 4) and updated in 1983 (Keene & Cullen 1983) to address 
innovations in the practice of critical care. Some items were deleted, some added, 
and others adjusted. The update evaluates 76 therapeutic tasks in 3 categories: 
active management, monitoring and ward care. Each applicable task is evaluated 
on a score of 1-4 depending on the intensity of intervention of medical or nursing 
care. TISS tasks and scores appear in Figure 5.1. The detailed explanations 
appear in the original text (Keene & Cullen 1983). On a daily basis, points from all 
tasks applicable to the patient are summed; the total is the TISS score. 
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Figure 5.1 
TISS tasks with point allocation. 
4 points 
1. Cardiac arrest and/or countershock within past 48 hours. 
2. Controlled ventilation with or without PEEP. 
3. Controlled ventilation with intermittent or continuous muscle relaxants. 
4. Balloon tamponade ofvarices. 
5. Continuous arterial infusion. 
6. Pulmonary artery catheter. 
7. Atrial and/ or ventricular pacing. 
8. Haemodialysis in unstable patient. 
9. Peritoneal dialysis. 
10. Induced hypothermia. 
11. Pressure-activated blood infusion. 
12. G-suit. 
13. Intracranial pressure monitoring. 
14. Platelet infusion. 
15. Intra-aortic balloon assist. 
16. Emergency operative procedures (within past 24 hours). 
17. Lavage of acute GI bleeding. 
18. Emergency endoscopy or bronchoscopy. 
19. Vasoactive drug infusion(> 1 drug). 
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(Figure 5. 1 continued ... ) 
3 points 
Study 1 
1. Central IV hyperalimentation (includes renal, cardiac, hepatic failure fluid). 
2. Pacemaker on standby. 
3. Chest tubes. 
4. Intermittent mandatory ventilation or assisted ventilation. 
5. Continuous positive airway pressure. 
6. Concentrated potassium infusion via central catheter. 
7. Nasotracheal or orotracheal intubation. 
8. Blind intratracheal suctioning. 
9. Complex metabolic (frequent intake and output). 
10. Multiple ABG, bleeding, and/or STAT studies(> 4 per shift). 
11. Frequent infusions of blood products(> 5 units per 24 hours). 
12. Bolus IV medication (nonscheduled). 
13. Vasoactive drug infusion (1 drug). 
14. Continuous antiarrhythmia infusions. 
15. Cardioversion for arrhythmia (not defibrillation). 
16. Hypothermia blanket. 
17. Arterial line. 
18. Acute digitilisation-within 48 hours. 
19. Measurement of cardiac output by any method. 
20. Active diuresis for fluid overload or cerebral oedema. 
21. Active treatment for metabolic alkalosis. 
22. Active treatment for metabolic acidosis. 
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(Figure 5.1 continued ... ) 
23. Emergency thoracentesis, paracentesis, or pericardiocentesis. 
24. Active anticoagulation (first 48 hours). 
25. Phlebotomy for volume overload. 
26. Coverage with more than 2 IV antibiotics. 
27. Treatment of seizures or metabolic encephalopathy (within 48 hours of onset). 
28. Complicated orthopaedic traction. 
2 points 
1. CVP monitoring. 
2. 2 peripheral IV catheters. 
3. Haemodialysis (stable patient). 
4. Fresh tracheostomy (less than 48 hours). 
5. Spontaneous respiration via endotracheal tube or tracheostomy. 
6. GI feedings. 
7. Replacement of excess fluid loss. 
8. Parenteral chemotherapy. 
9. Hourly neuro vital signs. 
10. Multiple dressing changes. 
11. Pitressin infusion IV. 
1 point 
1. ECG monitoring. 
2. Hourly vital signs. 
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(Figure 5. 1 continued ... ) 
3. 1 peripheral IV catheter. 
4. Chronic anticoagulation. 
5. Standard intake and output. 
6. STAT blood tests. 
7. Intermittent scheduled IV medication. 
8. Routine dressing changes. 
9. Standard orthopaedic traction. 
10. Tracheostomy care. 
11. Decubitus ulcer. 
12. Urinary catheter. 
13. Supplemental oxygen (nasal or mask). 
14. Antibiotics IV (2 or less). 
15. Chest physiotherapy. 
16. Extensive irrigations, packings or debridement of wound, fistula, or colostomy. 
1 7. GI decompression. 
18. Peripheral hyperalimentation/Intralipid therapy. 
5.2. 6 Organ failure score (Cape Town) 
This score was conceptualised and developed at about the same time as definitions 
for organ-system failure were published by Knaus et al (Knaus et al 1985). The 
definitions were derived from local clinical experience and are therefore somewhat 
different from the above well-used and now familiar ones. Each organ failure is 
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more simply but less tightly defined and hepatic failure is included. The complete 
definitions are tabulated below (Figure 5.2). 
Figure 5.2 







Serum creatinine > 150 µmol/1. 
Systolic blood pressure < 80 mmHg ( or requiring inotropes 
to maintain blood pressure) with adequate volume 
replacement. 
Requiring mechanical ventilation or Pa02 < 15 kPa on Fi02 
?: 0.5. 
Unconscious (no response to verbal command in absence of 
sedation). 
Bilirubin or liver enzymes > twice normal. 
Platelet count < 50x 1 o9 or white cell count < 2x 1 o9. 
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5.3 Results 
5.3.1 Demographics 
Seven hundred and twenty-eight patients (375 males and 353 females) were 
admitted to the Respiratory ICU during 1985 and 1986. The mean age was 43 
years (range 12-88 years). Of these patients 522 (71.7%) received intermittent 
positive-pressure ventilation (IPPV), 72 (9. 9%) received continuous positive 
airway pressure (CPAP) by facemask, and 101 (14.9%) received oxygen by 
facemask. There were 130 deaths, giving an ICU mortality rate of 17.9%. 
In 1989 there were 3 7 4 admissions, with a mean age of 41.2 years (range 12-85 
years), with 300 patients (80.2%) receiving intermittent positive-pressure 
ventilation. 
5.3.2 Scoring systems and mortality 
The major diagnostic categories, mean TISS and AP ACHE II scores and mortality 




Major diagnostic categories, mean TISS and APACHE II scores and 
mortality rates for the years 1985 and 1986. 
Number TISS APACHE II Mortality(%) 
Year 1985 1986 1985 1986 1985 1986 1985 1986 
Diagnosis 
Pneumonia 43 54 24.3 26.1 20.4 18.2 42 35 
Asthma 60 36 13.7 19.3 15 16 3.3 2.7 
Flail chest 44 45 20.9 19.6 9.9 9.5 6.8 6.6 
ARDS 41 32 23.5 30.4 15.5 17.5 24.4 31 
Postop* 27 23 18.7 23.4 7.6 10.1 3.7 0 
Overdose 25 16 18 21.8 15.8 15.3 16 0 
Other 131 151 
TOTAL 728 19.9 14.1 17.9 
* Elective postoperative admission 
Study 1 
The relationship between severity of illness scores (TISS, AP ACHE II and organ 
failure) and mortality for the total number of patients in 1985 and 1986 are shown 
in Figures 5.3-5.5 (reproduced from South African Medical Journal 1989;76:18-
19). 
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Figure 5.3 
TISS score vs ICU mortality (all patients) 
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Figure 5.5 
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Selected disease categories (pneumonia and adult respiratory distress syndrome 
(ARDS)) with the relation between APACHE II score and mortality in 1985 and 
1986 are shown in Figures 5.6 and 5.7 (reproduced from South African Medical 




APACHE II score vs mortality in patients with ARDS 
100 
n • 73 
80 
11 












0-5 6-10 11-15 16-20 21-25 2&-30 31-35 >35 
APACHE II SCORE 
Figure 5.7 


















0-5 6-10 11-15 16-20 21-25 28-30 31-35 >35 





In 1989 the average APACHE II score was 14.1 (range 1-44). The average risk of 
dying was 17.6% (range 12% - 94.3%). From this figure 65.7 deaths were 
predicted. There were 51 actual deaths (mortality rate 13.6%). The standardised 
mortality ratio (actual deaths divided by predicted deaths) was therefore 0.776. 
5.4 Discussion 
These three systems were selected for evaluation because they cover a broad 
spectrum of ways to score severity of illness. The AP ACHE II score has been 
shown to predict severity of illness efficiently if mortality is used as the end-point 
(Knaus et al 1985a). It has also been found to be useful in comparing the quality of 
care provided by different ICUs (Knaus et al 1986) and may be of value in 
assessing therapeutic protocols and evaluating efficacy of new treatments. In our 
study we have confirmed that TISS, AP ACHE II and the organ failure score all 
show a good relation with mortality in all patients admitted to the Respiratory ICU 
when they were scored over the first 24 hours after admission. Mortality in 
relation to severity of illness in individual disease groups (e.g. pneumonia) indicates 
a similar outcome in our ICU for 1985 and 1986, which suggests that the quality of 
care for the 2 years remained the same. The organ failure score appeared to show 
the best relation between increase in score and mortality. APACHE II and the 
organ failure score proved to be easy and quick to perform. Both score the 
severity of illness by measuring physiological deviation ( directly in the case of 
AP ACHE II, indirectly in the organ failure score) from normal and thus would 
appear more valuable than TISS, which measures the degree of invasiveness of 
management and investigation and degree of monitoring of the patients. Although 
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TISS may determine the severity of illness in an individual ICU, it may be of less 
value when comparing different ICUs where different levels of invasive 
management are used, either because of availability of resources or treatment 
philosophy. Although the predictive value of these scoring systems was high there 
were notable exceptions, since some patients with low scores died. These deaths 
were usually due to sudden unexpected events (intracranial haemorrhage, 
unexplained cardiac arrest), late complications (progressive multiple organ failure 
secondary to sepsis) or delayed effects (paraquat poisoning). 
In certain individual diseases, notably pneumonia, the relation between severity of 
illness scores and mortality is excellent. However, in the group of patients with 
ARDS the relation between AP ACHE II and mortality is very poor. This is 
probably due to the heterogeneous causation of ARDS and subsequent 
complications which may develop. If ARDS were to be defined by specific causes 
the relation with these scoring systems might be improved. However, numbers 
were too small in our study to separate aetiological groups. Even in individual 
diseases, however, the correlations between mortality and score were insufficiently 
accurate to determine individual patient outcome. Scoring patients on subsequent 
days after initiating therapy, which would evaluate response to treatment, might 
improve the prognostic value in individual patients. 
The organ failure score showed the best overall correlation with mortality and is 
the simplest system to use. Knaus et al have used and validated a system which 
examines only 5 organ systems, namely cardiovascular, respiratory, renal, 
haematological and neurological failure (Knaus et al 1985b ). They have shown 
that 3-organ failure on day 1 predicts about 80% mortality and a 3-organ failure 
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score on day 5 predicts 100% mortality, as does 3-organ failure on subsequent 
days, thus allowing prognostic estimates accurate enough to support clinical 
decisions and thereby providing the most appropriate care for the patients. Scoring 
patients later in their illness allows better predictability and decision-making for 
individual patients, and to achieve maximum benefit from severity of illness scores 
these should be repeated on successive days following admission if predictive 
decisions are to be made in individuals. 
The ICU mortality ratio of O. 77 6 calculated for 1989 admissions compares 
favourably with those reported by Knaus et al (Knaus et al 1986) when evaluating 
outcome in 13 major medical centres in the USA. In this study, mortality ratios 
ranged between 0.59 and 1.58. Knaus et al found that a full-time director, 24-hour 
in-unit physician coverage, and a well coordinated staffing structure were most 
important in determining the performance ofICUs in the USA. In the Respiratory 
ICU, all these positive features are present. 
5.5 Conclusions 
Scoring of severity illness is valuable for measuring the standard of care in 
intensive care units. The AP ACHE II scoring system is particularly well suited for 
this purpose, since it is easy to perform and, done on admission, will allow results 
of intensive care management to be compared nationally and internationally. In 
addition, the results of different therapies can be compared, because AP ACHE II 
accurately predicts severity of illness in a large group of patients. It may also be 
valuable in identifying problem areas and allowing changes in therapy to be 
carefully monitored. For making a decision regarding an individual patient, 
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however, the organ failure system is more valuable, using the definitions of Knaus 
et al (Knaus et al 1985b) and particularly if it is extended up to and possibly even 
beyond day 7. 
Having evaluated AP ACHE II in a general ICU setting and found the above 
limitations, especially the disease-specificity, it seemed pertinent to examine its 
performance in a narrower patient profile. An opportunity presented itself to study 
this in cardiothoracic surgery patients, and this is described in the next chapter. 
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CHAPTERS 
Study 2 
APACHE II SCORING IN A CARDIOTHORACIC SURGERY INTENSIVE 
CARE UNIT 
6.1 Introduction 
The AP ACHE II score has not previously been evaluated in a large number of 
patients undergoing cardiothoracic surgery, apart from those patients used in the 
original AP ACHE II database (where the numbers were given in the details for 
calculations for risk of dying (Knaus et al 1985a). In addition, patients admitted 
to ICU after coronary artery bypass grafts (CABG) were later to be excluded from 
the AP ACHE III data collection and prognostic system (Draper et al 1989, Knaus 
et al 1991a)). 
Cardiothoracic surgical patients are unique in several ways. Firstly, they may have 
severely abnormal physiology after surgery and cardiopulmonary bypass, most of 
which will revert to normal spontaneously and over a short period of time, and 
which may have no bearing on outcome. Secondly and conversely, many 
physiological abnormalities may be masked by multisystem support devices such as 
pacemakers, inotropic drugs, intra-aortic balloon pumps, mechanical ventilation, 
and haemofiltration. Thirdly, morbidity and mortality may be related to the 
presence of chronic health status (which scores only 2 AP ACHE II points in 
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elective postoperative patients) and to unpredictable and unexpected events 
occurring in the immediate postoperative period. It would therefore not be 
unexpected if the AP ACHE II scoring system, essentially only looking at a short 
period of physiological measurements, were a poor predictor of outcome in this 
group of patients. 
6.1.1 Aims of this study 
This study was set up to evaluate the applicability of the AP ACHE II scoring 
system in cardiothoracic surgical patients by correlating AP ACHE II scores and 
predicted risk of dying with mortality. 
6.2 Protocol 
6.2.1 Site 
The Royal Brompton National Heart and Lung Hospital in London is a tertiary 
cardiothoracic referral centre and as such deals with a large number of high-risk 
patients. Both NHS and private patients are admitted, and there are also contracts 
with other health authorities and foreign governments. 
The Adult ICU has a potential of 14 beds and deals principally with immediate 
post-surgical cardiac and thoracic patients. However not all such patients are 
admitted to the ICU; low risk patients go from the Operating Theatre to a 
Recovery area for a few hours and from there to a High-Dependency Unit in the 
ward. Other less frequently admitted patients include those with acute lung injury, 
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major vascular surgery, and cardiology patients needing mechanical support 
(mechanical ventilation, haemofiltration, or intra-aortic balloon pump). 
Study 2 
The ICU is staffed by a director and a team of intensivists ( consultants from 
anaesthetics and thoracic medicine), as well as a rotating surgical senior house 
officer and an anaesthetic registrar. The patients are managed jointly by their 
surgeons and the intensivists. There is 24-hour in-house physician cover provided 
by a surgical senior house officer and an anaesthetic registrar; there is always a 
consultant intensivist on call. 
6. 2. 2 Entry criteria 
All patients admitted to the Adult ICU of the Royal Brampton National Heart and 
Lung Hospital between 25/09/1987 and 24/11/1988 were consecutively entered 
into the study. A subset of patients was subsequently excluded for purposes of 
analysis (see Section 6.3.1 below). 
6. 2. 3 Exclusion criteria 
There were no exclusions. 
6. 2. 4 Data collection 
Physiological data appropriate to the AP ACHE II scoring system (Knaus et al 
1985a) were collected daily, verified by checking patient charts, and together with 
demographic data were entered into a dedicated computer program for analysis 
(Riyadh ICU Program 3.0, Copyright R Chang 1988, Medical and Associated 
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Software House, London, UK). Risk of dying was calculated for each patient 
using the AP ACHE II score and a logistic regression formula (Knaus et al 1985a). 
Some data fields (including demographics, reason for admission, details specific to 
each operation performed, duration of ventilation and ICU stay, chronic health, 
emergency status, and outcome) were later entered from the original data sheets 
into another database (Paradox 2.0, Ansa Software, Belmont, California, USA) for 
ease and flexibility of analysis and to facilitate transfer of data to a statistical 
analysis program (Statgraphics 4.0, Manugistics Inc, Rockville, Maryland, USA). 
The original data collection and data entry was performed by Drs Cliff Morgan and 
Yugan Mudaliar. Data entry to the subsequent database and all analyses were 
performed by myself 
The physiological values used for the AP ACHE II score were based on the worst 
values for that 24 hour period except for the Glasgow Coma Scale which was 
scored as 15 (best possible value) unless there was clear evidence of neurological 
dysfunction. This was retrospectively scored if abnormalities were noted once 
sedation had worn off. 
6.3 Results 
6.3.1 Demographics 
A total of 869 consecutive patients was entered into the study. The data on 12 
patients were incomplete, 43 patients had non-surgical diagnoses, and 3 patients 
had non-cardiothoracic operations. This left a total of 811 cardiothoracic surgical 
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patients for analysis, and all the results below pertain to this group of patients 
alone. 
The mean age was 57 years (range 15-87 years), 78% of patients were male and 
22% were female, and the mean duration of admission was 2.3 days (median 1 day, 
range 1-39 days). Elective surgery was performed in 90.3% of patients and 
emergency surgery in 9.7%. 
Surgical procedures performed on the study patients are listed in Table 6.1 




Surgical procedures with mean APACHE II scores and predicted (by 
APACHE II) and actual ICU mortality rates. 
Study 2 
Procedure Number APACHE II Predicted (%) Actual 
(%) 
CABG* 527 8.9 3.4 3.2 
Valve surgery 186 10.4 5.7 4.3 
Thoracic surgery 37 10.6 9.1 13.5 
Congenital disorders 26 8.6 4.0 11.5 
Other cardiac 14 11.3 10.7 14.3 
Transplants 12 13.9 13.4 8.3 
Aortic aneurysm 9 12.3 12.2 11.1 
* CABG = Coronary Artery Bypass Graft 
6. 3. 2 APA CHE II scores and mortality 
The mean APACHE II score was 9.5 (median 9, range 0-33). The ICU mortality 
rate was 4.56% and the hospital mortality rate was 5.43%. The relationship 
between APACHE II score and ICU mortality is shown in Table 6.2 and Figure 6.1 
(chi-square for trend 97.8, p<0.001, chi-square for departure from trend 53.4, 
p<0.001). The overall predicted risk of dying was 4.59%. The relationship 
between predicted risk of dying and mortality is shown in Table 6.3 and Figure 6.2 
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(chi-square for trend 139.0, p<0.001, chi-square for departure from trend 2.1, 
p>O. l). 
Table 6.2 
APACHE II scores and ICU mortality. 
APACHE II Number Mortality(%) 
0-5 128 0.79 
6 - 10 410 0.98 
11 - 15 208 5.29 
16 - 20 42 23.81 
>20 23 47.82 
Figure 6.1 













0-5 >5-10 >10-15 
APACHE II score 
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Table 6.3 
Predicted risk of dying and actual ICU mortality. 
Predicted risk (%) 
0 - 10 
>10 - 20 



























0-10 >10-20 >20-30 >30 
Predicted risk of dying(%) 
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The mean AP ACHE II score of survivors was 9.1 (median 9, range 0-28), while 
that of nonsurvivors was 17.0 (median 16, range 5-33), p<0.001, Mann-Whitney 
test. 
There was a significant correlation between AP ACHE II score and duration of 
ventilation (p<0.001) and between APACHE II score and duration ofICU 
admission (p<O.001). 
6. 3. 3 Chronic health 
There was a significant difference in mortality between patients with a chronic 
health history as defined by the APACHE II scoring system (n=145, mortality 
11.0%, mean APACHE II score 12.2) and patients without (n=666, mortality 
3.15%, mean APACHE II score 8.9), p<0.001, chi-square test. 
6.3.4 Ventilation 
ICU survivors were ventilated for a mean duration of 1.6 days (median 1 day, 
range 0-29 days) while nonsurvivors were ventilated for a mean of 9.3 days 
(median 9 days, range 1-37 days), p<0.001, Mann-Whitney test. 
6. 3. 5 Duration of admission 
The mean duration of admission of patients who were discharged alive from ICU 
was 2.0 days (median 1 day, range 1-30 days) while that of patients who died in 
ICU was 9.8 days (median 5 days, range 1-39 days), p<0.001, Mann-Whitney test. 
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6.3. 6 Emergency surgery 
Patients who had elective surgery had a mortality rate of 4.0%, while those who 
had emergency surgery had a mortality rate of 11.4%, p<0.01, chi-square test. 
6.3. 7 CABG patients only 
The subgroup of patients undergoing CABG (n=527) had a mean age of 57.5 years 
(range 33-79 years) and a mean duration of admission of 1.86 days (range 1-27 
days). Elective surgery was performed in 91.8% of patients, and emergency 
surgery in 8.2%. There were only two patients who survived the ICU to die in 
hospital, so hospital mortality will not be separately analysed. 
The relationship between AP ACHE II score and ICU mortality is shown in Table 
6.4 (chi-square for trend 69.6, p<0.001) and Figure 6.3, while the relationship 
between predicted risk of dying and mortality is shown in Table 6. 5 ( chi-square for 
trend 131.4, p<O.001 ), with no bar chart to accompany it. 
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Table 6.4 
APACHE II scores and ICU mortality in CABG patients. 
APACHE II Number Mortality(%) 
0-5 90 1.11 
6-10 287 0.69 
11-15 122 2.46 
16-20 14 28.57 
>20 12 58.33 
Figure 6.3 
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Although the AP ACHE II scoring system has been evaluated in large studies in a 
wide number of general and specific applications, this is the first large study of its 
use in cardiothoracic surgical patients. It is also the first independent study 
( outside the AP ACHE II database). Due to the unique physiological disturbances 
in these patients ( not necessarily indicative of a poor outcome) it was necessary to 
assess its validity and predictive powers as well as its shortcomings. 
The patient profile reflects the type of patient undergoing cardiothoracic surgery in 
First World countries today: generally older (mean age 57 years), males (78% 
males in this study), and often with a positive chronic health history (18% in this 
study). The majority (65%) of patients had coronary artery bypass grafts, a result 
of the high incidence of ischaemic heart disease in such countries. 
The AP ACHE II scores in this study were generally lower than those found in 
general ICUs worldwide (Marsh et al 1990, Lockrem et al 1991, Rutledge et al 
1991, Jacobs et al 1988, Turner et al 1989, Joshua et al 1989, Dragsted & Qvist 
1989b, Giangiuliani et al 1989, Berger et al 1992, Oh et al 1993, Chisakuta & 
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Alexander 1990, Rowan et al 1993). This is not unexpected as the cardiovascular 
system is often the only organ-system involved in these patients; even when 
patients score AP ACHE II points for temperature and blood gases, biochemical 
abnormalities are rare. Other reasons are that the Glasgow Coma Scale was scored 
as 15 out of 15 in the AP ACHE II score (leading to no neurological points being 
scored) unless there was obvious neurological impairment, and that patients 
undergoing elective surgery score only 2 AP ACHE II points for chronic health. 
No patient with an AP ACHE II score ofless than 5 died, and the mortality rate for 
the 538 patients with scores less than 10 was 0.93%. This is useful prognostic data 
for survival. Unfortunately, prognostic data for death is less helpful. Mortality 
was only 47.8% when the APACHE II score was greater than 20, with only 23 
patients in this group. Death was certain only when the AP ACHE II score was 
greater than 30, but there was only one patient in this category. Statistical analysis 
suggested a significant relationship between increasing AP ACHE II score and 
mortality which may be exponential. 
The mortality rate for patients with a predicted risk of dying of less than 10% was 
2.15%. Statistical analysis suggested a significant linear relationship between 
increasing risk of dying and mortality. Only a predicted risk of dying of more than 
50% was universally associated with death, but there were only two patients in this 
group. 
The AP ACHE II score correlated well with duration of ventilation and duration of 
ICU admission. This suggests that patients with high scores might benefit from 
more aggressive early therapy in an attempt to shorten these times. However the 
abnormal physiology would in itself probably lead to the use of such therapy. 
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The predicted mortality rate (4.59%) was very close to the actual ICU mortality 
rate (4.56%). Firstly this would suggest the accuracy of the weighting for risk of 
dying based on the AP ACHE II score in cardiothoracic surgical patients. This 
study includes a larger group of cardiothoracic surgical patients than those used in 
the original calculations (Knaus et al 1985a) in which 225 patients had heart valve 
surgery and 90 had surgery as a result of chronic cardiovascular disease. Secondly 
it reflects the performance capability of the ICU. Knaus et al found that a full-time 
director, 24-hour in-unit physician coverage, and a well coordinated staffing 
structure were most important in determining the performance ofICUs in the USA 
(Knaus et al 1986). In the ICU in which this study was performed, there is a full-
time director and 24 hour in-unit physician coverage although care of the patients 
is sometimes loosely defined. However, in the various subgroups there were 
differences between predicted and actual mortality, although the patient numbers 
are obviously smaller. AP ACHE II underestimated mortality for thoracic surgery 
and congenital heart disease surgery. This may be due to referral patterns, as the 
thoracic surgical patients often had advanced neoplastic disease and the patients 
with congenital heart disease had particularly complex problems and had frequently 
had multiple previous operations. On the other hand, AP ACHE II overestimated 
mortality for heart transplants, though the numbers are too small (n=l2) to draw 
any major conclusions from this. 
The markers for mortality were presence of a chronic health history (p<O.001 ), 
length ofICU stay (p<0.001), a high APACHE II score (p<0.001), and the need 
for emergency surgery (p<0.01). None of these markers on its own was able to 
adequately predict mortality. 
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Patients undergoing CABG (65% of patients in the study) had lower mean 
AP ACHE II scores and mortality than the group as a whole. The predicted and 
actual mortality rates were very close (3.4% and 3.2% respectively), and the 
relationship between increasing AP ACHE II score and mortality was good. This is 
the largest group of CABG patients studied to date, and would suggest that 
APACHE II is useful in these patients as a group. However, once again the 
prognostic data for survival, with a mortality rate of O. 79% for patients with 
APACHE II scores ofless than 10, is more useful than the data for mortality. 
6.5 Conclusions 
Low AP ACHE II scores and predicted risk of dying predicted survival with some 
certainty but only very high scores accurately predicted death (in a small number of 
patients). In the final analysis the APACHE II scoring system is useful in generally 
predicting outcome ( and specifically predicting survival in patients with low scores) 
but does not have the power to predict death and thereby potentially influence 
decisions to withdraw therapy. This power might, however, be increased by 
inclusion of preoperative, intraoperative, and postoperative variables. 
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CHAPTER 7 
Study3 
A NOVEL COMBINATION OF PREOPERATIVE, INTRA OPERATIVE, 
AND POSTOPERATIVE FACTORS TO PREDICT OUTCOME IN 
CARDIAC SURGERY 
7.1 Introduction 
Although the major severity scoring systems for general Intensive Care Unit (ICU) 
purposes have matured through two or three generations, they still do not 
adequately address cardiac surgery patients. Patients undergoing coronary artery 
bypass grafts (CABG) were excluded from the AP ACHE III data collection 
(Knaus et al 1991a), and all cardiac surgery patients from the Mortality Prediction 
Model II (Lemeshow et al 1993) and Simplified Acute Physiology Score (SAPS) II 
(LeGall et al 1993). Although mortality for cardiac surgery patients in our unit is 
acceptably low at 3.2% for CABG and 4.3% for heart valve surgery, non-survivors 
stay in the ICU for longer (mean of 9.8 days vs 2 days for survivors), using more 
resources (Turner et al 1991 ). 
Responsible use of ICU facilities and cost containment are becoming more 
important and are significant political issues in the UK, with sweeping changes 
proposed for the National Health System. In addition the cost of intensive care is 
high, with the mean daily cost of survivors in an ICU in the UK being £550 and 
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nonsurvivors £816 (Ridley et al 1993). Medical costs have increased dramatically 
in the last decade (Jacobs & Noseworthy 1990), with much of the expenditure 
occurring in the ICU setting. 
A variety of cardiac operative risk systems have been developed from analyses of 
large numbers of patients (see Chapter 3), several of which derive a numerical 
score. Some of these scores are sums of points allocated for the presence or 
absence of risk factors, while others involve calculation of exponential functions. 
Interpretation of the literature is confusing, as all risk systems evaluate different 
patient populations and types of operation ( some include coronary artery surgery 
only), as well as different combinations of predictive factors and end-points (with 
different definitions for each of these), and although more recent ones have used 
earlier studies as their basis, no single system has gained widespread acceptance. 
In a recent review, the effects of impaired left ventricular function, older age, sex, 
and reoperation were singled out as consistent predictors of high operative risk 
(Rosenfeldt & Wong 1993). The Parsonnet system has been independently 
validated (N ashef et al 1993 ), although this relatively small study has been 
criticised for both its methodology and its conclusions (Spiegelhalter 1992). Part 
of the problem may be that the above studies span many years; patient profile and 
mortality has changed during that time (Naunheim et al 1988) and continue to 
change. The largest study of coronary artery bypass surgery patients is almost 
certainly the Collaborative Study in Coronary Artery Surgery (CASS), which has 
been reported at various times and with regard to various subgroups and has been 
comprehensively reviewed (Anderson 1986). Impressive in size and scope, it 
consists of two elements: a randomised trial of surgical versus medical therapy, and 
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a registry which includes a risk equation to estimate hospital mortality. The risk 
equation involves exponential functions and needs a computer or programmable 
calculator to perform. 
More and more cardiac surgery is being performed on higher-risk patients 
(including more redo operations as more patients outlive their grafts or valve 
replacements), many of whom will do poorly. There was thus a need to develop a 
better prognostic system for these patients, in order to assist in the prediction of 
mortality, complications, and length of ICU stay. 
7.1.1 Aims 
The aims of this study were as follows: 
1. To develop a prognostic index for cardiothoracic surgical patients which may 
ultimately be used to help make decisions to withdraw therapy in hopeless cases. 
2. To develop a predictive index for length ofICU stay and for the occurrence of 
complications. 
7 .2 Protocol 
7.2.1 Site 
(See Section 6.2.1 for basic description). There were some important changes 
between the second and third studies. Firstly the Royal Brompton National Heart 
and Lung Hospital moved about 200 metres to a newly constructed site with new 
equipment in Sydney Street in December 1990. The new ICU has a physical 
potential of 19 beds but is only routinely staffed for 11 beds; additional patients are 
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looked after by staff from nursing agencies. Secondly the junior staffing changed 
to there being three senior house officers directly responsible for the intensivists' 
patients and one responsible for the surgeons' patients. Thirdly the responsibility 
for patient management became more formalised: cardiac surgery patients were 
looked after by the surgeons initially (with exceptions made in the case of the more 
critically ill) and then handed over to the care of the intensivists if they stayed 
longer than 48 hours in ICU. 
7.2.2 The Hewlett-Packard CareVue 9000 data management system 
7.2.2. 1 Introduction 
The Royal Brompton National Heart and Lung Hospital was the first site in the 
United Kingdom to install the Hewlett Packard CareVue 9000 data management 
system (Hewlett Packard, Andover, Massachusetts, California, USA). Its current 
and potential ability for data collection and storage makes it an integral part of this 
study. A full description therefore follows. 
The Hewlett Packard Care Vue 9000 data management system consists of a 
computer hardware system upon which runs a specialised software package 
enabling the rapid recording, storage, display and reporting of a wide range of 
clinical data. It addresses current and future projected needs for patient monitoring 
and the increasingly obvious need for sophisticated online data management. It 
includes a new range of bedside monitoring (the Merlin system) and a 
comprehensive and high powered computer solution to the management of the 
enormous quantity of data that is produced by the monitor and from other sources 
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such as laboratory measurements and patient record data base. Hewlett Packard 
believe they have achieved future proofing by the use of high quality engineering 
and a component based design. That is, the core of the system is a computer type 
system unit with an expansion bus which can contain a range of hardware and 
software expansion cards which can control various types of video display unit and 
provide interfaces to other equipment. Monitoring is broken down into individual 
physiological parameters such as ECG, invasive blood pressure, oxygen saturation, 
etc., and each of these functions is subserved by a separate compact robust module 
which can be plugged in to a purpose built rack system. Currently available and 
soon to be available options cover the whole range of monitoring requirements for 
use in operating theatres, intensive care and coronary care units. 
Actual configurations are variable; currently there is one work station per patient 
bed. The all important software and the appearance of the high resolution 
multicolour display units of the work stations has been designed to maximise user 
friendliness and ease of use whilst the redundancy and obsessional backup of the 
central file server ensures reliability. The screen display can be custom configured 
to almost mimic pre-existing paper records and in so doing to make those paper 
records redundant. The obvious difference is that data entry into the computer 
version is automatically channelled effortlessly and accurately without transcription 
error from the digital output from the network of individual patient monitors. This 
data can then be displayed on the computer screen in either tabular or graphical 
forms depending on preference and individual users can manipulate the display for 
their own personal preference, time scales, combinations of parameters, etc. 
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This system totally replaces nursing charts and is an attractive option in terms of 
labour saving, accuracy, convenience and immediacy. 
7.2.2.2 Hardware 
In normal operation the system runs on two Hewlett Packard 9000 S/300 
computers. In the event of one processor failing the system automatically falls back 
to running on the remaining functioning processor, although there will be some loss 
of speed. The data is stored on two 300 Megabyte hard disks. The disks are 
arranged to back each other up. Thus there is no loss of information in the event 
of a disk failure. A quarter inch magnetic tape drive is provided for archive and 
long term backup. At each bed a workstation is provided. This consists of a 17 
inch high-resolution colour display, a keyboard, and a trackerball. The workstation 
can either be on a table mounting or fitted to a specially designed trolley. The 
workstations are connected to the processors by an Ethernet bridge. A maximum 
of 20 workstations can be supported by a pair of processors. 
There are a number of routes for data input to the system. Information from patient 
monitors is transmitted to a Hewlett Packard Careport. Manually entered data can 
be entered from the bedside workstation using either the keyboard, trackerball or 
screen. In addition facilities are provided to link to other computer systems or non 
Hewlett Packard monitoring instruments via an Ethernet bridge. Two laser 
printers are provided for producing hard copy reports. 
The computers can be sited remote from the clinical area and require no special 
environmental or power supply requirements. A back up power supply is provided 
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with the system. The bedside unit is fairly large ( on a trolley 800mm x 800mm x 
1400mm) and requires a mains supply and signal link cable. 
Facilities are provided for multi user access. This will enable remote review or 
entry of data e.g. from the consultant's office or central station. One workstation 
can support more than one patient, enabling economies to be made in the less 
critical areas. Data can be transferred from one workstation to another. This is 
useful when a patient is moved from one area to another. 
7.2.2.3 Software and facilities 
The application software runs on the Hewlett Packard UNIX operating system. It 
comprises an ALLBASE relational data base on top of which lies object orientated 
code ( C ++) to provide a high degree of system configurability. X windows is used 
for the human interface. Facilities are provided via a remote procedure call to a 
programmatic interface enabling links to other data bases for example Oracle and 
DBase using simple C programs. 
Manual data entry can be in the form of structured text by selection with a 
trackerball or free text may be entered via the keyboard. Facilities may in future be 
provided for data input via a barcode reader. 
Data can be presented in graphical, tabular or text form. The amount of data 
displayed at any instant is determined by the user. Facilities exist for scrolling both 
through data lists and time. The maximum time to present new data on the screen 
is specified as 2 seconds. The screens can be individually configured to suit a 
hospital, unit, patient type or individual. Some configuration can be performed by 
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the bedside e.g. adding drugs whilst others will be performed by the local system 
support team. 
Facilities exist to change any data entered. This action is recorded by the system 
and a comprehensive audit trail provided. The previous data, together with the 
identification of the person changing the data and the time at which this took place, 
is recorded. Password protection is provided and this could be implemented via 
the barcode reader. There are checks on the input of data and if "limits of 
unreasonableness" are violated an alarm is shown. All data is initially stored as non 
validated. This can be changed to validated by the action of an authorised person. 
The software is non hardware specific. This will enable it to be transferred to more 
powerful computers as they become available and thus enable advanced features to 
be developed e.g. artificial intelligence and expert systems. Custom databasing will 
be possible. 
Interfaces: Hewlett Packard undertake to provide software or hardware interfaces 
to any existing hospital data bases or laboratory systems. The potential for 
automatic transfer of any existing computerised data into the Intensive Care data 
base is an extremely attractive option in terms oflabour saving and accuracy, 
convenience and immediacy. 
Severity and Acuity: Most of the components of the APACHE II severity of illness 
scoring system are available from the physiological monitor data and the typically 
available laboratory data. The latest phase of development of the software is to 
automatically compute an AP ACHE II score daily for each patient. The 
Therapeutic Intervention Scoring System (TISS) has been chosen as the most 
representative acuity score and again can be computed mostly from already 
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available data. The automatic or semi-automatic availability of these measurements 
offer an enormously valuable insight into intensive care practice. 
Medical Records: The system provides a configurable template for the 
construction of accurate, prospective comprehensive and legible records. The core 
data is shared by all users but separate sub-units serve the specific purposes of 
nurses, doctors, physiotherapists, pharmacists etc. 
7.2.2.4 Implementation 
Care Vue came on line in the Adult ICU in July 1991 after a 6 week training period; 
a senior nurse was employed specifically for the purpose of training and to solve 
problems during the initial 18 months of implementation. There was no crossover 
period with the simultaneous use of conventional nursing charts and the Care Vue 
system. 
7.2.3 Entry criteria 
All patients undergoing cardiac surgery and subsequently admitted to the ICU were 
consecutively entered into this study. Specifically this did not include surgery for 
coarctation of the aorta, thoracic aortic aneurysm repair (unless the aortic valve 
was involved), or repair or rewiring of sternal wounds. However patients who had 
cardiac procedures which did not involve cardiopulmonary bypass (for example 
closed mitral valvotomy) or aortic cross-clamping (for example pericardiectomy) 
were included. 
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The study period ran from 25/1/93 to 15/1/94 and all ICU admissions during this 
time were eligible for entry into the study. 
7. 2. 4 Exclusion criteria 
Patients excluded from this study included those having other surgical procedures, 
medical patients, and patients who had cardiac surgery but went straight from 
Theatre Recovery to a High Dependency Unit in a surgical ward (locally known as 
"fast track" patients). The reason for not including the latter patients is that their 
APACHE scores are not comparable with those of the ICU patients, as both 
physiological measurements and blood tests are carried out at different intervals in 
the High Dependency Unit; their demographic details are however presented. 
Failed "fast-track" patients are however included in the study group. 
7. 2. 5 Ethical approval 
Ethical approval for this study was obtained from the Ethics and Research 
Committee of the Royal Brompton National Heart and Lung Hospital (Reference 
93/43). The full application is shown in Appendix 1 
7. 2. 6 Variable selection 
A very large number of demographic, clinical, physiological, haematological, 
microbiological, and biochemical variables can be measured but obviously not all 
can be selected for collection and analysis. The precise choice of variables reflects 
the hope and the unstated hypothesis that that combination will be significantly 
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related to an outcome measure. The process involved in defining the variable 
selection began with a review of the literature (see Chapters 2 and 3). Then 
followed identification of routinely performed measurements and tests, together 
with data availability and ease of access. From this a data sheet was produced (see 
below). 
7. 2. 7 Definitions for complications 
Postoperative myocardial infarct: Myocardial infarct confirmed by sequential ECG 
changes and cardiac enzymes. Chest pain not a prerequisite as patients may have 
been anaesthetized/sedated. 
lnotropes: Postoperative introduction of inotropic drugs. Dopamine at a dose of 
less than 5 ug/kg/min not included (such a dose is often used as "renal support"). 
IABP: Postoperative insertion of intra-aortic balloon pump. 
VAD: Postoperative insertion of ventricular assist device (left ventricular assist 
device, right ventricular assist device, or biventricular assist device). 
Ventilated >48 hours: Mechanical ventilation (not including Continuous Positive 
Airway Pressure) for more than 48 hours. 
Reintubation: Does not include accidental extubation and subsequent reintubation, 
or insertion of mini-tracheostomy. 
Pneumonia: Diagnosed by clinical criteria of pyrexia, raised White Cell Count, 
purulent secretions, new infiltrates on chest radiograph, deterioration in gas 
exchange. Protected specimen brush or lavage confirmation not necessary. 
Creatinine x 2: Based on immediate preoperative value. 
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Dialysis: Any form of renal support, usually involving Continuous Veno-Venous 
Haemofiltration (CVVH), or Continuous Veno-Venous Haemofiltration with 
Dialysis (CVVHD). 
Neurological deficit: The presence for more than 6 hours of any neurological 
deficit from confusion to focal deficit. The effects of anaesthetic drugs or sedation 
must be excluded. 
Cardiac arrest: The cessation of effective circulation leading to the initiation of 
Cardiopulmonary Resuscitation. May be caused by arrhythmia, bradycardia, 
asystole, electromechanical dissociation. 
Reoperation: Reopening of the chest for any indication, either in the ICU or in the 
operating theatre. 
Readmission: Readmission to the Adult ICU following ICU discharge but not 
hospital discharge. 
Other: Includes any other complications thought by the investigator or attendant 
surgeons to be of significance. 
7. 2. 8 Data entry 
A data sheet (Figure 7. I) was developed for use in this study after due 
consideration had been taken of the variables chosen to be collected. 
Demographic data, medical histories, physiological data (starting at the induction 
of general anaesthesia), and laboratory investigations were collected from the 
clinical records, the Care Vue 9000 system, and the McDonnell-Douglas laboratory 
computer and entered on to the above data sheets for subsequent entry into the 
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computer program described below. Patients were followed up to hospital 
discharge. 
Study 3 
All data were checked for errors once the data sheet was completed. Data were 
then entered into the microcomputer program, and checked again. 
If the patient was unable to be discharged from the ICU simply because there was 
no ward bed available, the discharge time was taken as the time he would have 
been discharged and the duration of admission calculated from this figure. 
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Figure 7.1 Data sheet 
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7.2.8.1 Computer software and program developed for the study 
An ObjectVision (Borland International Inc, Scotts Valley, California, USA) 
program was developed to handle the data collected. The requirements were for a 
simple and aesthetic screen interface (preferably Windows based) for data entry, 
the ability to allocate points to demographic and physiological information and 
moreover add up these points to calculate scores, and an automatic link to a 
database. 
The final program consisted of three separate computer screen forms: 
demographics (including intraoperative data, complications, and outcome), details 
relevant to the Parsonnet score, and measurements to perform AP ACHE II and III 
scores. An example of two of the forms appears in Figure 7.2. 
Raw data were entered into each form, and a value tree for each field allocated 
points relevant to the above scoring systems. An example of a value tree appears 
in Figure 7.3. From these allocated points a further value tree performed the 
calculations to give the Parsonnet, AP ACHE II, and AP ACHE III scores. 
Each form was linked to a separate Paradox (Borland International Inc, Scotts 
Valley, California, USA) database, with the study number being the index field and 
the common link. Both the raw data and the calculated scores were stored in the 
databases. 
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Figure 7.2 
Examples of Object Vision forms (in this case the forms for demographic data 
and Parsonnet score). 
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Figure 7.3 
Example of an ObjectVision value tree (allocating APACHE ID points to the 
heart rate value). 
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7. 2. 9 Missing data 
All data were available apart from bilirubin and albumin measurements ( only 
relevant to the AP ACHE III score) in only 12 of 1008 ( 1. 19°/o) patients. By 
default, no AP ACHE III points were scored for these variables in these patients. 
7. 2.10 Outcome measures 
Hospital mortality ( or in some studies, 30 day mortality) is a better representation 
of outcome and is much more widely used than ICU mortality. In this study 
variables were thus assessed against hospital mortality. 
7. 2.11 Statistical analysis 
The basic principles of statistical analysis, were discussed in Chapter 4. Statistical 
analyses were performed using Instat 2.04 (GraphPad Software, San Diego, 
California, USA) on a microcomputer, and BMDP 7.0 (BMDP Statistical Software 
Inc., Los Angeles, California, USA) on a VAX mainframe computer at the 
University of Cape Town. 
7. 2. 11. 1 Planning of the study 
A statistician was consulted during the planning of the study and directed the 
analysis. In planning the study, it was estimated that there would be approximately 
1000 patients enrolled in the space of one year; with a hospital mortality rate of 
approximately 4-5 % this would mean 40-50 deaths. The possibility of a type II 
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error emerges when death is used as the outcome measure; this is unlikely to be a 
problem when assessing complications or length of stay. Ideally data collection 
would have continued for longer and involved more patients, but this was not 
possible due to constraints on time and funding. However the integrity of the data 
collection ( collected by a single person dedicated to the project) may partially make 
up for this potential weakness. 
7.2.11.2 Statistical methodology and tests 
Data were statistically analysed as follows. 
Firstly the association between selected simple binary variables and outcome was 
examined by Fisher's exact test. These variables were selected from previous 
experience and from review of the literature. 
Then scores (APACHE II, APACHE III, Parsonnet) and times (ischaemic, bypass) 
were put into groups and tests of association with outcome were carried out using 
the chi-squared for trend test. 
Then comparisons of samples of non-parametric data were performed using the 
Mann-Whitney test. 
Then univariate logistic regression of all preoperative, intraoperative, and 
postoperative variables with hospital outcome was performed. Complications were 
excluded from this model as they occurred at varying times after surgery and their 
presence in the model would have been of little practical use. 
Finally forward stepwise logistic regression was used to find the best predictive 
variables for hospital outcome, important and evaluable complications, and ICU 
stay of more than 24 hours. The BMDP LR program was used for these analyses. 
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All variables relevant to the nature of the models were entered into them. The 
entry and removal P values were O. 1 and O. 15 respectively, and categorical 
variables had to be present in at least 2% of the study population for entry. 
Probabilities were calculated in two steps. 
Firstly the logit was computed, using the following formula: 
Logit = Po+ P1x1 + P2 x2 + .... + PkXic, where Po is the constant and Pn is the 
coefficient for the nth variable and Xn the value of that variable, with n taking the 
values from 1 to k, and k being the total number of variables in the model. 
Secondly the probability of death was calculated using the formula: 
Probability = e1ogit / 1 + e10git 
Finally the fit of the model was assessed by the Hosmer-Lemeshow goodness-of-fit 
statistic (Hosmer & Lemeshow 1989 ), while the performance of the derived model, 
the Parsonnet score, and the AP ACHE II risk of dying were evaluated by 
calculating the area under the receiver operating characteristic (ROC) curve 




7.3.1.1 All ICU admissions 
There were 1298 patients admitted to the ICU during the study period. The main 
diagnostic categories are listed in Table 7.1. The categorisation is observer 
dependent and some categories may be subject to different interpretation. For 
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example, a patient admitted with left ventricular failure may be found to have mitral 
stenosis and then go on to have cardiac surgery. Such a patient might be classified 
as medical or surgical (in this study they are classified as surgical). The cardiac 
surgery grouping here includes surgery for coarctation of the aorta, thoracic aortic 
aneurysm repair, and repair or rewiring of sternal wounds. 
Table 7.1 
Main diagnostic categories (all patients during study period). 
Diagnosis Number 
Cardiac surgery 1054 
Thoracic surgery 97 




There were 87 deaths, giving an overall ICU mortality rate of 6. 7%. 
7.3.1.2 Study patients 
There were 1008 patients who met the entry criteria and were entered into this 
study, out of a total of 1298 ICU admissions during the study period. There were 
733 males and 275 females. Data for age, bypass time, ischaemic time, Parsonnet 
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score, AP ACHE II and III score, and duration of ICU admission, are outlined in 
Table 7.2. 
Table 7.2 
Data for age, bypass time, ischaemic time, Parsonnet score, APACHE Il 
score, APACHE ill score, and duration of ICU admission. 
Variable Mean SD Median Range 
Age (years) 60.29 12.78 63 13-84 
Bypass time (minutes) 92.44 36.42 88 0-336 
Ischaemic time (minutes) 55.87 25.60 51 0-210 
Parsonnet score 7.78 6.69 6 0-33 
AP ACHE II score 11.75 4.17 11 3-33 
AP ACHE III score 42.45 15.23 40 9-132 
Duration (hours) 46.94 108.74 20 7-1440 
Seventy-two patients had emergency surgery, and 49 patients were failed "fast 
tracks". There were 45 patients who had chronic ill-health as defined by AP ACHE 
II, and 3 as defined by AP ACHE III. Operations performed with mean AP ACHE 
Il and APACHE III scores and hospital mortality(%) are outlined in Table 7.3. 
ICU mortality was 2.68%, while hospital mortality was 3.77%. The overall 
predicted risk of dying calculated from AP ACHE II methodology was 5 .31 %, 
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giving a standardised mortality ratio ( actual deaths divided by predicted deaths) of 
0.71. 
Table 7.3 
Operations performed, with mean APACHE II and APACHE ill scores and 
hospital mortality (% ). 
Operation Number AP II AP III Mort 
CABG 646 11.5 40.8 2.48 
CABG + valve surgery 89 14.1 52.6 10.11 
CABG + aneurysm/ablation 7 13.0 48.1 14.29 
Aortic valve surgery 97 11.2 42.2 2.06 
Mitral valve surgery 84 12.1 44.4 2.38 
Double valve surgery 23 10.7 42.3 8.70 
Congenital heart disease 34 9.15 35.6 8.82 
Other valve surgery 6 13.2 48.3 0 
Aortic dissection repair 6 19.3 71.8 33.3 
Other operation 16 13.1 46.9 6.25 
TOTAL 1008 
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7.3.2 Selected single variables and mortality 
Patients who had emergency surgery had a mortality of 13. 89%, while those who 
had elective surgery had a hospital mortality of 2.99% (relative risk 4.64, 95% 
confidence interval 2.35-9.18, P=0.0002, Fisher's exact test). 
Patients admitted on inotropes had hospital mortality of 16. 11 %, while those who 
did not had a mortality of 1.63% (relative risk 9.88, 95% confidence interval 5.23-
18.67, P<0.0001, Fisher's exact test). 
Patients who had an intra-aortic balloon pump (IABP) had a hospital mortality of 
23.26%, while those who did not had a mortality of 2.90% (relative risk 7.74, 95% 
confidence interval 4.12-14.51, P<0.0001, Fisher's exact test). 
Hospital mortality for patients readmitted to ICU (n=26) was 30.8%, and for 
patients not readmitted was 3.1% (relative risk 10.07, 95% confidence interval 
5.12-19.80, P<0.0001, Fisher's exact test). 
Failed "fast-track" patients had a hospital mortality of 4.08 %, compared with the 
other patients' mortality of 3.75% (P=0.71, Fisher's exact test), while patients with 
a chronic health history as defined by AP ACHE II had a hospital mortality of 6.67 
%, compared with the other patients' mortality of 3.63% (P=0.24, Fisher's exact 
test). 
7. 3. 3 Scoring systems and mortality 
The relationship between Parsonnet and AP ACHE II and III scores and mortality, 
together with chi-squared test for trend and P values, is shown in Table 7.4. 
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Table 7.4 
The relationship between Parsonnet, APACHE II, and APACHE ID scores 
and mortality. 
Parsonnet score Number ICU mortality(%) Hospital mortality (%) 
0-4 381 0.5 0.5 
5-9 254 0 1.2 
10 - 14 198 3 3.5 
15 - 19 117 10.3 12.8 
?:: 20 58 12.1 18.97 
TOTAL 1008 
Chi-squared for trend 46.64 64.29 
P value <0.0001 <0.0001 
AP ACHE II score Number ICU mortality(%) Hospital mortality (%) 
0-5 53 0 0 
6 - 10 332 0 0.6 
11 - 15 466 0.6 1.5 
16 - 20 121 10.7 14.9 
21 - 25 28 14.3 14.3 
>25 8 87.5 87.5 
TOTAL 1008 
Chi-squared for trend 112.9 101.1 
P value <0.0001 <0.0001 
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(Table 7.4 continued ... ) 
AP ACHE III score Number ICU mortality(%) Hospital mortality (%) 
0 - 20 43 0 0 
21 - 40 466 0 0.2 
41 - 60 396 1.2 2.8 
61 - 80 77 13.0 16.9 
81 - 100 23 39.1 43.5 
>100 3 100 100 
TOTAL 1008 
Chi-squared for trend 135.5 135.1 
P value <0.0001 <0.0001 
No patient with an AP ACHE II score ofless than 14 or AP ACHE III score ofless 
than 47 died in ICU, though two patients with APACHE II scores of 8 and 9 
respectively and one with an AP ACHE III score of 3 7 died in hospital. In addition 
there were no survivors with an AP ACHE II score of more than 26 (7 patients) or 
AP ACHE III score greater than 93 ( 6 patients). 
7.3.4 Bypass and ischaemic times and mortality 
The relationship between bypass and ischaemic times and mortality, together with 
chi-squared test for trend and p values, is shown in Table 7.5. 
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Table 7.5 
The relationship between bypass and ischaemic times and mortality. 
Bypass (minutes) Number ICU mortality(%) Hospital mortality (%) 
0 - 60 155 0.7 1.9 
61 - 120 685 1.6 2.3 
121 - 180 147 8.8 9.5 
181 - 240 14 0 14.3 
> 240 7 28.6 42.9 
TOTAL 1008 
Chi-squared for trend 26.13 33.14 
P value <0.0001 <0.0001 
Ischaemic (minutes) Number ICU mortality (%) Hospital mortality (%) 
0 - 30 110 2.7 3.6 
31 - 60 545 1.5 2.4 
61 - 90 255 3.9 4.7 
91 - 120 79 6.3 8.9 
121 -150 16 0 0 
> 150 3 33.3 66.7 
TOTAL 1008 
Chi-squared for trend 6.57 9.89 
P value 0.01 0.0017 
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7.3.5 Simple combinations of variables and mortality 
There were no simple combinations of preoperative, intraoperative, and 
postoperative factors that unfailingly predicted death in any substantial number of 
patients. 
7.3. 6 Univariate logistic regression 
Results of univariate logistic regression of all variables with hospital outcome are 
shown in Table 7.6. 
Table 7.6 
Univariate logistic regression with hospital outcome. 
Variable Odds ratio (95% CI) P value 
Age 1.04 (1.00-1.07) 0.031 
Albumin 0.88 (0.81-0.95) <0.0001 
Aortic valve surgery 2.07 (1.02-4.18) 0.043 
Acute renal failure 56.05 (20.17-155.72) <0.0001 
Bilirubin 1.03 (1.02-1.04) <0.0001 
Bypass time 1.02 (1.01-1.02) <0.0001 
CABG and valve surgery 4.08 (1.91-8.71) <0.0001 
Creatinine 1.01 ( 1. 10-1.01) <0.0001 
Diabetes 2.55 (1.09-5.97) 0.031 
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(Table 7.6 continued ... ) 
Emergency surgery 5.23 (2.43-11.26) <0.0001 
Failed "fast track" 1.09 (0.25-4.67) 0.907 
Glucose 1.19 (1.08-1.30) <0.0001 
Glasgow Coma Scale 0.505 (0.321-0.794) <0.0001 
Haematocrit 0.94 (0.87-1.03) 0.173 
Heart rate 1.01 (1.00-1.02) 0.005 
Hypertension 1.13 (0.57-2.25) 0.719 
IABP 10.14 (4.55-22.59) <0.0001 
Inotropes 11. 59 ( 5. 84-23. 00) <0.0001 
Ischaernic time 1.02 (1.01-1.03) 0.001 
Potassium 2.00 (1.20-3.33) 0.008 
LVEF 2.34 (1.53-3.58) <0.0001 
LV aneurysm 7.64 (1.53-38.09) 0.013 
Mean arterial pressure 0.92 (0.90-0.95) <0.0001 
Mitra! valve surgery 1.09 (0.42-2.86) 0.854 
Morbid obesity 0.74 (0.17-3.13) 0.679 
Sodium 1.06 (0.96-1.17) 0.267 
Pacing 0.51 (0.07-3.78) 0.508 
PAP> 60 mmHg All survived, therefore not analysed 
Preoperative IABP 8.71 (0.88-85.76) 0.064 
PSG > 120 mmHg 2.89 (0.36-23.38) 0.321 
Reoperation 1.58 (0.94-2.65) 0.083 
Respiratory rate 0.90 (0.85-0.96) 0.001 
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(Table 7.6 continued . . ) 
Sex (male) 




White cell count 
Worst pH 
Acute Physiology Score 
AP ACHE II score 






1. 00 ( 1. 00-1. 00) 
1.03 (0.96-1.10) 
0.004 (0.00-0.12) 
1.45 ( 1.33-1. 57) 
1.41 ( 1. 3 0-1. 5 3) 
1. 10 ( 1. 08-1. 13) 
1.16 (1.11-1.21) 













The model for hospital mortality, derived by forward stepwise logistic regression, 
is shown in Table 7. 7. The Hosmer-Lemeshow goodness-of-fit statistic was 1.282 
(P=0.733). 
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Table 7.7 
Forward stepwise logistic regression model for hospital mortality 
Variable Coefficient Odds ratio (95% CI) 
Bypass time -0.01134 0.989 (0.982-0.996) 
Inotropes -1.285 0.277 (0.119-0.645) 
Mean arterial pressure 0.0694 1.07 (1.04-1.10) 
Urea -0.09081 0.913 (0.858-0.972) 
Glasgow Coma Scale 0.5933 1.81 (1.28-2.55) 
Constant -7.116 
7.3.8 ROC curve analysis 
The areas under the ROC curves for hospital mortality and Parsonnet score, 
APACHE II risk of dying, and the derived model are shown in Table 7.8. The 
ROC curves themselves are shown in Figures 7.4 -7.6. 
Table 7.8 
The areas under the ROC curves for hospital mortality. 
Test 
Parsonnet score 
AP ACHE II risk of dying 
Derived model 







ROC plot of Parson net score vs hospital mortality . 
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Figure 7.5 
ROC plot of APACHE II risk of dying vs hospital mortality . 
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ROC plot of the derived model vs hospital mortality . 
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7.3. 9 Subgroup of CABG patients 
A model was developed in a similar manner to predict hospital outcome in the 646 
patients undergoing CABG only. It is not shown as it included too large a number 
of variables (sixteen) for any practical use. The Hosmer-Lemeshow goodness-of-
fit statistic was 1.615 (P=0.204) 
7.3.10 Complications 
Postoperative complications (see above for the definitions of those chosen for 
evaluation) are shown in Table 7.9. 
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Table 7.9 
Postoperative complications. 
Complication Number of patients 
Postoperative myocardial infarct 5 
IABP (new) 17 
Inotropes (new) 74 
Ventilated > 48 hours 81 
Reintubation 20 
Pneumonia 12 
Creatinine x 2 (from preoperative) 17 
Dialysis 12 
Neurological deficit 15 
Cardiac arrest 18 
Reoperation 53 
Readmission 26 
Any complication occurring in less than 2% of the study population was not 
analysed further. Reoperation and new inotrope administration often occurred 
during the first 24 hours of admission and the physiology variables may have been 
at their worst before, during, or afterwards, making analysis difficult. Readmission 
may be influenced by a number of variables in the ICU and the ward, and therefore 
was not analysed either. A model was developed from all relevant variables to 
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predict the occurrence of ventilation for more than 48 hours but was not practical 
as it included 11 variables. 
7. 3.11 Length of stay in ICU 
The mean length of stay of patients with chronic health by AP ACHE II criteria was 
116. 3 hours ( median 44 hours) while that of patients without chronic health was 
43.7 hours (median 20 hours), P<0.0001, Mann-Whitney test. The mean length of 
stay of failed "fast track" patients was 4 7. 8 hours ( median 21 hours) while that of 
the other patients was 3 1. 1 hours ( median 16 hours), P<O.0001, Mann-Whitney 
test. 
A model was developed from variables available at the time of ICU admission to 
predict a length of stay of more than 24 hours (Table 7.10). There were 230 
patients in this group. The Hosmer-Lemeshow goodness-of-fit statistic was 3. 218 
(P=0.920). 
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Table 7.10 
Model for length of stay more than 24 hours, from variables available at time 
of ICU admission. 
Variable Coefficient Odds ratio (95% CI) 
Emergency surgery 1.283 3.61 (1.95-3.66) 
Failed fast track 1.049 2.85 (1.45-5.61) 
Bypass time -0.01093 1.01 (1.01-1.02) 
Inotropes 1.941 6.97 (4.36-11.1) 
IABP 3.005 20.2 (2.62-155) 
LVEF* 0.3423 1.41 (1.04-1.90) 
Constant -3.402 
* L VEF scored as 1 if ~50%, 2 if 30-49%, and 3 if <30%. 
7.3.12 APACHE II vs APACHE III scores 
AP ACHE II scoring was compared with AP ACHE III scoring in all patients 
entered into the study. The scatterplot is presented in Figure 7.7 (r2 = 0.645). 
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Figure 7.7 
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7.3.13 Cardiac surgery patients not admitted to ICU 
There were 257 patients who had cardiac surgery procedures but were not 
admitted to the ICU during the study period ("fast-track" patients). None died and 
they are not described further. 
7.4 Discussion 
It is perhaps for good reasons that the major severity of illness scoring systems, in 
particular the more recent SAPS II (LeGall et al 1993) and :MPM II (Lemeshow et 
al 1993), have excluded all cardiac surgery patients, while AP ACHE III has 
excluded those undergoing CABG (Knaus et al 1991a). High scores do not 
reproducibly transfer into high mortality, and in addition the ability of 
pharmacological and mechanical support to normalise physiology makes the 
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interpretation of physiology-based scoring systems difficult. We have previously 
found limitations in the application of AP ACHE II scoring in cardiac surgery 
patients (Turner et al 1991) and in this study have attempted to rectify this by 
collecting preoperative and intraoperative variables, as well as using both 
AP ACHE II and III scores and the raw physiological variables that generate them. 
Thus we are not competing with a number of preoperative risk evaluations, which 
obviously cannot take into account the intraoperative course of the patient, but 
rather attempting more accurate prediction by including intraoperative events and 
the physiological abnormalities of the first 24 hours in ICU. Missing data in this 
study was minimal. This may be compared with the AP ACHE II data collection 
where all 12 physiological variables were available in only 87% of patients (Knaus 
et al 1985a), and also with the APACHE III data collection where 99% of patients 
had complete heart rate, respiratory rate, blood pressure, and urine measurements 
and 85% of patients had sodium, potassium, and haematocrit measurements. 
However only 65% of patients had arterial blood gas measurements performed 
(Knaus et al 1991a). 
While demographic data were generally similar to our previous study, there was a 
significant difference in the numbers of patients allocated AP ACHE II chronic 
health points (45 out of 1008 patients here vs 145 out of 811 patients). As the 
patient population is unlikely to have substantially changed, this may show that 
application of the definitions may be more subjective than previously thought. 
Hospital mortality was 3. 77% in the whole study group and 2.48% in the patients 
undergoing CABG alone. These numbers are consistent with current mortality 
rates worldwide (Hannan et al 1990, Geraci et al 1993, Daly et al 1993). 
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Combination of CABG with valve surgery, aneurysm resection, or ablation of 
bypass pathway increased mortality appreciably. The standardised mortality ratio 
of O. 71 looks impressive but it may simply reflect the inaccuracy of current 
physiology-based severity scoring in cardiac surgery. 
The present study was successful in deriving models for mortality and a length of 
stay of more than 24 hours. Models for complications were less useful. Although 
the patient numbers are relatively small, these models are powerful by virtue of 
their derivation, namely forward stepwise logistic regression. This is a very 
powerful statistical tool which allows variables to be objectively selected and 
weighted, with each variable in the final model controlled for the other variables 
(Hosmer & Lemeshow 1989). Of course the choice of which variables to include 
is a subjective one, but if a large enough number of variables is chosen it is unlikely 
that any important ones will be omitted. In addition, the variables in the final 
model may be dependent upon the data set used, as may the size of the coefficients. 
Thus models so derived should be validated using other data sets; split-halves 
validation may go some of the way towards this if the numbers are large enough, as 
in the APACHE III methodology (Knaus et al 1991a). Stepwise forward logistic 
regression in this study allowed the derivation of a model for hospital mortality. 
This model included bypass time, need for inotropes, mean arterial pressure, urea, 
and Glasgow Coma Scale. None of the variables available preoperatively survived 
the regression process. The model fitted the data well, with an impressive Hosmer-
Lemeshow goodness-of-fit statistic and an area under the ROC curve of0.87. 
However the numbers of deaths was small, possibly weakening the predictive 
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ability. In addition, the model is complicated to calculate and the probability of 
death could only be computed after 24 hours. 
On a simpler note, single variables which were statistically associated with hospital 
outcome by 2x2 table analysis included emergency surgery, readmission to ICU, 
and the need for inotropes or IABP. The presence of chronic health (APACHE II 
criteria) was not associated with significantly increased mortality, unlike in our 
previous study, while failed fast-track patients also had no significantly increased 
mortality. The reasons for this are unclear. However, both these groups had 
significantly longer ICU stays. 
Increasing Parsonnet score, bypass time, ischaemic time, AP ACHE II score, and 
AP ACHE III score were all significantly correlated with mortality. This was 
shown in another way by univariate logistic regression. The chi-squared for trend 
values were highest for AP ACHE III and lowest for ischaemic time. The 
Parsonnet score overestimated hospital mortality, particularly in the lower ranges, 
just as it did in a previous UK study (Nashef et al 1992). Low APACHE II and III 
scores were still associated with hospital mortality in a small number of patients, as 
were high scores with survival. There was no combination of Parsonnet score, 
bypass time, or AP ACHE II and III scores which infallibly predicted death in any 
but a very small number of patients; in fact simple AP ACHE II and III scores had 
more patients beyond a 100% mortality cutoff score. 
The AP ACHE II risk of dying had an area under the ROC curve of O. 84. This is 
close to the area of0.85 previously reported for APACHE II (Knaus et al 1991a), 
but not as good as the 0.90 reported for APACHE III (Knaus et al 1991a) or 0.88 
for SAPS II (LeGall et al 1993). These differences may be clinically insignificant. 
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We were unable to calculate AP ACHE III risk of dying as the equations are 
copyright, but as the reasons for admission and treatment locations were similar in 
all patients, the equations may not have added much to the predictive ability. In 
any case the relationship between AP ACHE III and hospital mortality as shown by 
the chi-squared for trend test was impressive. 
In practical terms, however, there are two important reasons for prognostic scoring 
in cardiac surgery. The first is for both the physician and the patient to get an idea 
of likely risk i.e. hospital mortality. This prepares the physician for complications 
and helps stratify the patient into needing ICU admission or not. It also helps the 
patient and family to weigh up the risks and benefits of the surgery and clarifies 
their expectations. The second is to be able to compare results for patients using 
equality of risk groups. The Parsonnet score seems able to perform the first 
function with reasonable facility, with an area under the ROC curve of 0.82; the 
overestimation of risk in low-risk groups was small and in this context not 
necessarily bad. 
A further more pragmatic reason for prognostic scoring (and one that is becoming 
more and more important in the United Kingdom with the ongoing health care 
reforms), is to provide the potential purchasers of health care with comparative 
performance figures. These can be used both to show that the standard of care is 
good and to negotiate prices and contracts for the relevant services. 
The relationship between AP ACHE II and AP ACHE III scores showed a fairly 
wide scatter with a relatively low correlation. This is not entirely unexpected, as 
the scores have markedly different scales for point allocation. There is no "gold 
standard", so further conclusions would be futile. 
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The model derived in this study should ideally have been prospectively validated, at 
least in the same ICU, if not in another cardiac surgery ICU in another country. 
Unfortunately and regrettably this was not possible for a number of reasons beyond 
the control of the researcher. It is hoped that the simpler hospital outcome model 
will be able to be validated in the near future but this will depend upon the 
availability of resources. 
7 .5 Conclusions 
In conclusion, cardiac surgery remains a very complex area for outcome prediction. 
Even the selection of preoperative, intraoperative, and postoperative variables does 
not seem to cover all outcome eventualities although it does improve upon 
available systems. Severity of illness scoring systems provide good predictive 
power for groups of patients, but individual patient prediction remains difficult. 
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CHAPTER 8 
Conclusions, future directions, publications, presentations 
8.1 Conclusions 
There have been important advances in both the growth and development of 
severity of illness scoring systems in the last decade, and the three studies 
presented here follow these trends. They also follow the advances in the 
understanding of the use of these scores and, perhaps more importantly, their 
limitations. 
Severity of illness scoring is certainly an effective means of stratifying critically ill 
patients, both in general ICUs and in most specialised areas. It is also effective in 
outcome prediction in patients as a group, though individual outcome prediction is 
substantially less useful, resulting at times in misconceptions and disappointment. 
This may change with the development of very large international databases and 
the mathematical and statistical ability to derive risk prediction equations and 
thereby improve the ability to predict death or survival with tight confidence 
intervals. 
Cardiac surgery presents particular problems both in the paucity of data regarding 
the use of general severity of illness scores, and in the predictive difficulties implicit 
in the discipline. The combination of variables used in the final study proved to be 
the best mortality predictor evaluated, and may show the way for future predictive 
instruments. 
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8.2 Future directions 
The models developed in the final study should ideally have been prospectively 
validated; this was unfortunately impossible due to a variety of reasons. However, 
depending on the availability of resources, it may be possible to validate the model 
for prediction of hospital mortality in the same ICU. 
It would appear that the combination of preoperative, intraoperative, and 
postoperative variables, as used in the third study, might be the best option for a 
scoring system and outcome predictor, balanced as it is between the preoperative 
risk predictions and the postoperative conventional scoring systems. Future 
studies might address different combinations of such variables, in larger groups of 
patients, and with prospective validation of the derived models. 
8.3 Publications related to this research 
1. Turner JS, Potgieter PD. Scoring severity of illness (Editorial). Southern 
African Journal of Critical Care 1987;3:25 
2. Turner JS, Linton DM, Potgieter PD. Systems for scoring severity of illness 
in intensive care. South African Medical Journal 1989;76: 17-20 
3. Turner JS, Potgieter PD, Linton DM. Severity of disease classification 
system (letter). Critical Care Medicine 1991;19:301-302 
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4. Turner JS, Mudaliar YM, Chang RWS, Morgan CJ. Acute Physiology and 
Chronic Health Evaluation (AP ACHE II) scoring in a cardiothoracic 
intensive care unit. Critical Care Medicine 1991; 19: 1266-1269 
5. Turner JS, Potgieter PD. Severity scoring in ARDS. In: ARDS (Eds Evans 
TW, Haslett C), Chapman and Hall, London, (in press) 
8.4 Abstracts related to this research 
1. Turner JS, Mudaliar YM, Chang RWS, Morgan CJ. APACHE II scoring in 
a cardiothoracic ICU. American Review of Respiratory Disease 
1991;143:A469 
2. Turner JS, Morgan CJ. Outcome prediction in cardiac surgery. Clinical 
Intensive Care 1993; 4: 314 
2. Turner JS, Morgan CJ. A novel approach to outcome prediction in cardiac 
surgery. Chest (in press) 
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8.5 Presentations to learned societies related to this research 
1. The application of severity of illness scoring systems in a Respiratory 
ICU. Congress of the Critical Care Society of Southern Africa, Port 
Elizabeth, South Africa, 1987 (Sabax award for best Registrar 
presentation). 
2. APACHE II scoring in a cardiothoracic ICU. American Thoracic 
Society International Conference, Anaheim, USA, 1991. 
3. Outcome prediction in cardiac surgery. Intensive Care Society (United 
Kingdom), London, England, 1993. 
4. A prospective study of outcome prediction in cardiac surgery. 
Congress of the Critical Care Society of Southern Africa, Johannesburg, 
South Africa, 1994. 
5. APACHE ill scoring in cardiac surgery: comparison with APACHE 
II. Congress of the Critical Care Society of Southern Africa, 
Johannesburg, 1994. 
6. A novel approach to outcome prediction in cardiac surgery. 60th 
Annual International Scientific Assembly of the American College of Chest 
Physicians, New Orleans, USA, 1994 . 
166 
Chapter 9 References 
CHAPTER 9 
References 
Abbott RR, Setter M, Chan S, Choi K ( 1991) AP ACHE II: prediction of outcome 
of 451 ICU oncology admissions in a community hospital. Annals of Oncology 
2:571-574 
Acar C, Jebara VA, Portoghese M, et al (1992) Revival of the radial artery for 
coronary artery bypass grafting. Annals of Thoracic Surgery 54:652-660 
Acinapura AJ, Jacobowitz IJ, Krame MD, et al ( 1992) Internal mammary artery 
bypass: thirteen years of experience. Influence of angina and survival in 5125 
patients. Journal of Cardiovascular Surgery 33:554-559 
Adam BA, Kin LC, Wahab ASA (1989) Therapeutic intervention scoring system in 
medical intensive care. Medical Journal of Malaysia 44: 134-139 
Ak1 ES, Ozdogan E, Ohri SK, et al ( 1992) Early and long term results of re-
operation for coronary artery disease. British Heart Journal 68: 176-180 
American Thoracic Society ( 1991) Withholding and withdrawing life-sustaining 
therapy. American Review of Respiratory Disease 144:726-731 
Anderson RP (1986) Will the real CASS please stand up? A review and 
perspective on the Coronary Artery Surgery Study. Journal of Thoracic and 
Cardiovascular Surgery 91 :698-709 
167 
Chapter 9 References 
Anonymous (1986) TPN and APACHE (Editorial). Lancet i:1478. 
Apgar V (1953) A proposal for a new method of evaluation of the newborn infant. 
Current Researches in Anesthesia and Analgesia 32:260-267 
Arregui LM, Moyes DG, Lipman J, Fatti LP (1991) Comparison of disease 
severity scoring systems in septic shock. Critical Care Medicine 19: 1165-1171 
Artigas A, Carlet J, Chastang C, et al (1992) Adult respiratory distress syndrome: 
clinical presentation, prognostic factors and outcome. In: Adult Respiratory 
Distress Syndrome (eds A. Artigas, F. Lemaire, P.M. Suter, W.M. Zapol), 
Churchill Livingstone, Edinburgh, 509-525 
Baker SP, O'Neill B, Haddon W, Long WB (1974) The injury severity score: a 
method for describing patients with multiple injuries and evaluating emergency 
care. Journal of Trauma 14:187-196 
Baldwin RT, Slogoff S, Noon GP, et al (1993) A model to predict survival at time 
of postcardiotomy intraaortic balloon pump insertion. Annals of Thoracic Surgery 
55:908-913 
Bastos PG, Sun X, Wagner DP, et al (1993) Glasgow Coma Scale score in the 
evaluation of outcome in the intensive care unit: findings from the Acute 
Physiology and Chronic Health III study. Critical Care Medicine 21: 1459-1465 
Baumgartner J, Bula C, Yaney C, et al (1992) A novel score for predicting the 
mortality of septic shock patients. Critical Care Medicine 20:953-960 
168 
Chapter 9 References 
Berger :MM, Marazzi A, Freeman J, Chiolero R (1992) Evaluation of the 
consistency of Acute Physiology and Chronic Health Evaluation (AP ACHE II) 
scoring in a surgical intensive care unit. Critical Care Medicine 20: 1681-168 7 
Bergner M, Bobbitt RA, Carter WB, et al (1981) The sickness impact profile: 
development and final revision of a health status measurement. Medical Care 
19:787-805 
Bickell NA, Pieper KS, Lee KL, et al (1992) Referral patterns for coronary artery 
disease treatment: gender bias or good clinical judgment? Annals of Internal 
Medicine 116: 791-797 
Bion JF, Aitchison TC, Edlin SA, Ledingham IMcA (1988) Sickness scoring and 
response to treatment as predictors of outcome from critical illness. Intensive Care 
Medicine 14:167-172 
Black PMcL (1978) Brain death. New England Journal of Medicine 299:338-344 
and 393-401 
Black PMcL (1985) Predicting the outcome from hypox.ic-ischemic coma: medical 
and ethical implications (Editorial). Journal of the American Medical Association 
254:1215-1216 
Blarney SL, Imrie CW, O'Neill J, et al (1984) Prognostic factors in acute 
pancreatitis. Gut 24: 1340-1346 
169 
Chapter 9 References 
Bland JM, Altman DG (1986) Statistical methods for assessing agreement between 
two methods of clinical measurement. Lancet i:307-310 
Bohnen JMA, Mustard RA, Oxholm SE, Schouten D ( 1988) AP ACHE II score 
and abdominal sepsis. Archives of Surgery 123 :225-229 
Bolsin SN, Morgan C, Ray R ( 1990) A simple, preoperative scoring system for 
predicting mortality and intensive care unit stay in adult patients undergoing heart 
surgery with cardiopulmonary bypass. Journal of Cardiothoracic Anesthesia 4 
(Supplement 3): 139 
Boyd CR, Tolson MA, Copes WS (1987) Evaluating trauma care: the TRISS 
method. Journal of Trauma 27:370-378 
Boyd 0, Grounds RM ( 1993) Physiological scoring systems and audit. Lancet 
341:1573-1574 
Brannen AL, Godfrey LJ, Goetter WE (1989) Prediction of outcome from critical 
illness. A comparison of clinical judgement with a prediction rule. Archives of 
Internal Medicine 149: 1083-1086 
Brawley RK, Merrill W, Gott VL, et al (1980) Unstable angina pectoris. Factors 
influencing operative risk. Annals of Surgery 191:745-750 
Bueno-Ca vanillas A, Rodriguez-Contreras R, Lopez-Luque A, et al ( 1991) 
Usefulness of severity indices in intensive care medicine as a predictor of 
nosocornial infection risk. Intensive Care Medicine 17:336-339 
170 
Chapter 9 References 
Bull JP (1971) Revised analysis of mortality due to bums. Lancet ii: 1133-1134 
Burgos LG, Ebert TJ, Assiddao C, et al (1989) Increased intraoperative 
cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 
70:591-597 
Castella X, Gilabert J, Tomer F, Torres C (1991) Mortality prediction models in 
intensive care: Acute Physiology and Chronic Health Evaluation II and Mortality 
Prediction Model compared. Critical Care Medicine 19: 191-197 
Cerra FB, Negro F, Abrams J (1990) AP ACHE II score does not predict multiple 
organ failure or mortality in postoperative surgical patients. Archives of Surgery 
125:519-522 
Chaitman BR, Rogers WJ, Davis K, et al ( 1980) Operative risk factors in patients 
with left main coronary-artery disease. New England Journal of Medicine 303 :953-
957 
Champion HR, Sacco WJ, Camazzo AJ, et al (1981) Trauma score. Critical Care 
Medicine 9:672-676 
Champion HR, Sacco WJ, Copes WS, et al (1990) A new characterization of injury 
severity. J Trauma 30:539-546 
Chang RWS, Jacobs S, Lee B (1986) Use of APACHE II severity of disease 
classification to identify intensive-care-unit patients who would not benefit from 
total parenteral nutrition. Lancet i: 1483-1487. 
171 
Chapter 9 References 
Chang RWS, Jacobs S, Lee B (1988) Predicting outcome among intensive care 
unit patients using computerised trend analysis of daily AP ACHE II scores 
corrected for organ system failure. Intensive Care Medicine 14:558-566 
Chang RWS, Lee B, Jacobs S, Lee B (1989) Accuracy of decisions to withdraw 
therapy in critically ill patients: clinical judgement versus a computer model. 
Critical Care Medicine 17:1091-1097 
Chang RWS, Bihari DJ (1993) Physiological scoring systems and audit (letter). 
Lancet 342:306 
Chen FG, Koh KF, Goh MH (1993) Validation of the APACHE II score in a 
surgical intensive care unit. Singapore Medical Journal 34:322-324 
Chisakuta AM, Alexander JP (1990) Audit in intensive care. The AP ACHE II 
classification of severity of disease. Ulster Medical Journal 59: 161-167. 
Christakis GT, Weisel RD, Fremes SE, et al (1992) Coronary artery bypass 
grafting in patients with poor ventricular function. Journal of Thoracic and 
Cardiovascular Surgery 103: 1083-1092 
Chu DY (1993) Predicting survival in AIDS patients with respiratory failure. 
Application of the AP ACHE II scoring system. Critical Care Clinics 9: 89-105 
Civetta JM, Hudson-Civetta JA, Kirton 0, et al (1992) Further appraisal of 
AP ACHE II limitations and potential. Surgery, Gynecology and Obstetrics 
175: 195-203 
172 
Chapter 9 References 
Civetta JM, Hudson-Civetta JA, Nelson LD ( 1990) Evaluation of AP ACHE II for 
cost containment and quality assurance. Annals of Surgery 212:266-274 
Civetta JM (1990) "New and improved" scoring systems (Editorial). Critical Care 
Medicine 18:1487-1490 
Civil ID, Schwab CW (1988) The Abbreviated Injury Scale, 1985 revision: a 
condensed chart for clinical use. J Trauma 28:87-90 
Clement R Rousou JA, Engelman RM, Breyer RH (1988) Perioperative morbidity 
in diabetics requiring coronary artery bypass surgery. Annals of Thoracic Surgery 
46:321-323 
Copeland GP, Jones D, Walters M (1991) POSSUM: a scoring system for surgical 
audit. British Journal of Surgery 78:356-360 
Copes WS, Champion HR Sacco WJ, et al ( 1988) The Injury Severity Score 
revisited. Journal of Trauma 28:69-77 
Cullen DJ, Civetta JM, Briggs BA, Ferrara LC (1974) Therapeutic intervention 
scoring system: a method for quantitative comparison of patient care. Critical Care 
Medicine 2: 5 7-60 
Cullen DJ (1977) Results and cost of intensive care. Anesthesiology 47:203-216 
Daly LE, Lonergan M, Graham I (1993) Predicting operative mortality after 
coronary artery bypass surgery in males. Quarterly Journal of Medicine 86:771-778 
173 
Chapter 9 References 
Dart R, Patel B, Perez-Alard J, et al ( 1991) Prognosis of oncology patients 
receiving intensive care using the AP ACHE II scoring system. Maryland Medical 
Journal 40:273-276 
Dawes RM, Faust D, Meehl PE (1989) Clinical versus actuarial judgement. 
Science 243:1668-1674 
Day AC, Rankin APN, Judson JA (1993) Grading asthma severity: using the APS 
component of the APACHE II system. Intensive Care Medicine 19:221-226 
Dobkin JE, Cutler RE (1988) Use of AP ACHE II classification to evaluate 
outcome of patients receiving hemodialysis in an intensive care unit. Western 
Journal ofMedicine 149:547-550 
Dragsted L, Jorgensen J, Jensen NH, et al (1989a) Interhospital comparisons of 
patient outcome from intensive care: importance oflead-time bias. Critical Care 
Medicine 17:418-422 
Dragsted L, Qvist J ( 1989b) Outcome from intensive care. I. A 5-year study of 
1308 patients: methodology and patient population. European Journal of 
Anaesthesiology 6:23-37 
Dragsted L, Qvist J (1989c) Outcome from intensive care III. A 5-year study of 
1308 patients activity level. European Journal of Anaesthesiology 6:385-396 
174 
Chapter 9 References 
Draper EA, Wagner DP, Russo M, et al (1989) APACHE III study design: analytic 
plan for evaluation of severity and outcome in intensive care unit patients. Study 
design-data collection. Critical Care Medicine 17: S 186-S 193 
Dripps RD, Lamont A, Eckenhoff JE (1961) The role of anesthesia in surgical 
mortality. Journal of the American Medical Association 178:261-266 
Ebell MH, Preston PS (1993) The effect of the APACHE II score and selected 
clinical variables on survival following cardiopulmonary resuscitation. Family 
Medicine 25: 191-196 
Edgren E, Hedstrand U, Kelsey S, et al (1994) Assessment of neurological 
prognosis in comatose survivors of cardiac arrest. Lancet 343:1055-1059 
Edmunds LH, Stephenson LW, Edie RN, Ratcliffe .MB (1988) Open-heart surgery 
in octogenarians. New England Journal ofMedicine 319:131-136 
Edwards FH, Albus RA, Zajtchuk R, et al (1989) A quality assurance model of 
operative mortality in coronary artery surgery. Annals of Thoracic Surgery 47:646-
649 
Edwards FH, Bellamy RF, Burge JR, et al (1990) True emergency coronary artery 
bypass surgery. Annals of Thoracic Surgery 1990;48:603-610 
Ephron B, Tibshirani R ( 1991) Statistical data analysis in the computer age. 
Science 253 :390-395 
175 
Chapter 9 References 
Escarce JJ, Kelley MA (1990) Admission source to the medical intensive care unit 
predicts hospital death independent of APACHE II score. Journal of the American 
Medical Association 264:2389-2394 
Fagon JY, Chastre J, Novara A, et al (1993) Characterization of intensive care unit 
patients using a model based on the presence or absence of organ dysfunctions 
and/or infection: the ODIN model. Intensive Care Medicine 19:137-144 
Faxon DP, Ryan TJ, Davis KB, et al (1982) Prognostic significance of 
angiographically documented left ventricular aneurysm from the Coronary Artery 
Surgery Study (CASS). American Journal of Cardiology 50:157-164 
Fedullo AJ, Swinburne AJ, Wahl GW, Bixby KRI (1988) APACHE II score and 
mortality in respiratory failure due to cardiogenic pulmonary oedema. Critical Care 
Medicine 16:1218-1221 
Feller I, Tholen D, Cornell RG (1980) Improvements in bum care, 1965 to 1979. 
Journal of the American Medical Association 244:2074-2078 
Ferraris VA, Propp ME (1992) Outcome in critical care patients: a multivariate 
study. Critical Care Medicine 20:967-976 
Fietsam R, Basset J, Glover J (1991) Complications of coronary artery surgery in 
diabetic patients. American Surgeon 57:551-557 
Firth WJ ( 1991) Chaos-predicting the unpredictable. British Medical Journal 
303:1565-1568 
176 
Chapter 9 References 
Fischl MA, Pitchenik A, Gardner LB ( 1981) An index predicting relapse and need 
for hospitalization in patients with acute bronchial asthma. New England Journal of 
Medicine 305: 783-789 
Fisher LD, Kennedy JW, Davis KB, et al (1982) Association of sex, physical size, 
and operative mortality after coronary artery bypass in the Coronary Artery 
Surgery Study (CASS). Journal of Thoracic and Cardiovascular Surgery 84:334-
341 
Fisher LD, Kennedy JW (1983) Operative mortality in coronary bypass grafting 
(letter). Journal of Thoracic and Cardiovascular Surgery 85: 146-14 7 
Foster ED, Fisher LD, Kaiser GC, et al (1984) Comparison of operative mortality 
and morbidity for initial and repeat coronary artery bypass grafting: the Coronary 
Artery Surgery Study (CASS) registry experience. Annals of Thoracic Surgery 
38:563-570 
Gagner M, Franco D, Vons C, et al ( 1991) Analysis of morbidity and mortality 
rates in right hepatectomy with the preoperative AP ACHE II score. Surgery 
110:487-492 
Geraci JM, Rosen AK, Ash AS, et al (1993) Predicting the occurrence of adverse 
events after coronary artery bypass surgery. Annals of Internal Medicine 118: 18-24 
Gersh BJ, Kronrnal RA, Frye RL, et al (1983) Coronary arteriography and 
coronary artery bypass surgery: morbidity and mortality in patients ages 65 years 
177 
Chapter 9 References 
or older. A report from the Coronary Artery Surgery Study. Circulation 67:483-
491 
Giangiuliani G, Mancini A, Gui D ( 1989) Validation of a severity of illness score 
(APACHE II) in a surgical intensive care unit. Intensive Care Medicine 15:519-522 
Gilbert J, Schoolfield J (1991) The outcome index and system outcome score: a 
method of quality assurance through outcome analysis in the special care area. 
International Journal of Clinical Monitoring and Computing 8: 85-94 
Glower DD, Christopher TD, Milano CA, et al (1992) Performance status and 
outcome after coronary artery bypass grafting in persons aged 80 to 93 years. 
American Journal of Cardiology 70:567-571 
Goldman L, Caldera DL, Nussbaum SR, et al ( 1977) Multifactorial index of 
cardiac risk in noncardiac surgical procedures. New England Journal of Medicine 
297:845-850 
Goldstein RL, Campion EW, Thibault GE, et al ( 1986) Functional outcome 
following medical intensive care. Critical Care Medicine 14:783-788 
Gross PA, DeMauro PJ, Van Antwerpen C, et al (1988) Number of comorbidities 
as a predictor of nosocornial infection acquisition. Infection Control and Hospital 
Epidemiology 9:497-500 
178 
Chapter 9 References 
Gross PA, Stein MR van Antwerpen C, et al ( 1991) Comparison of severity of 
illness indicators in an Intensive Care Unit. Archives of Internal Medicine 
151:2201-2205 
Grover FL, Johnson RJ, Marshall G, Hammermeister KE (1993) Factors predictive 
of operative mortality among coronary artery bypass subsets. Annals of Thoracic 
Surgery 56:1296-1307 
Hammermeister KE, Burchfiel C, Johnson R Grover FL (1990) Identification of 
patients at greatest risk for developing major complications at cardiac surgery. 
Circulation 82(Suppl IV):380-389 
Hammermeister KE, Kennedy JW (1974) Predictors of surgical mortality in 
patients undergoing direct myocardial revascularisation. Circulation 49(Suppl 
2):112-115 
Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver 
operating characteristic (ROC) curve. Radiology 143:29-36. 
Hannan EL, Kilburn H, O'Donnell JF, et al (1990) Adult open heart surgery in 
New York State. An analysis of risk factors and hospital mortality rates. Journal of 
the American Medical Association 264:2768-2774 
Hannan EL, Beranrd HR Killburn HC, O'Donnell JF (1992) Gender differences in 
mortality rates for coronary artery bypass surgery. American Heart Journal 
123:866-872 
179 
Chapter 9 References 
Hasibeder W, Haisjackl M, Germann R, et al (1993) Physiological scoring systems 
and audit (letter). Lancet 342:307 
Headley J, Theriault R, Smith TL (1992) Independent validation of AP ACHE II 
severity of illness score for predicting mortality in patients with breast cancer 
admitted to the intensive care unit. Cancer 70:497-503 
Hickling KG, Henderson SJ, Jackson R (1990) Low mortality associated with low 
volume pressure limited ventilation with permissive hypercapnia in severe adult 
respiratory distress syndrome. Intensive Care Medicine 16:372-377 
Higgins TL, Estafanous FG, Loop FD, et al (1992) Stratification of morbidity and 
mortality outcome by preoperative risk factors in coronary artery bypass patients. 
Journal of the American Medical Association 267:2344-2348 
Holt AW, Bersten AD, Worthley LI, Vedig AE (1993) Physiological scoring 
systems and audit (letter). Lancet 342:307-308. 
Holt AW, Bury LK, Bersten AD, et al (1992) Prospective evaluation of residents 
and nurses as severity score data collectors. Critical Care Medicine 20: 1688-1691 
Hopefl AW, Taaffe CL, Herrmann VM (1989) Failure of AP ACHE II alone as a 
predictor of mortality in patients receiving total parenteral nutrition. Critical Care 
Medicine 1 7 :414-417 
Hom SD, Hom RA (1986) The Computerized Severity Index. A new tool for case-
mix management. Journal of Medical Systems 10:73-78 
180 
Chapter 9 References 
Horst HM, Mild LJ, Obeid FN, et al (1987) The relationship of scoring systems 
and mortality in the surgical intensive care unit. American Surgeon 53 :456-459 
Hosmer DW, Lemeshow S (1989) Applied logistic regression. New York, John 
Wiley & Sons 
Irwin D, Jessop EG (1993) Severity of sickness at admission to hospital in 
Colchester 1985 and 1990. Public Health 107: 171-17 5 
Istre GR, Gustafson TL, Baron RC, et al ( 1985) A mysterious cluster of deaths and 
cardiopulmonary arrests in a pediatric intensive care unit. New England Journal of 
Medicine 313 :205-211 
Iyer VS, Russell WJ, Leppard P, Craddock D (1993) Mortality and myocardial 
infarction after coronary artery surgery. A review of 12003 patients. Medical 
Journal of Australia 159: 166-170 
Jacobs P, Noseworthy TW (1990) National estimates of intensive care utilization 
and costs: Canada and the United States. Critical Care Medicine 18: 1282-1286 
Jacobs S, Arnold A, Clyburn PA, Willis BA ( 1992) The Riyadh Intensive Care 
Program applied to a mortality analysis of a teaching hospital intensive care unit. 
Anaesthesia 4 7:775-780 
Jacobs S, Chang RWS, Lee B, Lee B (1988) Audit of intensive care: a 30 month 
experience using the AP ACHE II severity of disease classification system. 
Intensive Care Medicine 14:567-574 
181 
Chapter 9 References 
Jacobs S, Chang RWS, Lee B, Lee B ( 1989) An analysis of the utilisation of an 
intensive care unit. Intensive Care Medicine 15: 511-518 
Jennett B, Teasdale G, Braakman R, et al (1979) Prognosis of patients with severe 
head injury. Neurosurgery 4:283-289 
Johnson MH, Gordon PW, Fitzgerald FT (1986) Stratification of prognosis in 
granulocytopenic patients with hematologic malignancies using the AP ACHE II 
severity of illness score. Critical Care Medicine 14:693-697 
Jones DR, Copeland GP, de Cossart L (1992) Comparison of POSSUM with 
AP ACHE II for prediction of outcome from a surgical high-dependency unit. 
British Journal of Surgery 79: 1293-1296 
Jones EL, Craver JM, King SB, et al (1980) Clinical, anatomic and functional 
descriptors influencing morbidity, survival and adequacy of revascularization 
following coronary bypass. Annals of Surgery 192:390-402 
Jones EL, Weintraub WS, Craver JM, et al ( 1991) Coronary artery bypass surgery: 
is the operation different today? Journal of Thoracic and Cardiovascular Surgery 
101: 108-115 
Joshua N, Jena GP, Mletelwa NV (1989) Multidisciplinary intensive care unit at 
Cecelia Makiwane Hospital, Mdantsane, Ciskei. South African Medical Journal 
75:286-289 
182 
Chapter 9 References 
Junod FL, Harlan BJ, Payne J, et al (1987) Preoperative risk assessment in cardiac 
surgery: comparison of predicted and observed results. Annals of Thoracic Surgery 
43;59-64 
Keene AR, Cullen DJ ( 1983) Therapeutic intervention scoring system: update 1983 
Critical Care Medicine 11: 1-3 
Kelly W, Parkin G, King RWF (1986) Intensive care unit audit. Prince Henry's 
Hospital 1983-4. Australian Clinical Review 6: 12-16 
Kennedy JW, Kaiser GC, Fisher LD, et al (1980) Multivariate discriminant analysis 
of the clinical and angiographic predictors of operative mortality from the 
Collaborative Study in Coronary Artery Surgery (CASS). Journal of Thoracic and 
Cardiovascular Surgery 80:876-887 
Kennedy JW, Kaiser GC, Fisher LD, et al (1981) Clinical and angiographic 
predictors of operative mortality from the Collaborative Study in Coronary Artery 
Surgery (CASS). Circulation 63:793-802 
Khan SS, Nessim S, Gray R, et al (1990) Increased mortality of women in 
coronary artery bypass surgery: evidence for referral bias. Annals of Internal 
Medicine 112:561-567 
King KB, Clark PC, Norsen LH, Hicks GL (1992) Coronary artery bypass graft 
surgery in older women and men. American Journal of Critical Care 1 :28-35 
183 
Chapter 9 References 
Kirklin JW, Akins CW, Blackstone EH, et al (1991) ACC/AHA guidelines and 
indications for coronary artery bypass graft surgery. Circulation 83: 1125-1173 
Knaus WA, Zimmerman JE, Wagner DP, et al (1981) APACHE - Acute 
physiology and chronic health evaluation: a physiologically based classification 
system. Critical Care Medicine 9:591-597 
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985a) APACHE II: A 
severity of disease classification system. Critical Care Medicine 13: 818-829 
Knaus WA, Draper EA, Wagner DP, Zimmerman JE ( 1985b) Prognosis in acute 
organ-system failure. Annals of Surgery 202:685-693 
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1986) An evaluation of 
outcome from intensive care in major medical centers. Annals of Internal Medicine 
104 :410-418 
Knaus WA (1989) Prognosis with mechanical ventilation: the influence of disease, 
severity of disease, age, and chronic health status on survival from an acute illness. 
American Review of Respiratory Disease 140:S8-13 
Knaus WA, Rauss A, Alperovitch A, et al (1990) Do objective estimates of 
chances for survival influence decisions to withhold or withdraw treatment? 
Medical Decision Making 10: 163-171 
Knaus WA, Wagner DP, Draper EA, et al (1991a) The APACHE III prognostic 
system. Chest 100: 1619-163 6 
184 
Chapter 9 References 
Knaus WA, Wagner DP, Lynn J (1991b) Short-term mortality predictions for 
critically ill hospitalized adults: science and ethics. Science 254:389-394 
Knaus WA, Sun X, Nystrom P, Wagner DP (1992) Evaluation of definitions for 
sepsis. Chest 101: 1656-1662 
Knaus WA, Harrell FE, Fisher CJ, et al ( 1993 a) The clinical evaluation of new 
drugs for sepsis. A prospective study based on survival analysis. Journal of the 
American Medical Association 270:1233-1241 
Knaus WA, Wagner DP, Zimmerman JE, Draper EA (1993b) Variations in 
mortality and length of stay in intensive care units. Annals of Internal Medicine 
118:753-761 
Koch CG, Estafanous FG (1993) Anesthesia for coronary artery surgery. Current 
Opinion in Cardiology 8:897-909 
Kollef MH, Enzenauer RJ ( 1992) Predicting outcome from intensive care for 
patients with rheumatologic diseases. Journal of Rheumatology 19: 1260-1262 
Kollef MH, Schuster DP (1994) Predicting intensive care unit outcome with 
scoring systems. Underlying concepts and principles. Critical Care Clinics 10: 1-18 
Kraus PA, Lipman J, Lee CCJ, et al (1993) Acute lung injury at Baragwanath ICU. 
An eight-month audit and call for consensus for other organ failure in the Adult 
Respiratory Distress Syndrome. Chest 103: 1832-1836 
185 
Chapter 9 References 
Kreuzer E, Kaab S, Pilz G, Werdan K (1992) Early prediction of septic 
complications after cardiac surgery by AP ACHE II score. European Journal of 
Cardiothoracic Surgery 6:524-528 
Kruse JA, Carlson RW (1993) Severity of illness scoring: East meets West 
(Editorial). Critical Care Medicine 21 :647-648 
Kruse JA, Thill-Baharozian MC, Carlson RW (1988) Comparison of clinical 
assessment with AP ACHE II for predicting mortality risk in patients admitted to a 
medical intensive care unit. Journal of The American Medical Association 
260: 1739-1742 
Lanken PN ( 1994) Critical care at a new crossroads: the intersection of economics 
and ethics in the intensive care unit. American Journal of Respiratory and Critical 
Care Medicine 149:3-5 
Larvin M, McMahon MJ (1989) APACHE II score for assessment and monitoring 
of acute pancreatitis. Lancet ii :201-204 
Lee KH, Hui KP, Lim TK, Tan WC (1993) Acute physiology and chronic health 
evaluation (AP ACHE II) scoring in the Medical Intensive Care Unit, National 
University Hospital, Singapore. Singapore Medical Journal 34:41-44 
Le Gall JR, Loirat P, Alperovitch A ( 1984) A simplified acute physiology score for 
ICU patients. Critical Care Medicine 12:975-977 
186 
Chapter 9 References 
Le Gall JR ( 1991) Do we need a new severity score? Critical Care Medicine 
19:857-858 
Le Gall JR Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology 
Score (SAPS II) based on a European/North American multicenter study. Journal 
of the American Medical Association 270:2957-2963 
Lehmkuhl P, Jeck-Thole S, Pichlmayr I (1989) A new scoring system for disease 
intensity in a surgical intensive care unit. World Journal of Surgery 13:252-258 
Lemeshow S, Teres D, Pastides H, et al (1985) A method for predicting survival 
and mortality ofICU patients using objectively derived weights. Critical Care 
Medicine 13: 519-525 
Lemeshow S, Teres D, Avrunin JS, Pastides H (1987) A comparison of methods to 
predict mortality of intensive care unit patients. Critical Care Medicine 15: 715-722 
Lemeshow S, Teres D, Avrunin JS, Gage RW (1988) Refining intensive care unit 
outcome prediction by using changing probabilities of mortality. Critical Care 
Medicine 16:470-477 
Lemeshow S, Teres D, Klar J, et al (1993) Mortality Probability Models (MPM II) 
based on an international cohort of intensive care unit patients. Journal of the 
American Medical Association 270:2478-2486 
Levy DE, Bates D, Caronna JJ, et al (1981) Prognosis in nontraumatic coma. 
Annals oflnternal Medicine 94:293-301 
187 
Chapter 9 References 
Levy DE, Caronna JJ, Singer BH, et al (1985) Predicting outcome from hypoxic-
ischemic coma. Journal of the American Medical Association 253: 1420-1426 
Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ (1988) Prognosis of patients 
receiving intensive care for lifethreatening medical complications of haematological 
malignancy. British Medical Journal 296: 1025-1029. 
Lockrem JD, Lopez E, Gallagher J, et al (1991) Severity of illness: APACHE II 
analysis of an ICU population. Cleveland Clinic Journal of Medicine 58:477-486 
Loop FD, Berrettoni JN, Pichard A, et al (1975) Selection of the candidate for 
myocardial revascularization. A profile of high risk based on multivariate analysis. 
Journal of Thoracic and Cardiovascular Surgery 69:40-51 
Loop FD, Golding LR, MacMillan JP, et al (1983) Coronary artery surgery in 
women compared with men: analyses of risks and long-term results. Journal of the 
American College of Cardiologists 1 :383-390 
Luce JM, Raffin TA (1988) Withholding and withdrawal oflife support in critically 
ill patients. Chest 94: 621-626 
Luce JM, Wachter RM (1994) The ethical appropriateness of using prognostic 
scoring systems in clinical management. Critical Care Clinics 10:229-241 
Maher ER, Robinson KN, Scoble JE, et al ( 1989) Prognosis of critically-ill patients 
with acute renal failure: AP ACHE II score and other predictive factors. Quarterly 
Journal of Medicine 72:857-866 
188 
Chapter 9 References 
Mancebo J, Artigas A (1987) A clinical study of the adult respiratory distress 
syndrome. Critical Care Medicine 15 :243-246 
Manske CL, Wang Y, Rector T, et al (1992) Coronary revascularisation in insulin-
dependent diabetic patients with chronic renal failure. Lancet 340:998-1002 
McCormick JR, Schick EC, McCabe CH, et al ( 1985) Determinants of operative 
mortality and long-term survival in patients with unstable angina. Journal of 
Thoracic and Cardiovascular Surgery 89:683-688 
Marks RJ, Simons RS, Blizzard RA, Brown DRG (1991) Predicting outcome in 
intensive therapy units-a comparison of AP ACHE II with subjective assessments. 
Intensive Care Medicine 17: 159-163 
Marsh HM, Krishan I, Naessens JM, et al (1990) Assessment of prediction of 
mortality by using the AP ACHE II scoring system in intensive-care units. Mayo 
Clinic Proceedings 65: 1549-1557 
McAnena OJ, Moore FA, Moore EE, et al (1992) Invalidation of the APACHE II 
scoring for patients with acute trauma. Journal of Trauma 33:504-507 
McCabe WR, Jackson GG (1962) Gram-negative bacteremia: etiology and 
ecology. Archives oflnternal Medicine 110:847-855 
McClish DK, Powell SH ( 1989) How well can physicians estimate mortality in a 
medical intensive care unit? Medical Decision Making 9: 125-132 
189 
Chapter 9 References 
Meehl PE (1954) Clinical versus statistical prediction. University ofMinnesota 
Press, Minneapolis 
Merrill WH, Elkins CC, Stewart JR, et al ( 1993) Third-time coronary artery bypass 
grafting: midterm results. Annals of Thoracic Surgery 55:582-585 
Merry AF, Ramage MC, Whitlock RM, et al (1992) First-time coronary artery 
bypass grafting: the anaesthetist as a risk factor. British Journal of Anaesthesia 
68:6-12 
Meyer AA, Messick WJ, Young P, et al (1992) Prospective comparison of clinical 
judgement and AP ACHE II score in predicting the outcome in critically ill surgical 
patients. Journal of Trauma 32:747-753 
Mohan R, Amsel BJ, Walter PJ (1992) Coronary artery bypass grafting in the 
elderly - a review of studies on patients older than 64, 69, and 74 years. Cardiology 
80:215-225 
Moreau R, Soupison T, Vauquelin P, et al (1989) Comparison of two simplified 
severity scores for patients with acute myocardial infarction. Critical Care Medicine 
17:409-413 
Murray LS, Teasdale GM, Murray GD, et al ( 1993) Does prediction of outcome 
alter patient management? Lancet 341: 1487-1491 
190 
Chapter 9 References 
Nashef SAM, Carey F, Silcock MM, et al ( 1992) Risk stratification for open-heart 
surgery: trial of the Parsonnet system in a British hospital. British Medical Journal 
305: 1066-1067 
Naunheim KS, Fiore AC, Wadley JJ, et al (1988) The changing profile of the 
patient undergoing coronary artery bypass surgery. Journal of the American 
College of Cardiology 11 :494-498 
Naunheim KS, Barner HB, Fiore AC (1992) Update to "Results of internal 
thoracic artery grafting over 15 years: single versus double grafts". Annals of 
Thoracic Surgery 5 3: 716-718 
NIH Workshop summary ( 1986) Withholding and withdrawing mechanical 
ventilation. American Review of Respiratory Disease 134: 1327-1330 
Niskanen M, Kari A, Nikki P, et al ( 1991) Acute physiology and chronic health 
evaluation (AP ACHE II) and Glasgow Coma Scores as predictors of outcome 
from intensive care after cardiac arrest. Critical Care Medicine 19: 1465-14 73 
O'Connor GT, Plume SK, Olmstead EM, et al (1991) A regional prospective study 
of in-hospital mortality associated with coronary artery bypass grafting. Journal of 
the American Medical Association 266:803-809 
O'Connor GT, Plume SK, Olmstead EM, et al (1992) Multivariate prediction ofin-
hospital mortality associated with coronary artery bypass graft surgery. Circulation 
85:2110-2118 
191 
Chapter 9 References 
Oh TE, Hutchinson R, Short S, et al ( 1993) Verification of the Acute Physiology 
and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. 
Critical Care Medicine 1993;2 l :698-705 
Oldham HN, Kong Y, Bartel AG, et al (1972) Risk factors in coronary artery 
bypass surgery. Archives of Surgery 105:918-923 
Osaka S, Barratt-Boyes BG, Brandt PWT, et al (1988) Early and late results of 
reoperation for coronary artery disease: a 13 year experience. Australian and New 
Zealand Journal of Surgery 58:537-541 
Osborne ML (1992) Physician decisions regarding life support in the intensive care 
unit. Chest 101:217-224 
Osborne ML, Evans TW (1994) Allocation ofresources in intensive care: a 
transatlantic perspective. Lancet 343: 778-780 
Palazzo M, Patel M (1993) The use and interpretation of scoring systems in ICU. 
Part 2. British Journal oflntensive Care 7:286-289 
Palazzo M, Soni N, Hinds C (1993) Physiological scoring systems and audit 
(letter). Lancet 342:307 
Pallis C ( 1983) ABC of brain stem death. London, British Medical Journal Press 
Parno JR, Teres D, Lemeshow S, et al (1984) Two-year outcome of adult intensive 
care patients. Medical Care 22: 167-176 
192 
Chapter 9 References 
Parsonnet V, Fisch D, Gielchinsky I, et al ( 1988) Emergency operation after failed 
angioplasty. Journal of Thoracic and Cardiovascular Surgery 96: 198-203 
Parsonnet V, Dean D, Bernstein AD (1989) A method of uniform stratification of 
risk for evaluating the results of surgery in acquired adult heart disease. Circulation 
79(Suppl 1):3-12 
Pelletier C, Cosette R, Dontigny L, et al ( 1980) Determinants of mortality 
following coronary bypass surgery. Canadian Journal of Surgery 23: 199-204 
Perkins HS, Jensen AR, Epstein WV (1986) Providers as predictors: Using 
outcome predictions in intensive care. Critical Care Medicine 14: 105-110 
Pierpont GL, Kruse M, Ewald S, Weir EK (1985) Practical problems in assessing 
risk for coronary artery bypass grafting. Journal of Thoracic and Cardiovascular 
Surgery 89:673-682 
Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality 
(PRISM) score. Critical Care Medicine 16: 1110-1116 
Poses RM, Bekes C, Copare FJ, Scott WE (1989) The answer to "What are my 
chances, Doctor?" depends on whom is asked: prognostic disagreement and 
inaccuracy for critically ill patients. Critical Care Medicine 17:827-833 
Poses RM, McClish DM, Bekes C, et al (1991) Ego bias, reverse ego bias, and 
physicians' prognostic. Critical Care Medicine 19: 1533-1539 
193 
Chapter 9 References 
Prasad US, Walker WS, Sang CT, et al ( 1991) Influence of obesity on the early 
and long term results of surgery for coronary artery disease. European Journal of 
Cardiothoracic Surgery 5:67-72 
Rafkin HS, Hoyt NI (1994) Objective data and quality assurance programs. 
Current and future trends. Critical Care Clinics 10: 157-177 
Rahimtoola SH, Fessler CL, Grunkemeier GL, Starr A (1993) Survival 15 to 20 
years after coronary bypass surgery for angina. Journal of the American College of 
Cardiology 21: 151-157 
Ranson me, Ritkind KM, Roses DF, et al ( 1974) Prognostic signs and the role of 
operative management in acute pancreatitis. Surgery, Gynecology and Obstetrics 
139:69-81 
Rapoport J, Teres D, Lemeshow S, Harris D (1990a) Timing ofintensive care unit 
admission in relation to ICU outcome. Critical Care Medicine 18: 1231-1235 
Rapoport J, T eres D, Lemeshow S, et al ( 1990b) Explaining the variability of cost 
using a severity-of-illness measure for ICU patients. Medical Care 28:338-348 
Reiman AS (1988) Assessment and accountability: the third revolution in medical 
care. New England Journal of Medicine 319: 1220-1222 
Rhee KJ, Fisher CJ, Willitis NH (1987) The Rapid Acute Physiology Score. 
American Journal of Emergency Medicine 5:278-282 
194 
Chapter 9 References 
Rhee KJ, Baxt WG, Mackenzie JR, et al (1990) AP ACHE II scoring in the injured 
patient. Critical Care Medicine 18:827-830 
Ridley S, Biggam M, Stone P (1993) A cost-benefit analysis of intensive therapy. 
Anaesthesia 48: 14-19 
Rocca B, Martin C, Viviand X, et al (1989) Comparison of four severity scores in 
patients with head trauma. Journal of Trauma 29:299-305 
Rockwood K, Noseworthy TW, Gibney RTL, et al (1993) One-year outcome of 
elderly and young patients admitted to intensive care units. Critical Care Medicine 
21:687-691 
Roi LD, Flora JD, Davis TM, Wolfe RA (1983) Two new bum severity indices. 
Journal of Trauma 23:1023-1029 
Rosenfeldt FL, Wong J (1993) Current expectations for survival and complications 
in coronary artery bypass grafting. Current Opinion in Cardiology 8: 910-918 
Rothwell PM (1993) Physiological scoring systems and audit (letter). Lancet 
342:306 
Roumen RMH, Schers TJ, de Boer HHM, Goris RJA (1992) Scoring systems for 
predicting outcome in acute haemorrhagic necrotising pancreatitis. European 
Journal of Surgery 158:167-171 
195 
Chapter 9 References 
Rowan KM, Kerr JH, Major E, et al (1993) Intensive Care Society's APACHE II 
study in Britain and Ireland-II: Outcome comparisons of intensive care units after 
adjustment for case mix by the American AP ACHE II method. British Medical 
Journal 307:977-981 
Ruark JE, Raffin TA (1988) Initiating and withdrawing life support. Principles and 
practice in adult medicine. New England Journal of Medicine 318:25-30 
Rutledge R, Fakhry SM, Rutherford EJ, et al (1991) Acute Physiology and 
Chronic Health Evaluation (AP ACHE 11) score and outcome in the surgical 
intensive care unit: an analysis of multiple intervention and outcome variables in 
1,238 patients. Critical Care Medicine 19:1048-1053 
Sage WM, Rosenthal MH, Silverman JF (1986) Is intensive acre worth it?-An 
assessment of input and outcome for the critically ill. Critical Care Medicine 
14:777-782 
Salomon NW, Page US, Bigelow JC, et al (1990) Reoperative coronary surgery. 
Journal of Thoracic and Cardiovascular Surgery 100:250-260 
Sarmiento J, Torres A, Guardiola J, et al (1991) Statistical modeling of prognostic 
indices for evaluation of critically ill patients. Critical Care Medicine 19:867-870 
Schafer JH, Maurer A, Jochimsen F, et al (1990) Outcome prediction models on 
admission in a medical intensive care unit: do they predict individual outcome? 
Critical Care Medicine 18: 1111-111 7 
196 
Chapter 9 References 
Schafer JH, J ochimsen F, Keller F, et al ( 1991) Outcome prediction of acute renal 
failure in medical intensive care. Intensive Care Medicine 17: 19-24 
Schein M, Gecelter G (1989) APACHE II score in massive upper gastrointestinal 
haemorrhage from peptic ulcer: prognostic value and potential clinical applications. 
British Journal of Surgery 76:733-736 
Selker HP (1993) Systems for comparing actual and predicted mortality rates: 
characteristics to promote cooperation in improving hospital care (Editorial). 
Annals of Internal Medicine 118: 820-822 
Shapiro AR ( 1977) The evaluation of clinical predictions. A method and initial 
application. New England Journal of Medicine 296: 1509-1514 
Shoemaker WC (1989) Methodologic assessment of outcome. Critical Care 
Medicine 1 7: S 169 
Sinclair JR, Magee PT, Gould TH, Collins CH ( 1991) A comparison of AP ACHE 
II and a clinical sickness score. A study of 97 consecutive admissions to a District 
General Hospital Intensive Care Unit. Anaesthesia 46:442-446 
Slatyer MA, James OF, Moore PG, Leeder SR (1986) Costs, severity of illness and 
outcome in intensive care. Anaesthesia and Intensive Care 14:381-389 
Sleigh JW, Labusch D, Loose R, Chinyanga HM (1989) Abdominal sepsis: The 
identification of a high risk subgroup using the AP ACHE II system in twenty-seven 
patients. Central African Journal of Medicine 3 5 :410-413 
197 
Chapter 9 References 
Sleigh JW, Brook RJ, Miller M (1992) Time-dependent error in the AP ACHE II 
scoring system. Anaesthesia and Intensive Care 20:63-65 
Smedira NG, Evans BH, Grais LS, et al (1990) Withholding and withdrawal oflife 
support from the critically ill. New England Journal of Medicine 322:309-315 
Snyder N, McGuirk M, Grenvik A, Stickler D (1981) Outcome of intensive care. 
An application of a predictive model. Critical Care Medicine 9:598-603 
Spiegelhalter DJ ( 1992) Risk stratification for open heart surgery (letter). British 
Medical Journal 305:1500 
Spitzer WO, Dobson AJ, Hall J, et al (1981) Measuring the quality oflife of cancer 
patients: a concise QL-index for use by physicians. Journal of Chronic Diseases 
34:585-597 
Stern M, Waisbren BA (1978) Comparison of methods of predicting burn 
mortality. Burns 6: 119-123 
Suma H, Wanibuci Y, Terada Yet al (1993) The right gastroepiploic artery graft: 
clinical and angiographic midterm results in 200 patients. Journal of Thoracic and 
Cardiovascular Surgery 105:615-623 
Teasdale G, Jennett B ( 197 4) Assessment of coma and impaired consciousness. A 
practical scale. Lancet ii: 81-84 
198 
Chapter 9 References 
Teres D, Lemeshow S, Avrunin JS, Pastides H (1987) Validation of the mortality 
prediction model for ICU patients. Critical Care Medicine 15:208-213 
Teres D (1989) Peer review, publication policy, and APACHE. Critical Care 
Medicine 17: S 169-S 172 
Teres D (1993) Trends from the United States with end oflife decisions in the 
intensive care unit. Intensive Care Medicine 19:316-322 
Teskey RJ, Calvin JE, McPhail I ( 1991) Disease severity in the coronary care unit. 
Chest 100:1637-1642 
The International Neonatal Network (1993) The CRIB (clinical risk index for 
babies) score: a tool for assessing initial neonatal risk and comparing performance 
of neonatal intensive care units. Lancet 342: 193-198. 
Thibault GE, Mulley AG, Barnett GO, et al (1980) Medical intensive care: 
indications, interventions, and outcomes. New England Journal of Medicine 
302:938-942 
Tobin JN, Wassertheil-Smoller S, Wexler JP, et al (1987) Sex bias in considering 
coronary bypass surgery. Annals oflnternal Medicine 107:19-25 
Tuman KJ, McCarthy RJ, March RJ, et al (1992) Morbidity and duration of ICU 
stay after cardiac surgery. A model for preoperative risk assessment. Chest 102:36-
44 
199 
Chapter 9 References 
Turner JS, Potgieter PD, Linton DM ( 1988) Systems for scoring severity of illness 
in intensive care. South African Medical Journal 76: 17-20 
Turner JS, Mudaliar YM, Chang R WS, Morgan CJ ( 1991) Acute Physiology and 
Chronic Health Evaluation (AP ACHE II) scoring in a cardiothoracic intensive care 
unit. Critical Care Medicine 19: 1266-1269 
Van Lanschot JIB, Feenstra BWA, Vermeij CG, Bruining HA (1988) Outcome 
prediction in critically ill patients by means of oxygen consumption index and 
simplified acute physiology score. Intensive Care Medicine 14:44-49 
Vassar MJ, Wilkerson CL, Duran PJ, et al (1992) Comparison of APACHE II, 
TRISS, and a proposed 24-hour ICU point system for prediction of outcome in 
ICU trauma patients. Journal of Trauma 32:490-499 
Verheul HA, Moulijn AC, Hondema S, et al ( 1991) Late results of 200 repeat 
coronary artery bypass operations. American Journal of Cardiology 67:24-30 
Viviand X, Gouvernet J, Granthil C, Francois G (1991) Simplification of the SAPS 
by selecting independent variables. Intensive Care Medicine 17: 164-168 
Wagner DP, Knaus WA, Draper EA ( 1983) Statistical validation of a severity of 
illness measure. American Journal of Public Health 73:878-884 
Wagner DP, Knaus WA, Draper EA (1987) Identification oflow-risk monitor 
admissions to medical- surgical ICUs. Chest 92:423-428 
200 
Chapter 9 References 
Wasson lli, Sox HC, NeffRK, Goldman L (1985) Clinical Prediction rules. 
Applications and methodological standards. New England Journal of Medicine 
313:793-799 
Waters M, Nightingale P, Edwards JD (1990) A critical study of the APACHE II 
scoring system using earlier data collection. Archives of Emergency Medicine 
7:16-20 
Watters DAK, Wilson IH, Sinclair JR, Ngandu N (1989) A clinical sickness score 
for the critically ill in Central Africa. Intensive Care Medicine 15:467-470 
Weinstein ND (1989) Optimistic biases about personal risks. Science 246: 1232-
1233 
Weintraub WS, Craver JM, Cohen CL, et al ( 1991) Influence of age on results of 
coronary artery surgery. Circulation 84:(Suppl III)226-235 
Wilson C, Heath DI, Imrie CW (1990) Prediction of outcome in acute pancreatitis: 
a comparative study of AP ACHE II, clinical assessment and multiple factor scoring 
systems. British Journal of Surgery 77: 1260-1264 
Wisner DH (1992) History and current status of scoring systems for critical care. 
Archives of Surgery 127:352-356 
Wong DT, Knaus WA (1991) Predicting outcome in critical care: the current 
status of the APACHE prognostic scoring system. Canadian Journal of Anaesthesia 
38:374-383 
201 
Chapter 9 References 
Yeung H, Lu M, Martinez EG, Puri VK (1990) Critical Care Scoring System -
New concept based on hemodynamic data. Critical Care Medicine 18: 1347-1352 
Zimmerman JE, Knaus WA, Sharpe SM, et al (1986) The use and implications of 
do not resuscitate orders in intensive care units. Journal of the American Medical 
Association 255:351-356 
Zimmerman JE, Knaus WA, Judson JA, et al ( 1988) Patient selection for intensive 
care: A comparison of New Zealand and United States hospitals. Critical Care 
Medicine 16:318-326 
Zimmerman JE, Shortell SM, Knaus WA, et al (1993a) Value and cost of teaching 
hospitals: a prospective multicenter, inception cohort study. Critical Care Medicine 
21:1432-1442 
Zimmerman JE, Shortell SM, Rousseau DM, et al (1993b) Improving intensive 
care: observations based on organizational case studies in nine intensive care units: 
a prospective, multicenter study. Critical Care Medicine 21: 1443-1451 
Zoch G, Schemper M, Kyral E, Meissl G (1992) Comparison of prognostic indices 
for burns and assessment of their accuracy. Burns 18: 109-112 
202 
APPENDIX 1 
Submission for ethical approval 
SUBMISSION TO THE ETHICS COMMITTEE 
OF 
Appendix 1 
THE ROYAL BROMPTON NATIONAL HEART AND LUNG HOSPITAL 
1. Project Title 
OUTCOME PREDICTION IN CARDIOTHORACIC SURGERY. 
2. Principle Investigator(s) 
John Turner MMed (Cape Town) FCP (SA) 
Clifford Morgan FRCA 
3. Consultant(s) accepting medical responsibility 
Clifford Morgan FRCA 
4. Purpose of the study 
To develop a prognostic index for cardiothoracic surgery patients which may 
ultimately be used to help make decisions to withdraw therapy in hopeless cases. 
5. Type of study 
(new, sequel, modification, local, multicentre) 
New. 
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where you will recruit them from 
what are you inclusion criteria 
exclusion criteria (eg age, sex, pregnancy, risk of pregnancy during trial, breast 
feeding, current disease, previous disease, occupation, ability to comprehend, 
ability to comply, travel problems, loss of income) 
(i) Records of in-patients admitted to the AICU of the Royal Brompton National 
Heart and Lung Hospital. 
(ii) All patients undergoing cardiac surgery (CABG, valve replacements/repair, 
correction of congenital heart disorder). 
(iii) None. 
8. Design justification 
Introduction 
Responsible use of intensive care unit (ICU) facilities and cost containment are 
becoming more and more important and have even become political issues. We have 
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already shown that although mortality for cardiothoracic surgery patients is relatively 
low (4.6%), non-survivors stay in the ICU for a long time (mean of 9.8 days vs 2 days 
for survivors) and use a large amount of resources ( 1 ). Current predictors of mortality 
in cardiothoracic surgery patients are inadequate for making decisions to withdraw 
therapy in the individual patient (1 ). 
The AP ACHE II scoring system (2) performed in the first 24 hours of ICU admission 
cannot reliably estimate prognosis for the individual patient (and is not designed to do 
so). The Organ-system failure score (3 ), the AP ACHE II trend analysis ( 4) and the 
mortality prediction model ( 5) have all been relatively successful in this respect, but at 
a later stage in the patient's admission. The AP ACHE III score may be the most 
successful model yet, but due to the difficulties in predicting mortality in cardiothoracic 
surgical patients, it excludes them (6, 7), as does the mortality prediction model (5). 
More and more cardiac surgery is being performed on higher-risk patients, many of 
whom will do poorly. There is thus a need to develop a better prognostic system for 
these patients. 
Materials and method 
This prospective study will be carried out in the Adult ICU at the Royal Brampton 
National Heart and Lung Hospital, London. The need for informed consent to enter 
the study will be requested to be waived by the Ethics Committee of the hospital, as 
this is purely observational data collection. All patients undergoing cardiac surgery 
will be consecutively entered into the study. Demographic data, medical histories, 
physiological data (starting at the induction of general anaesthesia), and laboratory 
investigations will be collected from clinical records, the CareVue 9000 system, and 
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the McDonnell Douglas network and will be entered ( or downloaded) into a 
microcomputer database. The Parsonnet Score (8) will be used to assess preoperative 
status. Patients will be followed up to hospital discharge to determine survival. 
Analysis 
Data will be simultaneously analysed in a variety of ways. Firstly tests of association 
of each of the data variables with mortality will be carried out. Then discriminant 
function analysis and multiple logistic regression analysis will be used to find the best 
predictive variables. The systems developed from these analyses will be further refined 
as the database expands. The area under receiver-operating characteristic curves will 
be used to determine the accuracy of prediction of each analytical method. 
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9. Resources 
Is any commercial organisation facilitating this study by the provision of: 
(i) staff (specify) 
(ii) drugs 
(iii) equipment 
(iv) finance of any kind 









route of administration 
frequency 
dosage 
stage ofCSM evaluation 






What else will be done to your subjects/patients that 1s extra to normal clinical management? Please 



















cardiovascular catheters / indwelling lines 
other invasive procedures (eg bronchoscopy) 
rmagmg 
biopsies (sites, method, size, number) 
anaesthetics 
involvement in other concurrent trials 
denial or withholding of conventional treatment 
temp/permanent withdrawal of current therapy 
agreement on indemnity 
agreement on statistical analysis 
agreement on publication 
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your control procedures on normal subjects 
your test procedures in normal subjects 
your control procedures in patients 
your test procedures in patients 
What are the potential benefits to your patients? 
What are the potential benefits to others? 
Appendix 1 
16. Please enclose a copy of your consent form for healthy volunteers and/or 
patients 
Not applicable. 
17. Informing the subjects and patients' general practitioners 
Not applicable. 
18. Untoward events 
Not applicable. 




20. Date of application 
18/01/1993 
21. Starting date of study 
January 1993 
22. Sponsors signature 
Not applicable. 
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